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Abstract 
Stimulating muscle metaboreceptive afferents alone via post exercise circulatory occlusion 
(PECO) typically does not result in hyperpnea in healthy humans. However ventilatory 
responses have been observed if metabolite accumulation is great enough (e.g. in diseased 
states) or during a concurrent hypercapnia-induced chemoreflex, suggesting a possible 
synergistic interaction. This thesis investigated the ventilatory responses to interactions 
between muscle afferent feedback and potentially synergistic inputs. It was firstly 
observed that muscle metabo/mechanoreflex activation (via PECO and passive muscle 
stretch, respectively) increases ventilation but only during acute hypercapnia. Additional 
investigations suggested that these ventilatory responses were caused by a central 
interaction, possibly between the medullary input from muscle afferents and central 
chemoreceptors. Secondly, experimental augmentation of the muscle metaboreflex 
enhances the ventilatory response during exercise, but not during PECO, suggesting 
interactions between the metaboreflex and other inputs activated in exercise. Lastly, PECO 
caused increased ventilation in COPD patients but this was unrelated to chronic 
hypercapnia. Collectively these findings suggest that in health, muscle 
metabo/mechanoreflex stimulation induces ventilatory responses, but their effects only 
appear to be unmasked in combination with secondary synergistic inputs. However, when 
the metaboreflex is powerful enough, arguably such as in COPD, ventilatory responses to 
metaboreceptor stimulation alone can be observed.   
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ABBREVIATIONS 
ANOVA = analysis of variance 
ASIC = acid-sensing ion channel 
ATP = adenosine triphosphate 
BP = blood pressure 
BECF = brains extracellular fluid 
BTPS = body temperature and pressure, saturated 
CHF = chronic heart failure 
CNS = central nervous system 
CO = circulatory occlusion 
CO2 = Carbon dioxide 
COPD = chronic obstructive pulmonary disease 
DBP = diastolic blood pressure 
ECG = electrocardiogram 
Ex = exercise 
Ex L = exercise of the left leg 
Ex R = exercise of the right leg 
GABA = gamma-aminobutyric acid 
GOLD = global initiative for chronic lung disease   
H
+
 = hydrogen ion/proton 
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H2PO4
- 
= diprotonated phosphate 
HCO3 = Bicarbonate 
HR = heart rate 
IRTX = iodoresinaferatoxin  
K
+ 
= potassium ion 
Kinin B2 = Bradykinin receptor 
MAP = mean arterial blood pressure 
mmHg = millimetres of mercury 
MSNA = muscle sympathetic nerve activity 
MVC = maximal voluntary contraction 
NTS = nucleus tractus solitarius 
P1 = purinergic 1 
P2X = purinergic 2X 
P2Y = purinergic 2Y 
PaCO2 = partial pressure of arterial carbon dioxide  
PAG = periaqueductal grey area 
PaO2 = partial pressure of arterial oxygen 
PECO = post-exercise circulatory occlusion 
PECO (L) = post-exercise circulatory occlusion of the left leg 
PECO (R & L) = post-exercise circulatory occlusion of the right and left legs 
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PECO (R) = post-exercise circulatory occlusion of the right leg 
PETCO2 = partial pressure of end-tidal carbon dioxide 
PLP = pyridoxal-5-phosphate 
PPADS = pyridoxal phosphate-6-azophenyl-2’,4’-disulfonic acid 
RRI = R-R interval 
SBP = systolic blood pressure 
SD = standard deviation 
SEM = standard error of the mean 
SNS = sympathetic nervous system 
TRPA1 = transient receptor potential A1 channel 
 
TRPv1 = Transient receptor potential vanilloid 1 receptor 
OCO2 = carbon dioxide production 
O = minute ventilation 
OO2 = oxygen consumption 
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1.1 Neural structures controlling ventilation at rest 
The respiratory neurones within the pons and medulla of the brainstem control breathing 
by generating and maintaining the respiratory rhythm, integrating sensory inputs and also 
relaying signals to the respiratory muscles. Respiratory neurones can be categorised based 
upon their location and each group provide different functions (West, 2008). Within the 
medulla are two identifiable areas. Dorsal respiratory group neurones (which is composed 
of cells in the nucleus tractus solitarii; NTS) are thought to be primarily responsible for the 
generation of inspiration and for receiving and processing sensory inputs from arterial 
chemoreceptors and baroreceptors. The ventral respiratory group regulates expiration as 
well as inspiration secondarily to the dorsal respiratory group. Finally, neurones in the 
pneumotaxic centre (pontine respiratory group) and apneustic centre, of the upper and 
lower pons respectively, can coordinate the transition between inhalation and exhalation 
by regulating inspiratory depth. Although there is an incomplete understanding in how 
respiratory rhythm is generated, two locations in the rostral ventrolateral medulla contain 
neurones with pacemaker like properties; the pre-Bötzinger complex (Smith et al., 1991) 
and the parafacial respiratory group (Onimaru & Homma, 2003), and there is evidence that 
these groups separately regulate inspiration and expiration, respectively (Janczewski & 
Feldman, 2006). For a review see Feldman et al. (2013). 
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Respiratory receptors. 
Several receptors project to the respiratory control centres of the brainstem and alter 
respiratory function (West, 2008). The integration of these separate inputs primarily aims 
to preserve arterial blood gas tensions and pH, and/or also to protect the health and 
physical condition of the respiratory airways and lungs.  
 
Figure 1.1 Respiratory centres in the brainstem. Left, dorsal view of the medulla and pons 
with cerebellum removed; Right, transverse sections of the medulla at three different 
levels. PRG, pontine respirtory group; PreBot, pre-Bötzinger complex; VRG, ventral 
respiratory group; DRG, dorsal respiratory group; IX cranial nerve (glossopharyngeal); X 
cranial nerve (vagus); NTS nucleus tractus solitarius; CC, central canal. (Powell Jr, 2003) 
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Upper-airway, tracheal, bronchial and lung receptors 
Receptors within the upper airways located in the nasal passage, pharynx, larynx and 
trachea are stimulated by both chemical and mechanical stimuli and elicit reflexes such as 
sneezing, coughing and bronchoconstriction to protect the lower portions of the respiratory 
tract (West, 2008). Similarly, the rapidly adapting pulmonary receptors (or irritant 
receptors) located between airway epithelial cells are stimulated by dust, cold air, noxious 
gases and also mechanical stimuli and elicit reflex responses such as bronchoconstriction 
and increases in ventilation.  
The slowly adapting pulmonary stretch receptors are mechanoreceptors found in the 
smooth muscle of airways and are stimulated by lung inflation. These receptors are 
responsible for the Hering-Breuer reflex, which is the reflex inhibition of inspiration from 
lung over-inflation. This reflex is thought to be unimportant in adult humans unless tidal 
volume increases above resting levels such as in exercise (Richerson & Boron, 2005). 
Juxtacapillary receptors or J-receptors are the free nerve endings of non-myelinated C 
fibres (group IV fibres), which are located in the alveolar walls close to capillaries. These 
receptors are stimulated by both chemical and mechanical stimulation, resulting in a reflex 
response of rapid shallow breathing, bronchoconstriction and increased secretion of mucus 
into the airways (Richerson & Boron, 2005).  Similarly bronchial C-fibres respond to 
chemical stimulation which also results in rapid shallow ventilation, mucus secretion and 
bronchoconstriction.  
 
Arterial Baroreceptors 
The arterial baroreceptors, located in the aortic arch and carotid sinuses, are 
mechanoreceptors and are primarily responsible for maintaining blood pressure 
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homeostasis. These receptors detect changes in pressure and signal information via the 
glossopharyngeal and vagus nerves  back to areas of the brainstem such as the NTS (Paton 
et al. 1999), which results in reflex changes in autonomic output to the heart and 
vasculature and the maintenance of blood pressure (the baroreflex). However, the neural 
feedback from arterial baroreceptors also alters the drive to ventilation (Heistad et al. 
1974, 1975; De Burgh Daly, 1997; Stewart et al. 2011). For example Stewart et al. (2011) 
demonstrated that when blood pressure is acutely changed, using the modified Oxford 
technique (bolus administrations of sodium nitroprusside and then phenylephrine) 
ventilation changes in an inverse relationship with blood pressure.  So increases in blood 
pressure not only reflexly reduce heart rate and total peripheral resistance but also 
suppresses ventilation.  
 
Peripheral chemoreceptors 
Multiple peripheral sites responsible for chemoreception have been identified and include 
the aortic body (located on the aortic arch) and the carotid body, with the latter widely 
considered as the most important (Prabhakar & Peng, 2004). The carotid bodies are highly 
vascularised bilateral organs located at the bifurcation of the carotid artery. The glomus 
type 1 cells of the organ, which are their primary site of chemoreception, are innervated by 
the carotid sinus branch of the glossopharyngeal nerve and neural signals are relayed to the 
NTS (Donoghue et al. 1984; Gonzalez et al. 1994). The carotid bodies sample the 
composition of arterial blood before it reaches the brain and are sensitive to changes in 
PO2, PCO2 and pH. It initiates rapid reflex ventilatory responses in order to maintain 
homeostasis of arterial blood gas composition. The sensory responses of the carotid bodies 
are fast allowing the detection of the breath to breath changes and oscillations in arterial 
blood gas composition.   
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Central chemoreceptors 
Arterial PCO2 is the most sensitively regulated variable in the control of ventilation and 
the central chemoreceptors are its primary regulator. These chemoreceptors respond to 
changes in H
+
 concentration in brain extracellular fluid (BECF). H
+
 concentration in the 
BECF increases when arterial PCO2 increases. Unlike H
+
, CO2 can freely diffuse across 
the blood brain barrier, so an increase in arterial PCO2 results in a proportional increase of 
the PCO2 in BECF, cerebral spinal fluid and inside brain cells. This results in the acidosis 
of these compartments due to the liberation of H
+ 
(Richerson & Boron, 2005). The 
following stimulation of the central chemoreceptors causes increases in ventilation and the 
maintenance of arterial PCO2 homeostasis. It was thought that these receptors sensitive to 
CO2/H
+
 are located near the ventral medullary surface (Loeschcke, 1982). It has since been 
shown that there are several possible individual receptor sites in the brain and include, 
among others, the retrotrapezoid nucleus, the NTS, the locus coeruleus, the medullary 
raphė, the periaqueductal grey (PAG) and the pre-Botzinger complex and Li et al. 1999; 
Nattie & Li, 2001, 2002; Feldman et al. 2003; Takakura et al. 2006; Krause et al. 2009; 
Putnam et al. 2010, Lopes et al. 2012) 
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1.2 The cardio-respiratory responses to exercise 
Exercise places a complex and powerful stress upon the ventilatory and cardiovascular 
systems as they attempt to meet the demands for greater oxygen delivery and carbon 
dioxide disposal from the working muscles. These demands will be met if alveolar 
ventilation increases proportionately to metabolic rate and if skeletal muscle blood flow is 
rapidly enhanced in order to deliver the required oxygen and nutrients to the exercising 
muscle.  
It has been well established that the cardiovascular responses to dynamic and static 
exercise are mediated by the autonomic nervous system, where sympathetic nerve activity 
increases and parasympathetic activity is withdrawn. Dynamic exercise results in intensity 
dependent increases in heart rate, stroke volume and cardiac output but only moderate 
increases in blood pressure as total periphery resistance may reduce. All together the 
hemodynamic alterations results in the increase of blood flow to the working muscles 
(Rowell, 1993). During static exercise however muscle blood flow is reduced due to the 
large sustained increases in intramuscular pressure. Therefore the heart rate mediated 
increase in cardiac output combined with a small or no change in total peripheral 
resistance results in a marked increase in blood pressure, which attempts to maintain 
perfusion of the muscle (Rowell, 1993). The neural control mechanisms behind these 
responses have been well demonstrated and include central command, the arterial 
baroreflex and the feedback from skeletal muscle afferents (Kaufman & Forster, 1996; 
Fisher & White, 2004; Smith et al. 2006; Williamson et al. 2006, Murphy et al. 2011; 
Basnayake et al. 2012), all of which converge and integrate into areas in the brainstem 
related to cardiovascular control such as the NTS (Paton, 1999). Neural projections from 
these centres relay to the heart, blood vessels and adrenal medulla so that appropriate 
cardiovascular responses to exercise are produced (Figure 1.1) 
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Figure 1.2 Neural cardiovascular control during exercise. Neural signals originating from 
the brain (central command), the aorta and carotid arteries (arterial baroreflex), and 
skeletal muscle (exercise pressor reflex) are known to modulate sympathetic and 
parasympathetic nerve activity during exercise (from Smith et al. 2006) 
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Despite the poor understanding of the control mechanisms behind the exercise hyperpnea, 
the ventilatory responses to exercise have been well described. In isometric exercise the 
increase in ventilation is related to the degree of muscle tension, where static contractions 
performed at higher intensities (% of the maximal voluntary contraction; MVC) results in 
significantly greater ventilatory responses (Imms & Mehta, 1989; Fontana et al. 1993, 
Iellamo et al. 1999). The magnitude of the ventilatory response is also related to the size of 
the muscle mass involved. The isometric exercise of larger muscle masses (handgrip 
exercise v.s. knee extensions) at the same relative intensity, but greater absolute intensity, 
elicits larger increases in ventilation (Iellamo et al. 1999). Furthermore fatiguing high 
intensity isometric exercise is associated with increases in ventilation which are 
disproportionately higher than metabolic rate and so can result in significant reductions in 
PETCO2 (Imms & Mehta, 1989).  
The magnitude of the ventilatory response to dynamic exercise is also dependent on 
exercise intensity and at a constant work rate the response appears to comprise of three 
distinct phases (Figure 1.2, Bennet et al. 1981; Whipp et al. 1982; Wasserman and Whipp 
1983; Casaburi et al. 1989). At the onset of exercise ventilation increases immediately 
(first phase) and after a transient plateau it continues to rise exponentially (second phase) 
until a steady state is reached (third phase). This steady state can be achieved within 2 to 3 
minutes of light to moderate intensity exercise, but during heavy exercise steady state is 
not achieved as ventilation continues to elevate until exhaustion (Casaburi et al. 1989). At 
moderate work rates the increases in oxygen consumption (OO2) and carbon dioxide 
production (OCO2) have a similar pattern to that of ventilation, although OO2 kinetics can 
be faster in phase two (Wasserman & Whipp 1983). Similarly to ventilation however, a 
steady state in OO2 and OCO2 is not achieved in phase three of heavy exercise (Casaburi et 
al. 1989). The key characteristic of the hyperpnea to light-moderate exercise is that at 
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steady state, the increase in ventilation is in proportion with OO2 and OCO2, whereas in 
heavy exercise ventilation increases comparatively more. 
 
 
 
 
Figure 1.3 Minute ventilation (O) during steady-state exercise, at a light to moderate 
intensity). The period of exercise is shaded in grey. The ventilatory responses to exercise can 
be separated into three distinct phases (I, II and III).  
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1.3 Control of the exercise hyperpnea 
Haldane & Priestley (1905) were among the first to show that the increase in pulmonary 
ventilation during moderate intensity exercise was in exact proportion to the increase in 
metabolic rate (as indexed by OCO2). It was suggested that during exercise an increase in 
arterial PCO2 (from the increased OCO2) would stimulate chemoreceptors and so link 
ventilation to metabolic rate. However, there is considerable evidence that suggests that 
the exercise hyperpnea is not driven by alterations in the PCO2 stimulus. 
Firstly the increase in metabolic rate during light and moderate exercise is so precisely 
matched by ventilation that arterial PCO2 does not change significantly from resting levels 
(first shown by Douglas & Haldine, 1909). In general a small transient hypocapnia is often 
observed at the onset of exercise, and during steady state light-moderate exercise PaCO2 
only changes at most by 1-3 mmHg from resting levels (Barr et al. 1964; Forster et al. 
1986). Preventing hypercapnia in spite of the large increase in OCO2 characteristic of 
exercise is an impressive accomplishment of the respiratory system given that its most 
tightly controlled variable, PaCO2/H
+
, does not provide an error signal for the central 
and/or peripheral chemoreceptors to trigger a reflex increase in ventilation. Furthermore 
during exercise at a heavy intensity and the concurrent lactic acidosis, phase three (figure 
1.2) can be characterised by a slow yet continuous increase in ventilation despite carbon 
dioxide clearance rate exceeding metabolic rate and the consequential decline in arterial 
PCO2 (Forster et al. 1986; Stringer et al. 1992; Sun et al. 2001). The most obvious and 
widely accepted mechanism for this hyperventilation is the lactic acid/H
+
, produced from 
anaerobic metabolism, stimulating carotid chemoreceptors, but the issue is still 
controversial and several other mechanisms may contribute (see Forster et al. 2012 for 
review). 
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Secondly, it is possible that the gain of the chemoreceptors increases in exercise so the 
same stimulus level (PaCO2/H
+
) results in greater receptor output. However the weight of 
evidence suggests that CO2 inhalation only has an additive effect on the exercise 
hyperpnea, with no observable changes in CO2 sensitivity (Asmussen & Nielson, 1957; 
Clark et al. 1980; Duffin et al. 1980; Poon et al. 1987).  
Third, if error signals are not provided by alterations in PaCO2 it is possible that the 
increases in venous PCO2 during exercise may provide an error signal for hypothetical 
mixed venous chemoreceptors. This would be the ideal mechanism to match metabolic rate 
with ventilation. However the infusion of hypercapnic blood into the right atrium or 
pulmonary artery of dogs only increases ventilation once the blood has passed through the 
pulmonary circulation and stimulates arterial chemoreceptors (Cropp & Comroe, 1961; 
Sylvester et al. 1973). Additionally in humans, when the circulation to exercising muscles 
becomes free flowing after a period of occlusion there is a significant lag time between 
inflections of PETCO2 and minute ventilation (Stanley et al. 1985), again implying the 
apparent absence of mixed venous chemoreceptors.   
Finally, the increase in ventilation immediately at the onset of exercise occurs too rapidly 
for it to be caused by the slow development of chemical factors in arterial or even venous 
blood (Krogh & Lindhard, 1913, 1917). It is therefore likely that the ventilatory response, 
in phase 1 at least, is triggered by a fast neural mechanism.  
So what is/are the mechanism/s responsible for signalling ventilation to increase 
immediately at the onset of exercise and in proportion to metabolic rate? To date no single 
postulated mechanism has proven to account for the entire ventilatory response. However, 
several mechanisms have been proposed which may be capable of stimulating ventilation 
in exercise (for review see Turner et al. 1991; Kaufman & Forster 1996; Waldrop et al. 
1996; Forster et al. 2012). These include other humoral mechanisms where stimulation of 
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the peripheral chemoreceptors could mediate a hyperpnea: 1) the workload dependent 
increases in arterial plasma potassium ([K
+
]) released from exercising muscles (Paterson, 
1992) or 2) increases in the amplitude/slope of the breath-to-breath oscillations of 
PaCO2/H
+
, which may provide a signal for an exercise hyperpnea despite the maintained 
mean PaCO2 (Yamamoto et al. 1960, Band et al. 1969, 1980). However the evidence for 
both of these hypotheses and the size of their relative contributions to the exercise 
hyperpnea remains controversial (Forster et al. 1989; Warner & Mitchell, 1990; Nye, 
1994; Kaufman & Forster, 1996). 
This review and thesis is concerned with examining the role played by neural feedback 
from metabolically and mechanically sensitive skeletal muscle afferent fibres, which is an 
attractive mechanism as it could hypothetically provide a stimulus at the onset of exercise 
and an error signal for steady-state ventilation to match metabolic rate. However the 
mechanism which currently seems to have the most convincing supportive data is that of 
central command, the evidence for which is briefly examined below. As such it is widely 
regarded to have the capacity to drive cardiorespiratory responses in exercise (Waldrop et 
al. 1996).  
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1.4 Central command – cardio-respiratory control in exercise 
The feedforward control mechanism known as central command consists of descending 
neural signals from higher brain centres, that excite locomotor neurones during exercise, 
concurrently converging onto cardiovascular and respiratory control areas of the brainstem 
to meet the anticipated demands of the exercising muscles. Thus there is a simultaneous 
excitation of those neuronal circuits containing locomotor neurones and also 
cardiorespiratory medullary neurones leading to the modulation of the sympathetic and 
parasympathetic output to blood vessels and the heart and to the motor output to 
respiratory muscles. However it has been a continual challenge for physiologists to 
definitively examine the concept of central command as a cardiorespiratory control 
mechanism. 
The central command hypothesis was first established from the work of Johansson (1895) 
and Krogh & Lindhard (1913, 1917). Krogh & Lindhards (1913) experiments were the 
first performed on humans and proposed that the concept of “cortical irradiation” (central 
command) caused the immediate ventilatory and heart rate increases observed at the 
beginning of exercise, and were responsible for the altered cardio-respiratory responses to 
changes in perceived load of a cycling exercise. Furthermore Krogh & Lindhard (1917) 
demonstrated that at the onset of electrically induced leg exercise, where central command 
is absent, the increase in heart rate is delayed. Although these results clearly demonstrate 
that other mechanisms must be capable of producing the tachycardia, albeit slightly 
delayed (e.g. reflexes from the peripheral muscle), they do suggest that mechanisms of a 
central origin also plays a role. 
Over many years, a wide variety of techniques have been used to study the role of central 
command in ventilatory and cardiovascular control. In general these studies fall into two 
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categories: 1) where the level of central command during exercise is manipulated, and 2) 
where attempts have been made to identify neural regions that may provide the drive to 
locomotor and cardiorespiratory control centres in exercise. 
 
Altering the level of central motor drive required to perform an exercise task          
Goodwin et al. (1972) used the technique of tendon vibration to manipulate the levels of 
central command required to perform a particular muscular action. During isometric 
exercise of the biceps or triceps brachii a vibrator was applied to the tendon of either the 
exercising muscle or its antagonist. Vibration is a stimulus for muscle spindle afferent 
endings and reflexly elicits tension in the muscle. Vibrating the tendon of the exercising 
muscle would therefore reduce the level of central command required to produce a given 
tension within the muscle and vibrating the tendon of the antagonist would increase it. As 
such the ventilatory and cardiovascular responses to the isometric exercise was greater 
when the level of central command was increased and these responses increased less when 
central command was reduced. Crucially the same muscle tension was produced during the 
exercise with and without vibration, so it appears that the altered responses were due to 
differences in central command involvement. 
Several studies have used the method of partial neuromuscular blockade (induced by 
curare) to examine the role of central command. Asmussen et al. (1965) and Galbo et al. 
(1987) demonstrated in humans that a partial curarization produced a greater response in 
ventilation, pulse rate and blood pressure during exercise. It is likely that the augmented 
cardio-respiratory responses to exercise reflect the greater central command activation 
needed to maintain the constant workload in the weakened muscles. In addition Innes et al. 
(1992) analysed the ventilatory and cardiovascular responses to single legged cycling 
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exercise in patients suffering from unilateral leg weakness caused by either orthopaedic or 
neurological disorders. It was shown that exercise with the weak leg produced exaggerated 
ventilatory and cardiovascular responses to achieve a given workload. These results 
provide evidence, albeit indirect, for the concept of central command as they demonstrate 
that the magnitude of the central drive affects cardio-respiratory responses to exercise.  
 
Identifying the neural structures and neurocircuitry involved in central command  
Several investigations with animals have electrically stimulated regions of the brain to 
locate possible areas involved in the parallel activation of locomotion and the 
cardiorespiratory systems. Using unanaesthetized decorticate cats Eldridge et al. (1981) 
was able to induce locomotion through electrical stimulation of the hypothalamic site 
called the subthalamic locomotor region, which resulted in respiratory and blood pressure 
responses similar to that of spontaneous exercise. Crucially, similar responses were 
generated when “fictive” locomotion was induced in paralysed cats, ruling out the factor of 
neural feedback from the exercising muscles. These results were subsequently confirmed 
(Eldridge et al. 1985; Waldrop et al. 1988) with the pharmacological stimulation of 
neuronal cell bodies in the subthalamic locomotor regions with picrotoxin (antagonist of 
the inhibitory neurotransmitter GABA) which produced similar responses even during 
fictive locomotion. 
Other decorticate animal studies have also demonstrated that the electrical stimulation of 
various areas of the brain, including the thalamus, hypothalamus, the basal ganglia and 
mesencephalic locomotor region (MLR), can also induce locomotion and also ventilatory 
and cardiovascular responses similar to spontaneous exercise (Smith et al. 1960; DiMarco 
et al. 1983; Ordway et al. 1989; Angyan, 1991; Bedford et al., 1992). These results are 
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consistent with the concept of central command as a locomotor/cardiorespiratory control 
mechanism during exercise (in animals at least) and provides evidence that these 
subcortical structures could theoretically be involved in its neurocircuitry. They also imply 
that the involvement of other mechanisms such muscle afferent feedback may not be 
essential for normal cardiorespiratory responses. However their involvement of course 
cannot be ruled out particularly as hypothalamic lesioning seems to have no effect on the 
cardiorespiratory responses to exercise in the awake animal (Waldrop et al. 1986), 
suggesting an element of redundancy is the system. 
In addition, functional neurosurgery has made it possible to electrically stimulate regions 
of the brain in awake humans. Those undergoing surgery for movement disorders or 
chronic pain have deep brain stimulating electrodes implanted stereotaxically into the 
relevant areas of the midbrain. This procedure not only allows the stimulation of these sites 
but can also provide information regarding their neural activity by recording local field 
potentials (below). It has been shown that stimulation of the subthalamic nucleus, thalamus 
and substantia nigra all result in significant increases in heart rate and mean arterial 
pressure (Thornton et al. 2002). Furthermore Green et al. (2005) found that the stimulation 
of ventral and dorsal periventricular/periaquital grey matter results in a decrease and 
increase in blood pressure, respectively. Although respiratory measurements could not be 
made in these studies, the findings indicate that these subcortical regions of the brain may 
be involved in the neurocircuitry of central command in humans.  
However, one must be cautious with the interpretation of these findings in relation to 
central command in exercise. Although these structures may form part of a relay system to 
the respiratory and cardiovascular control centres in the brainstem, “their role has to be 
viewed in context with the higher centres that are responsible for initiating exercise” 
(Thornton et al., 2002). So although electrical/chemical stimulation of these areas can 
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induce cardiorespiratory responses, it is not possible to determine whether their stimulation 
is analogous to activation of these pathways during normal exercise.   
As such various techniques have been used to establish regions of the brain that are active 
during exercise. For example in rats, areas active during exercise have been identified 
using the immunocytochemical labelling of c-fos, where its expression was used as a 
marker for neural activity (Iwamoto et al. 1996). After dynamic exercise on a treadmill 
there was increased activation of hypothalamic and mesencephalic locomotor regions, the 
periaqueductal gray matter (PAG) as well as the NTS, and the rostral and caudal 
ventrolateral medulla. These results appear to support the findings of those studies 
discussed above that used electrical/chemical stimulation techniques. 
Extensive work has also been conducted in humans during exercise. Using positron 
emission tomography to record changes in the regional cerebral blood flow Thornton et al. 
(2001) analysed the areas of increased brain activity during imagined exercise under 
hypnosis. The advantage of imagined exercise is that any cardiorespiratory responses 
and/or alterations in regional cerebral activity will not be altered by peripheral feedback 
from the muscles. When the hypnotised subjects were asked to imagine exercising on a 
bicycle an increase in ventilation and heart rate was observed, and is consistent with the 
concept of central command. Furthermore several motor areas of the brain were also 
shown to be activated during the imagined exercise (e.g. dorsolateral prefrontal cortex, the 
primary and supplementary motor areas, cerebellum), as they are in voluntary exercise 
(Fink et al. 1995). These areas are known to be involved with motor control including the 
volitional control of respiratory muscles (Colebatch et at., 1991; Ramsay et al. 1993) and 
as such these structures could be part of a central command mechanism which mediates 
the exercise hyperpnea. 
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In addition these findings might support the notion that the central command mechanism 
for ventilatory control incorporates a learned component. Because the respiratory 
responses to the imagined exercise might be driven by neurocircuitry involved in 
locomotion and voluntary respiratory control, and that the “dorsolateral prefrontal cortex is 
crucial in actions generated on the basis on working memory” (Thornton et al. 2001), it 
could mean that the feed-forward control of ventilation in exercise is based upon 
previously learned information and practice in producing suitable ventilatory responses to 
exercise. Indeed it was concluded by Thornton et al. that “these areas may encode a 
respiratory motor programme (central command) that evolves as the motor task is learnt in 
development, interacting with classical error signals in real exercise”.  
The regulation of breathing from memory can also be called long term modulation (LTM). 
In humans the LTM of breathing has been demonstrated where by the exercise hyperpnea 
under normal conditions is augmented after subjects repeatedly exercised with increased 
internal dead space (Wood et al., 2003) or increased respiratory resistance (Turner & 
Stewart, 2004). These results may provide insight into how a feed-forward mechanism that 
regulates ventilation could be calibrated by sensory feedback (in this case from repeated 
increases in chemoreceptor activity), so it can learn to more closely match the respiratory 
response with metabolic rate.       
The results from Thornton et al. also imply that a central command response may not 
necessarily require the concurrent activation of a central motor command but perhaps the 
sense of effort drives the response. This idea was further demonstrated by Williamson et 
al. (2001, 2002) also using hypnoses techniques so participants imagined performing 
cycling or handgrip exercise respectively. When performing exercise it was demonstrated 
that in those with high ‘hypnotisability’, imagining the exercise resulted in significant 
increases in heart rate and blood pressure. Therefore it is possible that central commands 
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control of the cardiorespiratory system does not require the parallel activation of 
locomotor systems, but in fact central command in exercise may involve the concurrent 
activation of two separate networks; the locomotor system and the cardiorespiratory 
systems.  
More recently Green et al. (2007) examined the neural activity of subcortical regions of 
the brain during exercise by recording local field potentials with deep brain stimulating 
electrodes. In anticipation to and during a low intensity (15W) pedalling exercise PAG 
activity increased. It was concluded that this area is possibly an important site in the 
control of the cardiorespiratory system during exercise and perhaps acts as a relay centre 
for central command from higher brain centres to cardiorespiratory neurones in the 
medulla. Furthermore the activity of the PAG increases during skeletal muscle afferent 
activation (via post-exercise circulatory occlusion, Basnayake et al. 2011) signifying that 
this site may be also be important in integrating the cardiorespiratory responses to muscle 
afferent activation and central command.    
In conclusion, the human studies described in this section have provided indirect evidence 
for central command and offer several possible cortical and subcortical areas that could be 
involved in its neurocircuitry, such as the PAG. Animal studies have provided more direct  
evidence (e.g. Eldridge et al. 1981) but it is not possible to tell whether the conditions of 
the studies are analogous to the activation of central command during normal exercise. 
Nevertheless, despite no definitive experiment and a lack in the full understanding behind 
the neurocircuitry involved, based upon the available evidence it is likely that central 
command does play a role in eliciting the normal ventilatory and cardiovascular responses 
in exercise.  
However, the relative importance of central command (in ventilatory control in particular) 
is still debated (Haouzi et al. 2006). The effects of metabolic rate and motor activity on 
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ventilation can be separated out by sinusoidal changes in work rate. Ventilation in exercise 
reduces in response to a decrease in the work rate oscillation period and as such follows 
the changes in OO2 and OCO2 despite the constant work rate amplitude. (Casaburi et al. 
1977, Haouzi et al. 2004). Therefore it appears that the ventilatory responses to exercise 
may be less related to the level of central drive and more to metabolic rate. This must 
make us consider that other mechanisms unrelated to central drive are involved in the 
control of the exercise hyperpnea. The neural feedback from metabolically and 
mechanically sensitive receptors in skeletal muscle, that clearly plays a role in controlling 
the cardiovascular system in exercise (below), has been proposed as a control mechanism 
for ventilatory increases in exercise and perhaps provides the error signal for steady-state 
ventilation to match metabolic rate. Indeed, Eldridge et al. (1981) concludes that other 
factors, such as feedback from the exercising muscle, cannot be ruled out as a mechanism 
contributing to the ventilatory response and they may be required to track ventilation with 
metabolic events in exercise. 
 
 
 
 
 
 
 
 
22 
 
1.5 Skeletal Muscle afferent feedback 
Skeletal muscle is innervated by five types of afferent nerve fibre. Group I (subdivided 
into Ia and Ib) and group II are thickly myelinated afferents and conduct impulses between 
72-120 m/s and 31-71 m/s, respectively. Group Ia and II afferents innervate muscle 
spindles and group Ib innervate Golgi tendon organs. Group III (Aδ) muscle afferents are 
thinly myelinated and conduct impulses between 2.5-30 m/s. Group IV  afferents (C-
fibres) are slower still (<2.5 m/s) and are unmyelinated. The free nerve endings of group 
III muscle afferents are often located in connective tissue and tendon, whereas the free 
nerve endings of group IV afferents are often found within the vascular network of muscle. 
Group III and IV afferents synapse in the laminae of the dorsal horn of the spinal cord and 
project to the medulla including the NTS (which also integrates the inputs from other 
afferents in the glossopharyngeal and vagus nerves) and can provide the brainstem with 
information regarding the conditions within the muscle (Kaufman & Forster, 1996).  
It has long been established that muscle afferent feedback is an important factor in the 
control of the cardiovascular system in exercise. Alam & Smirk (1937) demonstrated that 
after the cessation of a dynamic calf exercise, performed with thigh cuffs inflated to a 
supra-systolic pressure and thus occluding blood flow to the exercising muscles, blood 
pressure reduced from the exercising level but was maintained significantly above resting 
levels. The occlusion of blood flow traps the metabolites produced in exercise within 
muscles and this blood pressure response to the post-exercise circulatory occlusion 
(PECO) was maintained for as long as the thigh cuffs were inflated.  As no exercise was 
being performed during PECO it was therefore concluded that a reflex arising from the 
muscles themselves was maintaining blood pressure. This is known as the exercise pressor 
reflex. One simple explanation for the function of this reflex is that during exercise at low 
muscle contractile forces it assists adequate perfusion of the muscles, washing out 
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metabolites to remove the metabolic error signal and protecting against early muscle 
fatigue (Fitzpatrick, 2012)  
 
Neurophysiological evidence for the exercise pressor reflex 
The reflex component of this pressor response was further examined by Coote et al. (1971) 
by electrically stimulating the ventral roots (L6-S1) in anaesthetised cats to induce hind 
limb muscle contractions. This allowed the investigators to examine the contribution of 
muscle afferent feedback to the cardiorespiratory responses during exercise in isolation 
from the influence of central command. The electrical stimulation produced an increase in 
blood pressure as well as smaller increases in heart rate and ventilation. Furthermore, this 
response was abolished if the muscle contraction was blocked by gallamine (a 
neuromuscular blocking agent) or if dorsal roots (L6-S1) were sectioned. It was suggested 
by Coote et al. (1971) that the pressor response was likely caused by the accumulation of 
metabolites which stimulated group III and group IV muscle afferents operating as 
“metabolic receptors” (or metaboreceptors). Indeed Coote & Perez-Gonzalez (1970) 
determined that the electrical stimulation of group III and IV afferents increases 
sympathetic nerve output in anaesthetised cats whereas as the stimulation group I and II 
muscle afferents did not. 
McClosky & Mitchell (1972) confirmed this by providing an anodal block to the dorsal 
roots from the hind limb muscles of anaesthetised cats. While selectively blocking group I 
and II muscle afferents the electrical stimulation of hind limb muscles resulted in the 
expected large increase in blood pressure and the smaller heart rate and respiratory 
responses. But these responses were abolished when the thin myelinated and unmyelinated 
group III and IV afferents were blocked. Furthermore the increase in blood pressure (but 
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not heart rate or ventilation) in response to the muscle contractions were augmented by the 
superimposition of circulatory occlusion during and after the contractions. All together 
these important studies suggest that feedback from contracting muscles can evoke 
cardiovascular and respiratory reflexes via group III and group IV muscle afferents.  
 
Discharge properties of group III and IV afferents 
Both electrically evoked isometric (Kaufman et al. 1983) and rhythmic (Kaufman et al. 
1984) hind limb muscle contractions increase the discharge of both group III and IV 
muscle afferents in anaesthetised cats and result in a pressor response. By analysing the 
discharge patterns it has been possible to speculate that these two afferent groups tend to 
respond to different stimuli. Group III afferents primarily fire rapidly after the initiation of 
the contractions and also in synchrony with rhythmic contractions and so appear to be 
stimulated to a greater extent by mechanical distortion of skeletal muscle (Kaufman et al. 
1983, 1984). These afferents are also stimulated by the non-noxious and purely mechanical 
stimuli of squeezing, probing, and external pressure on the muscle (Kaufman et al. 1983, 
1984; Mense & Stahnke, 1983; Kaufman & Rybicki, 1987; Hayward et al. 1991). 
Furthermore Mense & Stahnke observed that most group III fibres were stimulated by 
tendon stretching, which was greater during sustained rather than repeated stretches, and 
concluded that these afferents tend to do be “contraction sensitive units with a mechanical 
mechanism of activation”.   
Conversely group IV afferents tend to respond with a latency consistent with the build up 
of metabolites produced during electrically evoked contraction contractions (Kaufman et 
al. 1983). Indeed, when these contractions were induced during the occlusion of local 
blood supply, the resulting metabolite accumulation within the muscle caused a greater 
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increase in the discharge of group IV afferents compared with group III afferents 
(Kaufman et al. 1984a). This implies that the group IV afferents are stimulated more by 
metabolic by-products of contraction. 
 
What metabolic by-products of muscle contraction stimulate muscle afferent fibres   
McCloskey & Mitchell (1972) demonstrated that the arterial injection of potassium 
chloride produced similar cardiovascular and ventilatory responses compared with 
electrically induced hindlimb exercise. It was suggested that substances like potassium, 
which are released by the exercising muscle, stimulate metabosensitive afferents and cause 
a reflex increase in blood pressure, heart rate and ventilation. Although potassium injection 
does stimulate group III and IV afferents (Kaufman & Rybicki 1987), this response adapts 
quickly while interstitial potassium levels remained elevated making it unlikely that it 
contributes to the exercise pressor response. However many more chemical substances 
which, are by-producs of muscle contractions, have been identified which stimulate group 
III and IV muscle afferents in cats and rats. 
The injection of bradykinin (Kaufman et al 1983; Mense & Meyer, 1988) and lactic 
acid/H
+
 (Rotto & Kaufman, 1988) into the arterial supply of anaesthetised cat hindlimbs 
increases the discharge of both group III and IV afferent fibres. Furthermore 
prostaglandins also appear to play a role as the injection of arachidonic acid increases the 
discharge of these afferents and the application of indomethacin, which inhibits the 
cyclooxygenase enzyme that converts arachidonic acid to prostaglandins, attenuates this 
increased afferent discharge (Rotto & Kaufman (1988). Finally the intra-arterial injection 
of ATP stimulates group IV afferent fibres but only some of the slowest conducting (<4 
m/s) group III afferents (Hanna & Kaufman, 2004).  
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Polimodility of group III muscle afferents  
After the rapid and transient discharge of group III afferents upon the initiation of the static 
muscle contractions almost half of them a displayed a secondary increase in firing 
(Kaufman et al 1983). These polymodal discharge properties suggest that a population of 
group III afferents may be sensitive to both the mechanical effects of the contraction and 
the metabolic by-products as well. These chemical stimuli may include ATP, lactic 
acid/H
+
, arachidonic acid metabolites (e.g. prostaglandins) and bradykinin as their inta-
arterial injection have all been shown to stimulate some group III muscle afferent fibres 
(Kaufman et al. 1983, Mense & Meyer, 1988; Rotto & Kaufman, 1988, 1990; Sinoway et 
al. 1993; Hanna & Kaufman, 2004).  
Furthermore, metabolites have also been found to sensitise group III afferent responses to 
mechanical stimuli. Adreani et al. (1997, 1998) and Hayes et al. (2006) induced rhythmic 
muscle contractions using MLR stimulation, a technique which is thought to more closely 
resembles normal voluntary exercise in terms of motor unit recruitment compared with 
ventral root stimulation. Contractions resulted in the activation of both group III and IV 
muscle afferents and during muscle ischemia their discharge was potentiated to a similar 
extent by the resultant local metabolite accumulation (Adreani & Kaufman, 1998). 
However, if this muscle ischemia continued after exercise (i.e. PECO) the increased 
discharge of group IV afferents continued but the discharge of group III afferents returned 
to baseline (Hayes et al. 2006). Therefore it appears that group III muscle afferents were 
not being stimulated by the accumulated metabolites per se but were perhaps sensitised by 
them to the mechanical stimulus of the muscle contractions.  
All together the findings above suggest that some group III afferents are not exclusively 
mechanoreceptive but can either be stimulated or sensitised by chemical stimuli and thus 
can be considered as polymodal.  
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1.6 Skeletal muscle afferent feedback – cardiovascular control  
Several investigations in humans have clearly demonstrated the importance of muscle 
afferent feedback in the control of the cardiovascular system in exercise. Electrically 
evoked muscle contractions, which will stimulate muscle afferents in isolation from central 
command activation, result in similar blood pressure compared with voluntary exercise 
(Bull et al. 1989) and also induces increases in heart rate, albeit with a delay by 1 cardiac 
cycle not observed in voluntary exercise (Krogh & Lindhard 1917, Iwamoto et al. 1987). 
Investigations have also inhibited the transmission of muscle afferent feedback from lower 
limbs by injecting anaesthetic (e.g. lidocaine, bupivacane or fentanyl) into the lumbar 
epidural space. It has been consistently demonstrated in humans that the cardiovascular 
responses to voluntary and electrically evoked exercise can be diminished by this reduced 
sensory feedback (Freund et al. 1979, Mitchell et al. 1989, Fernandes et al. 1990, Kjaer et 
al. 1994; Amann et al. 2010). These studies clearly suggest that muscle afferent feedback 
is an important control mechanism in the normal pressor responses to exercise. However, 
several techniques have also been used to try and differentiate the contributions of muscle 
metaboreceptor stimulation (metaboreflex) and mechanoreceptor stimulation 
(mechanoreflex) in the cardiovascular responses to exercise. 
 
Mechanoreflex 
It is thought that the mechanoreflex might provide feedback on the force of contraction so 
that suitable cardiovascular responses are made to the exercise (Kaufman & Forster, 1996). 
The techniques of passive muscle/tendon stretch and external muscle compression have 
been used to selectively stimulate muscle mechanoreceptors in isolation and therefore 
observe there relative contribution to the control of the cardiovascular system. 
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In animal models, stretching the tendon increases both blood pressure heart rate with a 
decrease in cardiac vagal activity and increase in cardiac sympathetic activity (Stebbins et 
al. 1988; Murata & Matsukawa, 2001). These responses could also be graded depending 
on the tension developed in the muscle by the stretch. In humans, sustained passive 
stretching of the calf muscle increases in heart rate which is vagally mediated as the 
response was abolished with glycopyrrolate administration (Gladwell & Coote 2002; 
Gladwell et al. 2005). Fisher et al. (2005) and Drew et al. (2008) also observed increases 
in heart rate and progressive increase in blood pressure throughout the stretch period of the 
calf. These results suggest that activation of the mechanoreflex through stretch increases 
heart rate through vagal withdrawal but it is also is capable of stimulating populations of 
mechanoreceptive afferents that can signal for an increase in sympathetic vasomotor 
activity. Sustained passive stretch of the forearm PECO has been shown to cause increases 
in MSNA, but only when the preceding handgrip exercise was performed to fatigue and 
not when it was non-fatiguing (Cui et al. 2008). This suggests that metabolites, which 
might include prostaglandins (Middlekauf & Chiu, 2004; Cui et al. 2008a), may sensitise 
muscle mechanoreceptors but only when they accumulate above a certain threshold.   
External compressions of the muscle increases interstitial pressure and in both animals 
(Stebbins et al., 1988) and humans (Williamson et al., 1994; Bell & White, 2005) 
increases in blood pressure has been observed. However, the local occlusion caused by 
compression will trap metabolites within muscles and concurrently stimulate muscle 
metaboreceptors, which might entirely explain the increase in blood pressure. Therefore 
Bell & White (2005), applied compression to the calf during periods of PECO which 
followed graded intensities of isometric calf exercise. The compressions caused 
incrementally larger increases in blood pressure following the greater exercise intensities 
and thus when there was a greater metabolic stimulus. This suggests that populations of 
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polymodal muscle mechanoreceptors stimulated by compression can be sensitised by the 
trapped metabolites within the muscle. 
 
Metaboreflex 
It is thought that the metaboreflex may signal for a greater blood supply to be sent to 
contracting muscles as there is mismatch between blood supply and the metabolic by-
products being produced (Kaufman & Forster, 1996). As there is no tension in the muscle 
PECO is a useful technique to examine the relative contribution of the metaboreflex to the 
exercise pressor response from other cardiovascular control mechanisms. As described 
above, metaboreflex activation through PECO causes reflex increases in blood pressure 
(Alam & Smirk 1937). Furthermore the pressor response observed during PECO increases 
along with the of the preceding exercise intensity and degree of muscle ischemia, and as 
such is proportionate to the degree of metabolite production and accumulation (Alam & 
Smirk 1937, Rowell et al. 1976).  
Throughout PECO there is a sustained sympathoexcitation and thus vasoconstriction until 
cuff deflation which accounts for the blood pressure responses first observed by Alam & 
Smirk (Mark et al. 1985; Victor et al. 1987; Seals et al. 1988). However it has been 
classically shown that heart rate returns to resting levels during PECO (Rowell et al. 
1976). It is likely that this recovery of heart rate is either because after exercise the 
baroreflex masks the response or because the metabolic error signal in the muscle plays 
little role in controlling the heart. Indeed other mechanisms have shown to provide a 
control of heart rate, such as the muscle mechanoreflex (Gladwell & Coote, 2002 and 
Gladwell et al. 2005; see below) and central command (Mark et al. 1985; Victor et al. 
1989).  For example Victor et al. (1989) observed that attempted handgrip contractions, 
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which yielded almost no force in the muscle due to neuromuscular blockade with 
tubocurarine, increased heart rate to a similar level recorded before the blockade but the 
blood pressure and MSNA responses were significantly smaller. Moreover the heart rate 
responses during attempted handgrip were abolished by atropine. Together these results 
suggest that central command is an important mechanism in controlling parasympathetic 
outflow to the heart but plays a much smaller role in the control of sympathetic outflow to 
skeletal muscle. 
More recently however the role of the metaboreflex in human cardiac control has been re-
examined by Fisher et al. (2010). During a period of circulatory occlusion following a 
moderate intensity static handgrip exercise (25% MVC) heart rate remained slightly 
elevated (but not significantly) above resting levels. This heart rate response to PECO was 
augmented during the pharmacological elimination of cardiac parasympathetic tone 
(glycopyrrolate), and it could be reduced during adrenergic blockade (propranalol). Similar 
findings have also been shown in animals (O’Leary, 1993) and collectively these results 
suggest that the metaboreflex increases cardiac sympathetic nerve activity during PECO, 
and can elicit a tachycardia, but this response is usually masked by parasympathetic 
reactivation post exercise. It is thought that this parasympathetic reactivation and resultant 
bradycardia in PECO is a consequence of the loss of central command and mechanoreflex 
activity and also the influence of the baroreflex on the heart. 
However, Fisher et al. also observed that during circulatory occlusion following a higher 
intensity static handgrip exercise (40% MVC) heart rate remains significantly elevated 
above baseline. These findings support those made by Iellamo et al. (1999) who found 
small heart rate response to PECO but only if the exercise was at a high enough intensity 
(15 vs. 30% MVC) and in a large enough muscle mass (handgrip vs. knee extension). 
Furthermore this incomplete recovery of heart rate was not affected by parasympathetic 
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blockade but was abolished by β-adrenergic blockade (Fisher et al. 2010). This suggests 
that stronger muscle metaboreflex activation (from a greater local metabolite 
accumulation) is required for the increase in cardiac SNA to overcome the cardiac 
parasympathetic reactivation and cause a heart rate response. Overall these results 
demonstrate that the metaboreflex may be capable of eliciting heart rate responses in 
normal exercise, but during PECO this affect may be masked by parasympathetic 
reactivation post exercise.    
Several chemicals which are by-products of muscle contraction have been identified which 
are known to stimulate metabolically sensitive afferents and cause the reflex 
cardiovascular responses. The injection of bradykinin, lactic acid/H
+
, ATP, and 
diprotonated phosphate (H2PO4
-
) into the arterial supply of anaesthetised cat hindlimbs all 
result in a pressor response (Stebbins & Longhurst, 1985; Rotto et al., 1989; Sinoway et 
al., 1994; Li & Sinoway, 2002; Hanna et al. 2002) which is abolished with the sectioning 
of the ventral and dorsal roots showing the reflex nature of the response. Arachidonic acid 
metabolites (such as prostaglandins) are also thought to stimulate the cardiovascular 
responses to exercise as the injection of the cyclooxygenase inhibitor, indomethacin, 
reduces the pressor response to electrically induced exercise (Stebbins et al. 1986). 
 By using 
31
P Nuclear Magnetic Resonance Spectroscopy (
31
P NMR), it is possible to 
perform investigations in humans. The time course and magnitude of the exercise pressor 
response to handgrip exercise was associated with intracellular concentrations of H
+
, 
suggesting that this is an important metabolic stimulus for the cardiovascular responses to 
exercise (Victor et al. 1988; Sinoway et al. 1989). In addition, Dichloroacetate infusion 
can blunt lactic acid production by stimulating pyruvate dehydrogenase activity. This 
therefore decreases the relative proportion of pyruvate converted into lactate by shifting 
the metabolism of pyruvate towards oxidation in the mitochondria. The infusion of 
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Dichloroacetate into healthy humans has shown to reduce the sympathetic nerve responses 
to static exercise and PECO (Ettinger et al. 1991). As infusion into anaesthetised cats 
reduces the discharge of group III afferent fibres to electrically induced static contraction 
(Sinoway et al. 1993), these effects are likely caused by a blunted lactic acidosis and a 
consequential reduction in muscle afferent activation. This again suggests that Lactic 
acid/H+ may be an important metabolite in stimulating the pressor response in humans. 
In conclusion, all the chemical substances described above, which are by-products of 
muscle contraction, do appear to be capable of stimulating metabolically sensitive 
receptors found on the free nerve endings of muscle afferents and provide a stimulus for 
the exercise pressor reflex.  However, in order to show that a specific metabolite, or 
mechanical stimulus, can contribute to the exercise pressor reflex, investigations must also 
demonstrate that blocking those receptor/s that are activated by the stimulus results in an 
attenuation of the cardiovascular response to: 1) the application or injection of the 
receptors agonist/ligand metabolite and more importantly to 2) exercise (e.g. electrically 
induced muscle contractions).  
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1.7 Receptor subtypes  
Since the investigations by Kaufman et al. (1983), more recent investigations have 
determined the sensitivity of group III and IV afferents to particular stimuli is determined 
by the receptor subtype/s located on the free nerve endings of these fibres. This research 
has studied the sympathetic, cardiovascular and/or respiratory responses to mechanical and 
metabolic stimuli during the blocking or stimulation of specific receptor subtypes.           
Mechanosensitive receptors 
Gadolinium blocks mechanoreceptive channels and its administration in anaesthetised cats 
reduces group III muscle afferents discharge to passive muscle stretching, electrically 
induced static muscle contractions (Hayes and Kaufman 2001) and dynamic exercise 
induced via MLR stimulation (Hayes et al 2009). But gadolinium had no effect on group 
IV muscle afferent impulse activity. Furthermore, Hayes and Kaufman (2001) 
demonstrated that these mechanoreceptive channels are capable of evoking 
cardiorespiratory responses, as these responses to muscle stretching and muscle 
contractions were also reduced with the administration of gadolinium. When Nakamoto & 
Matsukawa (2007, 2008) injected gadolinium locally into the myotendinous junction of the 
triceps surae of anaesthetised rats, the pressor response induced from passive stretching of 
the muscle and electrically induce static contractions were significantly reduced. It is 
unlikely that any mechanoreceptors were located in the more distal part of the tendon as 
the cardiovascular responses to stretching and contraction were similar pre and post 
sectioning of the Achilles tendon. All together these results suggest that mechanosensitive 
receptors may be at least partly located in the myotendinous junction of the Achilles 
tendon and can evoke reflex cardiovascular and respiratory responses.  
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Metabosensitive afferents 
Transient receptor potential vanilloid 1 (TRPv1) receptor 
In both cats and rats the stimulation of the TRPv1 receptor (also known as vanilloid 
receptor 1 or capsaicin receptor) with its agonist capsaicin results in increases in blood 
pressure and heart rate, similar to that during exercise (Kaufman et al. 1982; Smith et al. 
2005) and is primarily mediated through group IV afferents (Kaufman et al 1983). 
However, the role of the TRPv1 receptor in eliciting the exercise pressor response is 
controversial.  
Kindig et al. (2005) found that blocking this receptor, with the arterial injection 
iodoresinaferatoxin (IRTX), abolished the pressor response to capsaicin injection but did 
not attenuate the exercise pressor response of cats to electrically stimulated static muscle 
contractions. Recently however, Smith et al. (2010) demonstrated in rats that the pressor 
response to electrically induced muscle contractions and capsaicin injection was 
significantly attenuated with the application of three antagonists of the receptor 
(capsazepine, IRTX and ruthenium red). However they had no effect on the pressor 
response to passive stretch, which may be expected as group IV afferents are more 
sensitive to capsaicin (Kaufman et al. 1983). 
Therefore, TRPv1 receptors do appear to contribute to the metabolic component of the 
exercise pressor response in rats and that these receptors mediate in the activation of group 
IV afferents. Furthermore Gao et al. (2006) has shown in rats that a possible metabolite 
that stimulates the TRPv1 receptor may be H2PO4
-
. Unlike monoprotated phosphate 
(HPO4
-2
), the injection of H2PO4
- 
into cat hindlimbs evokes increases in BP (Sinoway et al. 
1994), which could be attenuated by ~60% with capsazepine (Gao et al. 2006). However, 
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because lactic acid/H
+
 has no effect on TRPv1 receptors (Li et al. 2004) it is unlikely that 
its stimulation by diprotonated phosphate is mediated by H
+
 delivery.      
However, due to the apparent species difference between cats and rats it becomes difficult 
to establish the role of the TRPv1 receptor in the human exercise pressor reflex and until 
testing can be completed in humans its role will remain unclear.      
 
Transient receptor potential A1 (TRPA1) channel 
Similar to the TRPv1 receptor, TRPA1 channels appear also to be preferentially found on 
group IV muscle afferents (Kobayashi et al. 2005; Anand et al. 2008) in rats and humans 
respectively. Recently Koba et al. (2010) demonstrated that stimulating TRPA1 channels 
with its agonist Allyl isothiocyanate (mustard oil) significantly increases renal SNA and 
blood pressure in a dose dependant manner, and this can be abolished with sciatic nerve 
section or with the application of the channels antagonist HC-030031. Crucially, the 
pressor response to electrically induced sustained muscle contraction was reduced with 
HC-030031 suggesting that the TRPA1 channel is involved in the metabolic component of 
the exercise pressor reflex. However this response to intermittent contractions (arguably a 
more mechanical stimulus) was not attenuated by HC-030031, either suggesting that the 
mechanical stimulus was not great enough to stimulate them or that TRPA1 channels are 
unreceptive to mechanical stimuli. Furthermore the increase in BP (and RSNA) from the 
arterial injection of arichidonic acid, bradykinin and diprotonated phosphate were all 
reduced between ~30 and ~50% with HC-030031, suggesting that these by products of 
muscle contraction may be stimuli for or mediate in the stimulation of TRPA1 during 
exercise.  
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Acid sensitive ion channels (ASIC) 
As previously described, the arterial injection of lactic acid/H
+
 and H2PO4
- 
results in a 
pressor response, which seems to be mediated though the stimulation ASICs as the 
administration of the ASIC antagonist amiloride significantly attenuates the response (Li et 
al. 2004; Gao et al. 2006). Furthermore injection the ASIC antagonist A-317567 into cats, 
reduces the blood pressure response to both static muscle contraction and post contraction 
circulatory occlusion (Hayes et al. 2008; McCord et al. 2009), implying its involvement in 
eliciting the exercise pressor reflex. However because there was no attenuation in the 
blood pressure response to tendon stretch, it is likely that ASIC play no role in the 
mechanical component of the pressor reflex (Hayes et al. 2008). 
 
Kinin B2 receptor 
Using two antagonists (NPC 11731 and HOE 140) Pan et al. (1993) demonstrated that 
blocking the bradykinin (or kinin) B2 receptor in cats significantly reduced the blood 
pressure (and heart rate) response to arterial injection of bradykinin and to electrically 
induced static contraction of the hindlimb muscle (by ~50%). This suggests that 
bradykinin is involved in inducing the cardiovascular responses in exercise and is at least 
partially mediated through the kinin B2 receptor. Furthermore, the application of 
indomethacin inhibits the pressor response to bradykinin injection, so perhaps 
prostaglandins sensitise muscle afferent nerve endings to bradykinin (Stebbins & 
Longhurst 1985; Pan et al. 1993). Indeed, the binding of bradykinin to the kinin B2 
receptor causes prostaglandin synthesis, so these receptors may mediate increases in the 
concentration of prostaglandins in the vicinity of muscle afferent nerve endings and as 
such the effects of bradykinin on kinin B2 receptors may be enhanced (Pan et al. 1993)  
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Purinergic receptors 
The agonist of the purinergic 1 (P1) receptor is adenosine, but its stimulation does not 
appear to have any cardiovascular effects (Hanna et al. 2002). The Purinergic 2 (P2) 
receptor is stimulated by ATP, the interstitial level of which increases during exercise in 
humans (Mortenson et al. 2009). The P2 receptor is expressed as two subtypes, P2X and 
P2Y. In cats the arterial injection of α,β-methylene ATP, a selective agonist of the P2X 
receptor, increases blood pressure (Hanna et al. 2002; Li & Sinoway, 2002; Hayes et al. 
2008a; McCord et al. 2010) but the selective stimulation of P2Y receptor has no such 
effect (Hayes et al. 2008a). Furthermore the arterial injection of α,β-methylene ATP in cats 
primarily stimulates group IV afferents suggesting that these fibres are where P2X 
receptors are principally located. 
However Kindig et al. investigated further and showed that both the group III and IV 
impulse activity responses to static muscle contraction could be significantly reduced with 
the P2 receptor antagonist pyridoxal phosphate-6-azophenyl-2’,4’-disulfonic acid 
(PPADS; Kindig et al. 2006). Hence P2 receptors on both group III and IV afferents may 
contribute to the exercise pressor response, but because PPADS only reduce the discharge 
of group IV afferent to the pure metabolic stimulus of circulatory occlusion post-muscle 
contractions (Kindig et al. 2007), it is likely that only P2 receptors on group IV afferents 
contribute to the metabolic component of the exercise pressor reflex.   
P2X receptors may play an even greater role however, as there stimulation may potentiate 
the pressor responses to mechanical stimuli. This is evidenced by 1) α,β-methylene ATP 
injection enhances the blood pressure increases to passive muscle stretching (Li & 
Sinoway, 2002), and 2) PPADS attenuate the impulse activity responses of group III 
muscle afferents to tendon stretch (Kindig et al. 2006). As such it appears that group III 
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afferents fibres and can be sensitised to mechanical stimuli by ATP present in the muscle 
interstitium.  
As discussed above, there may be a species difference in the relative importance of each 
receptor that are capable of evoking the exercise pressor response, so experiments in 
humans are always preferential if possible. Recently Cui et al. (2011) locally infused 
pyridoxine hydrochloride (vitamin B6) into the forearms of humans via a bier block. 
Pyridoxine hydrochloride converts into pyridoxal-5-phosphate which is a P2 receptor 
antagonist, and during its application MSNA (~50%) and blood pressure (5 mmHg) 
responses were significantly attenuated to both isometric handgrip exercise and PECO. 
However, in contrast to the animal data of Li & Sinoway (2002), the block did not affect 
the increase in MSNA to passive stretch from levels observed in PECO suggesting that P2 
receptor stimulation does not potentiate the cardiovascular responses to the mechanical 
stimuli of stretch in humans. This may signify an underlying species difference or the 
contrasting results may be due to the stretch being performed during PECO in the study by 
Cui et al. Therefore other metabolites will have accumulated which may sensitise 
mechanoreceptors independently of P2 receptors e.g. prostaglandins, (Cui et al. 2008a). 
Notwithstanding, Cui et al. (2011) have elegantly demonstrated that P2 receptor 
stimulation are involved in exercise pressor response in humans. 
In conclusion these studies collectively suggest that ATP, Lactic acid/H
+
, diprotonated 
phosphate, bradykinin and also arichdonic acid metabolites may all have a role in the 
generation of the exercise pressor reflex by stimulating the metabolically sensitive 
receptors on the free nerve ending of muscle afferent fibres. 
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1.8 Skeletal muscle afferent feedback- ventilatory control 
Due to the clear importance of muscle afferent feedback on cardiac and circulatory control 
in exercise it is also reasonable to hypothesise that this feedback also plays a role in 
eliciting the exercise hyperpnea. Indeed neural signals emanating from an exercising 
muscle may not only be in proportion to metabolic rate but also may account for the rapid 
increase in ventilation that is classically associated with the onset of exercise (Asmussen, 
1973). 
 
Animal studies 
Extensive work has been completed in animal preparations which utilise electrically 
induced muscle contractions to activate the muscle without the co-activation of central 
command. Early studies performed by Comroe & Schmidt (1943) demonstrated that that 
muscular work induced by electrical stimulation of the ventral roots in anaesthetised dogs 
results in hyperpnea, which can be abolished through spinal cord transection. Kao et al. 
(1963) improved upon this study design by using a cross-circulation technique in 
anaesthetised dogs so the effects of muscle afferent feedback on ventilation could also be 
isolated from humoral factors. The ventral roots of the “neural dog” were electrically 
stimulated to induce hindlimb muscles contractions, while these muscles were 
concurrently perfused by the blood of the “humoral dog”. The muscle contractions resulted 
in the immediate increase of ventilation (~6 l.min
-1
) in the neural dog, but not in the 
humoral dog, and this response was abolished through the transection of the spinal cord. 
These finding support the concept that nervous signals emanating from the working 
muscle can mediate in the exercise hyperpnea.    
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In addition to the studies of Coote et al. (1971) and McCloskly & Mitchell (1972) 
described above, Tibes (1977) also examined the reflex component of the exercise 
hyperpnea. Tibes demonstrated that the ventilatory responses of dogs to electrically 
stimulated dynamic hindlimb contractions were eliminated by a cold block of muscle 
afferents, but only when the blocking temperature reached that for group III and IV 
afferent fibres.  All together these findings clearly indicate that neural feedback from the 
contracting muscles of animals can cause respiratory reflexes via group III and group IV 
muscle afferents. Comroe & Schmidt (1943) suggested that these respiratory responses 
could also be caused by the stimulation of receptors located in joints. However Coote et al. 
prevented joint movements by ensuring that the limbs were in a fixed position suggesting 
that the cardiorespiratory responses observed were caused by afferent feedback from the 
muscle.  
Several investigations have examined the possible metabolic and mechanical stimuli which 
can activate group III and IV afferent fibres and cause a reflex hyperpnea. Although 
respiratory data is rarely recorded in these types of studies there is evidence that the 
injection of bradykinin, lactic acid/H
+
 and ATP into arteries supplying the hind limb of 
animals causes increases in ventilation (Tallarida et al. 1979, Rotto & Hill 1989; Hanna et 
al. 2002).  In addition the hyperpnea could be abolished with either the sectioning of the 
ventral and dorsal roots (Tallarida et al. 1979; Rotto & Hill, 1989) or the blockade of ATP 
sensitive P2 receptors with PPADS (Hanna et al. 2002) showing the reflex nature of the 
response.  
In anaesthetised cats the mechanical stimulus of passive muscle stretching of the triceps 
surae also causes increases in ventilation, the magnitude of which is related to the degree 
of the stretch (Wilson et al. (1994) and which is completely abolished by blocking 
mechanosensitive channels with the arterial injection of gadolinium (Hayes et al. 2001). 
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Furthermore in addition to the stretch the ventilatory response to electrically induced 
muscle contractions are also abolished by gadolinium application. As such this provides 
clear evidence in animals that muscle contraction and passive stretching of muscles can 
stimulate muscle mechanoreceptors and contribute to ventilation in exercise.  
However, the supportive findings for the involvement of muscle afferent feedback in the 
generation of the exercise hyperpnea described above have not been unanimously 
demonstrated. Although Comroe & Schmidt (1943) found that spinal cord transection 
eliminated the ventilatory response to muscle contraction in anaesthetised dogs, it was 
shown to have no effect on the response in anaesthetised cats. Other investigators have 
shown similar finding in cats and dogs whereby after spinal cord transection ventilation 
still increased proportionately to metabolic rate (with maintained arterial blood gas 
homeostasis) in response to electrical stimulation of hindlimb muscles (Lamb, 1968; 
Levine, 1979; Weissman et al. 1980). Weissman et al. concluded that muscle afferent 
feedback was not required for matching ventilation to the metabolic demands of the 
exercising muscle. Furthermore because all afferent feedback was abolished and central 
command was not activated these imply that humoral factors may stimulate the exercise 
hyperpnea, which is in direct contrast to the findings of Kao et al. described above. As 
such it is not yet possible to conclude in animals whether feedback from muscle afferents 
stimulated by electrically induced contractions can cause a hyperpnea. The significant 
variation in results may be related to the highly unphysiological nature of the experiments. 
Furthermore, the electrically induced muscle contractions in animals only cause very small 
increases in ventilation which either means that 1) this is an unreliable method to test 
whether feedback from exercising muscles plays a role in the associated hyperpernea or 2) 
muscle afferent feedback plays no significant role. Certainly, further examination is 
required.          
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Human studies - electrically induced muscle contractions  
Adams et al. (1984) and Brice et al. (1988) demonstrated in awake humans that both 
voluntary exercise and electrically induced muscle contractions produce similar increases 
in ventilation which are exactly proportional to metabolic rate. Although it is obviously not 
possible to examine the ventilatory response to electrically induced muscle contraction pre 
and post spinal cord transection in humans, these investigators compared the ventilatory 
responses between healthy individuals and paraplegic humans with complete spinal cord 
transaction. In this population all afferent feedback from skeletal muscles below the level 
of the lesion will be blocked from reaching respiratory control areas in the brainstem. 
Adams et al. (1984a) and Brice et al. (1988a) demonstrated that electrically induced 
muscle contractions of the quadriceps and hamstring muscles, stimulated ventilation in 
both healthy and paraplegic individuals. Although the responses of paraplegics were often 
smaller (e.g. 4.4 vs. 7.6 l.min
-1
, Adams et al. 1984a), critically the increase in ventilation in 
both groups was in proportion to OCO2. These findings therefore suggest that muscle 
afferent feedback is not necessary to produce an exercise ventilatory response which 
matches the increased metabolic rate. As such the findings seem to provide support for a 
humoral mechanism.  
However when venous return is inhibited by the inflation of cuffs around the contracting 
muscle, ventilation decreases in paraplegics but only several seconds after, and in 
proportion to, a decrease in PETCO2 (Brown et al. 1990). Furthermore the decrease in 
ventilation was predictable from normal CO2 responsiveness. This suggests that the change 
in PaCO2 caused this reduction in the ventilatory response and thus does not support the 
concept of a humoral mechanism controlling the exercising hyperpnea, as of course during 
normal mild-moderate exercise in healthy humans PaCO2 remains stable. It is worth noting 
that further examination of the data shows that ventilation did not return to resting levels 
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during occlusion as ~50% of the response was maintained (Brown et al. 1990). As the 
contractions were applied in the apparent absence of a central command, muscle afferent 
and humoral stimulus the mechanism of the response is unknown.  
To summarise, the cause of the hyperpnea in paraplegic humans is not clear but feedback 
from muscle afferents may not be necessary to induce an increase in ventilation that 
matches metabolic rate. However the finding by Brown et al., and the inconsistency in the 
animal data (described above), may imply that electrically induced muscle contractions 
may not be a suitable or reliable method for analysing the role of muscle afferent feedback 
in controlling the exercise hyperpnea.    
 
Epidural anaesthesia during exercise in humans 
 By using spinal anaesthesia (e.g. lidocaine or bupivacane injected into the lumbar epidural 
space) afferent feedback from lower limbs during exercise can be reduced. Seemingly in 
contrast to cardiovascular responses the hyperpnea to cycling exercise is not attenuated 
during anaesthetic block in man (Hornbien et al. 1969; Fernandes et al. 1990), suggesting 
that muscle afferent feedback is not required to elicit the normal hyperpnea to exercise. 
However, one concern with the studies is that epidural anaesthesia will also reduce efferent 
nerve activity to the exercising muscles and thus cause muscle weakness. This will 
enhance the level of central motor drive required to achieve the same work load and thus 
increase central command activation, possibly masking any effects from the reduced 
sensory feedback. 
More recently however, Amann et al. (2010) injected the μ-opiate agonist fentanyl 
intrathecally into the L3-L4 vertebral space to inhibit the neurotransmission from group III 
and IV muscle afferents projecting into the dorsal horn of the spinal cord. Crucially 
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fentanyl has shown not to alter the force generating capacity of skeletal muscle (Amann et 
al. 2009). Amann et al. (2010) demonstrated that the ventilatory and cardiovascular 
responses to dynamic cycling exercise were significantly attenuated with the use of 
fentanyl compared to normal exercise. This data is clearly the most compelling evidence to 
date that muscle afferent feedback does contribute to the mediation of the exercise 
hyperpnea.  
 
Muscle metaboreflex activation via PECO 
PECO stimulates metabolically sensitive afferents in complete isolation of central 
command, and although it is known to increase sympathetic vasomotor activity most 
evidence suggests it does not cause increases in ventilation. For example Rowell et al. 
(1976) found that following a bout of exercise on a cycle ergometer (50-250 W) PECO of 
both legs using thigh cuffs inflated to 300 mmHg did not maintain ventilation at exercising 
levels but returned to baseline. Conversely blood pressure was maintained at the exercising 
level until the thigh cuffs were realised. In direct contrast to the findings of Amann et al. 
above, Rowell et al. concluded that because the “muscle ischemia (post exercise) did not 
alter minute ventilation... respiratory control ‘centres’ appear to receive no significant 
input from ‘metabolic sensors’ in muscle”. This finding has been confirmed in healthy 
humans by several other investigations employing circulatory occlusion following cycling 
exercise (Innes et al. 1989; Haouzi et al. 1993, 2001; Scott  et al. 2000; Fukuba et al. 
2007, Olson et al. 2010) and rhythmic handgrip exercise (Scott et al. 2002). The method of 
PECO after static exercise has been less extensively tested but similar effects have been 
found. Wiley & Lind (1971) demonstrated that following static handgrip exercise of 
varying intensities (30-50% MVC until fatigue), blood pressure remained elevated 
throughout PECO but ventilation returned to resting levels. 
45 
 
Therefore the technique of PECO has been widely used to test the role of the muscle 
metaboreflex in cardio-respiratory control. Although it clearly is a powerful activator of 
the sympathetic nervous system and plays a role in controlling blood pressure, it appears to 
play no critical role in ventilatory responses for healthy humans. However, the technique 
of PECO used in the way described above may not be suitable for testing the ventilatory 
responses to the stimulation of muscle metaboreceptive afferents. This is because of two 
factors that may suppress ventilation during PECO.  
Firstly, some group III and IV afferents appear to respond to vascular distension, perhaps 
to monitor blood flow to the muscle, as their impulse activity increases in response to 
vasodilatory agents and venous occlusion (Haouzi et al. 1999). Furthermore inflating thigh 
cuffs to sub-systolic pressures after cycling exercise, in order to occlude blood flow from 
previously exercised legs muscles, results in a slower and attenuated recovery of 
ventilation compared with complete circulatory occlusion to the exercised muscle (Haouzi 
et al. 2001). Therefore during PECO where muscle blood flow is occluded the discharge of 
these few group III and IV afferents may be abolished and their possibly stimulatory 
effects on ventilation may be removed. However, it is not clear whether this will have 
more than a negligible effect as PECO of course takes place at rest when the discharge 
rates of these afferents appear to be low (Haouzi et al. 1999). Therefore the difference in 
the impulse activity between resting and arterial occlusion conditions may be negligible 
and so may not suppress any ventilatory responses to  muscle metaboreflex activation. 
Secondly we must consider the effects of the ventilatory baroreflex. PECO induced 
metaboreflex activation preferentially causes the elevations in blood pressure to be 
maintained post exercise, and so the consequential stimulation of the baroreceptors will 
suppress ventilation via the opposing effects ventilatory baroreflex (Heisted et al. 1975; 
Stewart et al. 2011). Therefore during PECO, where the stimulatory effect of central 
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command is not activated, ventilation may return back to baseline because the 
metaboreflex alone cannot overcome the suppression from the simultaneous activation of 
the ventilatory baroreflex. The effects of the mechanoreflex will also be lost during PECO 
which could additionally contribute to a reduction of ventilation. Currently however, 
unlike central command, the role of the mechanoreflex on ventilation in humans is still 
unclear and requires further examination. Data from studies which have utilised rhythmic 
passive limb movements in humans have hinted that mechanically sensitive muscle 
afferents can stimulate ventilation (Bell & Duffin, 2006), but one cannot discount the 
influence of joint receptor activation (Barron & Coote, 1973). Therefore sustained passive 
stretch, which increases ventilation in animals (Wilson et al. 1994), may provide a more 
selective stimulus (chapter 3).    
Nevertheless these observations above may provide a explanation for the apparent 
disparity in the conclusions drawn from the experiments by Amann et al. (2010) and those 
that applied PECO to stimulate muscle afferents (e.g. Rowell et al. 1976). When inhibiting 
the neural transmission of muscle afferents during exercise, when central command is 
activated, the hyperpnea is attenuated. But stimulating afferents after exercise with PECO, 
where central command is not active, classically has no effect on ventilation in healthy 
individuals. Therefore it is possible that muscle afferent stimulation alone is ineffective at 
driving ventilation without the presence of a potentially interactive/synergistic input to the 
central respiratory neuronal pool such as central command, or perhaps a ventilatory 
chemoreflex. 
Indeed recently Lykidis et al. (2010) has demonstrated that muscle metaboreflex activation 
through PECO maintains ventilation significantly above baseline until cuff deflation, but 
only under conditions of concurrent hypercapnia (PETCO2 of 47 mmHg) and not while 
breathing air. These observations suggest the occurrence of a synergistic interaction, where 
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in effect the hypercapnia-induced ventilatory chemoreflex seems to unmask the 
involvement of muscle afferent feedback in ventilatory control. A central interaction is 
possible as both skeletal muscle and peripheral chemoreceptor afferents project to the NTS 
(Paton, 2001), a possible site of central chemoreception itself (Nattie & Li, 2009).  
Conversely, there is an additional/alternative mechanism that might be accountable for the 
ventilatory responses observed by Lykidis et al. The acute hypercapnia may decrease the 
pH of the exercised muscle further and consequently augment the afferent feedback. 
Indeed in animals muscle acidosis is a factor in stimulating the exercise pressor reflex 
(Rotto & Kaufman, 1988; Rotto et al. 1989; Sinoway et al. 1992, 1993) and ventilatory 
response (Rotto et al. 1989). Therefore maybe only during concurrent hypercapnia is the 
metaboreflex powerful enough to maintain ventilation above resting levels during PECO. 
Whether this possible interaction in the peripheral exercised muscle contributes to the 
observed ventilatory responses requires further examination (chapter 4). 
Nevertheless this concept may account for the atypical findings of Iellemo et al. (1999) 
where ventilation was maintained slightly (yet significantly) above baseline during PECO 
but only when the exercised muscle mass was great enough (static knee extesnion vs. static 
handgrip) and when the preceding exercise was performed at a high enough intensity (30% 
vs. 15% MVC for 3 minutes). It was argued that there would be greater local metabolite 
accumulation and as such only when the resultant metaboreflex is powerful enough can 
ventilatory responses to PECO be observed. Indeed it is possible the metaboreflex must be 
robust enough for the ventilatory responses overcome the opposing effects of its 
baroreflex. 
To summarise, the role of muscle metaboreflex activation on ventilatory control seems to 
be unmasked by the sensitising effects of hypercapnia. Currently it is unclear whether this 
is achieved through a central synergistic interaction or an interaction in the peripheral 
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muscle. Furthermore the role of the mechanoreflex in human ventilatory control is poorly 
understood and requires further examination.  
 
Chronic obstructive pulmonary disease (COPD) 
The observation of an augmented ventilatory response to metaboreflex activation during 
acute hypercapnia (Lykidis et al. 2010) could have implications for disease states that can 
result in CO2 retention and chronic hypercapnia such as that in chronic obstructive 
pulmonary disease (COPD). COPD is an umbrella term for the occurrence of both chronic 
bronchitis and emphysema and results in increases in airflow resistance. One of the most 
common symptoms of COPD is a decreased exercise capacity which is thought to be 
largely due to the sensations of dyspnea (O’Donnell et al. 2009), but also due to 
abnormalities in skeletal muscle metabolism and function resulting in weakness and early 
muscle fatigue (Serres et al. 1998; Casaburi et al. 2001).  
One characteristic of some importance is the occurrence of an early and exaggerated 
muscle acidosis during exercise (Kutsuzawa et al. 1992), which may of course increase the 
stimulation of muscle metaboreceptive afferents. Patients with chronic heart failure (CHF), 
who appear to have similar abnormalities in skeletal muscle (Franssen et al. 2002), have 
been shown to display augmented metaboreflex activity during PECO producing 
exaggerated ventilatory responses (Piepoli et al. 1996, 1999; Scott et al. 2000, 2002; Olson 
et al. 2010). Therefore augmented skeletal muscle afferent feedback may perhaps provide 
a neural link between skeletal muscle dysfunction and dyspnea during exercise in COPD, 
as there would be an even greater mismatch between the central drive to increase 
ventilation and the lungs impaired capacity to do so. However, whether these patients have 
an augmented metaboreflex and/or a metaboreflex induced ventilatory response is still yet 
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to be fully examined. Furthermore, based upon the findings of Lykidis et al., it is 
conceivable that the chronic hypercapnia of some patients may also enhance the 
ventilatory response to muscle metaboreflex activation and as such could provide another 
mechanism that causes dyspnea upon exertion in these patients.  Indeed it has been shown 
that in patients with a wide range in COPD severity and who also retain CO2, the most 
important stimulus for dyspnea during an incremental cycling exercise appeared to be the 
increased PaCO2 (Cloosterman et al. 1998). 
 
 
Summary  
The cardiovascular system in exercise is regulated by a combination of central command, 
the arterial baroreflex and the feedback from group III and IV skeletal muscle afferents 
responding to mechanical and metabolic stimuli in the exercising muscle. The control 
mechanisms of the exercise hyperpnea are still not fully understood, yet central command 
is widely thought to play an integral role. Historically there has been limited and 
conflicting evidence that neural feedback from exercising muscles can control ventilatory 
responses in humans. Recently however evidence has suggested that muscle afferent 
feedback is capable of driving human ventilatory responses as: inhibiting its 
neurotransmission to the dorsal horn of the spinal cord attenuates the exercise hyperpnea, 
and the stimulation of muscle afferents in combination with the sensitising effects of 
hypercapnia causes ventilatory responses. However the latter evidence requires further 
examination.   
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1.9 Proposed studies in human participants 
Based upon the preceding literature review the following studies are proposed. 
1) To examine: 
 the ventilatory responses to muscle metaboreflex activation in the calf muscle 
during concurrent acute hypercapnia.  
 The ventilatory responses to muscle mechanoreflex activation during concurrent 
hypercapnia. 
 The combination of metabo and mechanoreflex activation during concurrent 
hypercapnia 
2) To determine: 
 If the interaction between muscle afferent activation and hypercapnia occurs 
centrally (i.e. in the CNS) or peripherally (i.e. in the exercised muscle).  
 Additionally to investigate whether the interaction between muscle afferent 
activation and hypercapnia occurs via a hypercapnia-induced stimulation of the 
central and/or peripheral chemoreceptors 
3) To investigate:  
 Whether the experimental augmentation of muscle afferent feedback can increase 
the exercise hyperpnea. 
 Whether muscle mass influences the ventilatory responses to muscle metaboreflex 
activation 
4) To determine whether patients with COPD display augmented ventilatory responses to 
muscle afferent stimulation (PECO) and if so is this related to chronic hypercapnia from 
CO2 retention.  
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CHAPTER 2: GENERAL METHODS 
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2.1 Experimental procedures 
Isokinetic dynamometer – calf plantarflexion exercise 
For the experiments in chapters 3 and 4 all participants were seated in a semi-recumbent 
position in a Biodex system 3 Pro isokinetic dynamometer (Biodex medical systems, 
Shirley, NY, USA). Their right foot was firmly strapped to the footplate using Velcro 
straps, with the centre of rotation of their ankle aligned with that of the machine with their 
lower leg parallel to the floor and knee flexed at 30° (Figure 2.1). The maximal voluntary 
contraction (MVC) of the calf plantarflexors was assessed by instructing participants to 
perform maximal efforts against the footplate and accepting three that were within 10% of 
each other. Each effort was separated by 1 minute and the highest of the three was taken as 
the MVC. During the experimental protocol participants maintained the required 
percentage of their MVC (50%) by matching their torque output to a target torque 
displayed on a computer screen positioned in front of them at eye level. 
 
Isokinetic dynamometer – passive calf muscle stretch 
In chapter 3 where passive stretch of the calf was also applied, the passive range of 
dorsiflexion around the ankle joint was determined before each trial by manually altering 
the angle of the footplate to a position as far as was comfortable for the participant. The 
information was programmed into the Biodex, so that the following passive stretching 
movement was automatically performed by the machine. Figure 2.2 shows an original 
record of the typical torques generated during a sustained passive stretch. 
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Figure 2.1 Participant seated in the isokinetic dynamometer 
Torque 
(nM) 
Figure 2.2 Original recording of a typical torque trace during three minutes of muscle stretch 
 
Time (seconds) 
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Cycle ergometer exercise 
In chapter 5, participants were seated in a semi-recumbent position in a customised 
electrically braked cycle ergometer (Angio, Lode, Groeningen, The Netherlands; Figure 
2.3). The seat of the cycle ergometer was adjusted for each individual, so that the 
participants knee was almost completely extended when their foot went through the 
bottom of the pedalling stroke. The participant’s right foot was strapped to the right pedal 
with Velcro straps by the experimenter. The exercise intensity performed by the 
participants was 50 watts (at 60 RPM).    
 
 
 
 
 
 
Figure 2.3 Customised electrically braked cycle ergometer 
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Handgrip dynamometer exercise 
In chapter 6, participants were seated in an upright position with their right hand holding a 
custom-made handgrip dynamometer (Figure 2.4). The device was clamped to a surface 
top which also supported the participants right arm. Maximal voluntary contractions 
(MVC) were determined by instructing participants to perform maximal handgrip efforts 
and accepting three that were within 10% of each other. Each effort was separated by 1 
minute and the highest of the three was taken as the MVC. During the experimental 
protocol participants maintained the required percentage of their MVC (40%) by matching 
their force output to a target force displayed on a computer screen positioned in front of 
them at eye level. The rhythmic handgrip exercise task was performed at a duty cycle of 1-
second contraction to 1-second relaxation 
 
 
 
Figure 2.4 Custom-made handgrip dynamometer 
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Circulatory occlusion 
Circulatory occlusion was achieved through the inflation of a thigh/arm cuff to a 
suprasystolic pressure (200 mmHg) using a rapid cuff inflator (E20, Hokanson Bellevue, 
WA, USA). In all trials in the thesis the circulatory occlusion of previously exercised 
muscles (PECO) maintained blood pressure above baseline until circulation was restored 
via cuff deflation (e.g. Figure 2.5). The deflation of the cuff also resulted in a transient 
hyperpnea. These observations are consistent with the trapping of exercised generated 
metabolites during cuff inflation and the consequential stimulation of the metaboreflex 
throughout PECO.   
 
  
 
 
 
 
Rest Exercise Recovery PECO 
ECG 
(V) 
BP 
(mmHg) 
O 
(l.sec
-1
) 
Time (seconds) 
Figure 2.5 Original recording of ECG, BP and ventilation (O) during rest, a rhythmic handgrip 
exercise task (40% MVC, 1 second duty cycle), PECO and recovery upon cuff deflation   
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2.2 Respiratory and Cardiovascular measures 
In all experiments ventilation was continuously monitored with a pneumotachograph 
(Flowmetrics, BRDL, fr-41 s, ultrasonic pneumotachograph, Chatsworth CA, USA) 
attached to the inspiratory side of a breathing valve (T-Valve) with a mouthpiece (Figure 
2.6). From this the inspiratory airflows (in litres per second) were recorded and minute 
ventilation (O) was calculated offline using custom-written script files. All volumes 
recorded were converted to BTPS. In chapters 3 and 4, where participants inhaled 
hypercapnic gas mixtures, corrugated tubing leading to a Douglas bag (filled with the 
hypercapnic gas mixture) was attached to the other end of the pneumotachograph. When 
participants inhaled air in these trials the corrugated tubing lead to open air. The 
pneumotachograph was calibrated with a three litre syringe to give a linear output over the 
range of 0.1 litres to 3 litres .  
End-tidal partial pressure of CO2 (PETCO2) was recorded throughout the protocol with a 
rapid gas analyser (Servomex, 1440, Sussex, UK) sampling the end tidal gases in the 
breathing valve. The analyser was calibrated using gases with a known concentration of 
CO2 (between 0% and 10%; BOC gases, Surrey, UK).    
R-R interval was measured from a 3-lead electrocardiogram (ECG; Cardiorator CR7, 
Cardiac Records Ltd, London, UK) in the lead II position. From this HR was continuously 
measured. Blood pressure was measured using finger photoplethysmography (Portapress, 
Finapress Medical Systems, Amsterdam, The Netherlands) with the cuff placed on the 
middle finger, and the hand supported at heart level on an adjustable table.  
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Mouthpiece 
Breathing valve 
To rapid gas 
analyser  
Pneumotachograph 
Figure 2.6 Pneumotachograph attached to the inspiratory side of a breathing valve (T-
Valve) with a mouthpiece. 
59 
 
2.3 Data analysis 
In all the experiments, all signals were sampled by an analogue-to-digital converter 
(Cambridge Electronic Design 1401 plus, CED, Cambridge, UK) at 1250 Hz, except the 
torque signal from the Biodex and handgrip dynamometer which was sampled at 625 Hz. 
Data was recorded and displayed using Spike 2 software (CED, Cambridge, UK). Raw 
data files were analysed offline using Custom Spike 2 script files which determined breath-
to-breath values for minute ventilation and PETCO2 as well as beat-to-beat values for heart 
rate, systolic blood pressure, diastolic blood pressure and mean arterial pressure. All 
statistical analysis was conducted using a standard statistical package (SPSS, Chicago, IL, 
USA). The statistical tests used in each experiment are detailed in the method sections in 
each chapter.  
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CHAPTER 3: THE VENTILATORY 
AND CARDIOVASCULAR 
RESPONSES TO MUSCLE 
METABOREFLEX AND 
MECHANOREFLEX ACTIVATION 
DURING CONCURRENT 
HYPERCAPNIA 
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3.1 Introduction 
It has been well established that the cardiovascular responses to exercise are in part 
controlled by the thin fibre (groups III and IV) afferent feedback arising from the 
exercising skeletal muscle (Alam & Smirk 1937; Coote et al. 1971, McCloskey & Mitchell 
1972). Traditionally, group IV afferents are primarily classified as chemically sensitive 
whereas group III afferents are predominantly mechanically sensitive, (Mense & Stahnke, 
1983; Kaufman et al. 1983, 1987), although the latter does display polymodal 
characteristics (Adreani & Kaufman 1998; Hayes et al. 2006). The role of muscle afferent 
feedback in the control of ventilation in exercise is more controversial. Several pieces of 
evidence from decerebrate animal preparations, where the modulating influences of higher 
brain areas are removed, have demonstrated that both metabolic and mechanical muscle 
afferent stimulation can result in hyperpnea (Coote et al. 1971; McCloskey & Mitchell 
1972, Tibes, 1977, Wilson et al. 1994, Hayes & Kaufman, 2001).  
In humans however the role of muscle afferent feedback was considered unimportant as 
evidenced by the classic finding in healthy humans that the activation of metabolically 
sensitive skeletal muscle afferents using PECO does not prevent the recovery of 
ventilation to resting levels (Rowell et al. 1976; Innes et al. 1989; Scott et al. 2000; 
Haouzi et al. 2001, Fukuba et al. 2007). Recently however Lykidis et al. (2010) found that 
muscle metaboreflex activation through PECO can produce ventilatory responses but only 
during a concurrent hypercapnia. The nature of this interaction between the metaboreflex 
and hypercapnia is not certain as of yet, but given that the muscle mechanoreflex may play 
a significant role in generating the respiratory response to exercise (Wilson et al. 1994; 
Hayes & Kaufman 2001) this study aims to examine the effects of muscle mechanoreflex 
activation during hypercapnia.  In addition the study will examine the combined effects of 
muscle mechano and metaboreflex activation on human ventilatory control in combination 
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with hypercapnia. A simple method of evaluating the effectiveness of human muscle 
mechanoreceptive afferents is the use of a sustained passive muscle stretch. This has the 
advantages of avoiding the involvement of both central command and muscle 
metaboreflex activation. 
Respiratory and cardiovascular responses to combinations of passive calf muscle stretch 
and PECO during inhalation of a hypercapnic gas mixture were examined in a series of 
trials. These controlled for the effects of 1) the sensitising effects on muscle afferents of 
metabolites produced during exercise and 2) hypercapnia induced elevated central 
respiratory drive, in the absence of central command. It was hypothesised that during 
concurrent hypercapnia, activation of the muscle metaboreflex would maintain ventilation 
at exercise levels and activation of the muscle mechanoreflex would further increase 
ventilation above levels recorded in PECO. During normocapnia it was hypothesised that 
mechano and metaboreflex activation would have no effect on ventilation.  
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3.2 Methods 
13 healthy male participants (20.8 ± 1.2 years old; 78.2 ± 11.1 kg; 179 ± 6.7 cm; mean ± 
SD) from the University of Birmingham student population took part in this study. All 
participants received written and verbal information regarding the experimental procedures 
prior to giving informed written consent. All subjects were habituated to all the 
experimental procedures, which conform to the Declaration of Helsinki and were approved 
by the local ethics committee. Participants visited the laboratory on two separate days 
following habituation. Before each day participants refrained from consuming food and 
caffeine in the 4 hours before the trial and from performing strenuous physical activity or 
consuming alcohol in the 12 hours before the trial. This study followed a within subject 
design with all subjects participating in all four trials. The order of each trial was 
randomised with a 30 minutes rest period in between.    
  
Experimental procedures 
Subjects were seated in the isokinetic dynamometer (Figure 2.1) and were prepared for the 
experiment as described in chapter 2. The experimental protocol is shown in figure 3.1. 
Prior to the start of the 13 minute protocol, participants inhaled either air or a normoxic, 
hypercapnic gas mix (5% CO2 in air; BOC gases, Surrey, UK) for 5 minutes (depending on 
the trial). This was done in order to establish a steady state in the ventilatory response to 
the hypercapnic gas mix before any further intervention. Pilot testing demonstrated that 5 
minutes was a long enough period to achieve this. Participants inhaled the 5% CO2 gas 
mix from a Douglas bag connected to the inspiratory side of a breathing valve and 
mouthpiece via a 2 metre length of corrugated tubing. Participants inhaled room air 
64 
 
through the corrugated tubing which was attached to a filled Douglas bag, but with a tap 
turned to room air.   
Following this 5 minute preparation period, data gathering commenced (time zero in figure 
3.1). Baseline measurements were taken for 2 minutes while the participants continued to 
rest. At 1: 55 minutes of this period a cuff around the participant’s right thigh was inflated 
to 200 mmHg to achieve circulatory occlusion. The 4 trials which then followed were: 
1) Control trial (CON), where after a further 5 minutes in the protocol, (minute 7 in figure 
3.1) passive stretch of the right calf was applied for 3 minutes.  
2) Exercise trial (EX), during which participants performed 90 seconds of isometric 
plantarflexion exercise (50% MVC) with their right leg (between 2 min and 3 min 30 s in 
figure 3.1). Passive stretch during PECO commenced at minute 7 of the protocol. 
3) CO2 trial (CO2), where participants inhaled 5% CO2 in air prior to commencement of 
the protocol which was the same as trial 1. This showed responses to passive stretch in 
hypercapnia.  
4) CO2+Exercise (CO2+EX), where participants inhaled 5% CO2 in air prior to 
commencement of the protocol which was the same as trial 2, during which the passive 
stretch was performed in PECO and with concurrent hypercapnia.         
In all 4 trials the cuff was then deflated at 11 minutes into the protocol followed by a 2 
minute recovery period.  All participants were asked to breathe normally and not to 
perform any abnormal respiratory manoeuvres throughout the protocol.  Participants were 
also asked to notify the experimenter if at any point they felt pain from the circulatory 
occlusion and muscle stretch so that the trial would be stopped. 
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Figure 3.1 Schematic diagram of the protocol. Ex signifies the period of isometric 
plantaflexion exercise. The period of circulatory occlusion in the 4 trials is shown by the 
black bar. All participants rested inhaling either air or the 5% CO2 in air gas mixture in the 
5 minutes immediately prior to the start of the above protocol. 
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Data analysis 
The respiratory and cardiovascular variables were recorded throughout the trial as 
described in chapter 2. Mean averages for minute ventilation (O), heart rate (HR), mean 
arterial pressure (MAP) and PETCO2 during each period of the trials were calculated. For 
both cardiovascular and respiratory data, these averages excluded the first 30 seconds after 
exercise, during which a new post-exercise steady state was established. In addition, for 
the respiratory data the final recovery value was calculated over the last 30 seconds of the 
2 minute recovery period, to allow adequate time for metabolite washout and the 
associated hyperpnoea to dissipate.    
A repeated measures two-way ANOVA, and where appropriate multiple comparison post 
hoc analysis, was used to examine differences in O, HR, MAP and PETCO2 between the 
four trials and between the six periods within each trial. A repeated measures one-way 
ANOVA and a students paired t test (two-tailed) was used to examine differences between 
the range of dorsiflexion about the ankle joint during passive stretch and the MVCs 
achieved between trials respectively. Data are expressed as mean ± SEM and statistical 
significance was taken as (P<0.05). Statistical analysis was conducted using a standard 
statistical package (version 19.0 SPSS, Chicago, IL, USA). 
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3.3 Results 
Contraction and passive stretch torques 
The MVCs measured prior to each exercise trial were not significantly different (P>0.05) 
from each other with values of 95.4 ± 8.2 and 99 ± 7.8 Nm being recorded before the 
CO2+EX and EX trials respectively. The range of motion about the ankle joint during the 
passive stretch was not significantly different (P>0.05) between trials with values of 32.7 ± 
1.4˚, 33.5˚ ± 1.7, 32.4 ± 1.4˚ and 32.5 ± 1.6˚ of dorsiflexion from vertical in the CON, EX, 
CO2 and CO2+EX trials, respectively. There were also no significant differences (P>0.05)  
between the peak torques generated during the passive stretch in each of these trial with 
values of 38.8 ± 1.4, 38.1 ± 2.4, 39.8 ± 2.3 and 39.8 ± 3 Nm respectively, then throughout 
the stretch period the torque decreased to 64.3%, 65.8%, 67.2% and 67.9% respectively of 
the peak torque generated in the four trials. 
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Differences between trials at baseline 
The mean O, HR and MAP during baseline are presented in Table 3.1 There were no 
significant differences in any of these variables between the CON and EX trials and also 
between the CO2 and CO2+EX trials. Breathing the normoxic hypercapnic gas mix 
significantly (P<0.05) increased O from CON by +27.67 ± 1.74 and +25.16 ± 1.89 l.min-1 
in the CO2 and CO2+EX trials respectively. MAP was also significantly higher during 
baseline in the CO2 trial (+13 ± 3.41 mmHg) and CO2+EX trial (+10 ± 2.66 mmHg) 
relative to the CON trial. However HR was not significantly different to the values 
recorded in the CON trial. The end-tidal partial pressure of CO2 (PETCO2) was 
significantly elevated from control values in the CO2 trial (+7 ± 0.85 mmHg) and in the 
CO2+EX trial (+8 ± 0.62 mmHg; P<0.05).  
 
 
 
 
 
 
 
Trial O(l.min-1) HR (beats.min-1) MAP (mmHg) PETCO2 (mmHg) 
CON 9.78 ± 0.86 62 ± 2.3 88 ± 2.6 40 ± 0.6 
EX 8.97 ± 0.64 63 ± 1.8 89 ± 3.2 41 ± 0.5 
CO2 37.44 ± 1.71* 68 ± 2 101 ± 3.3* 47 ± 1* 
CO2+EX 34.94 ± 1.78* 69 ± 2.7 98 ± 3.3* 48 ± 0.6* 
Table 3.1 Mean O, HR MAP and PETCO2 values recorded during the two minute baseline 
period in the CON, EX, CO2, CO2+EX trials. * Significant difference from CON trial 
(P<0.05).    
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Respiratory responses 
Figure 3.2.1 and 3.2.2 shows changes in mean O relative to baseline during each of the 
four trials. Figure 3.2.1 shows that exercise significantly increased O by +5.74 ± 0.82 
l.min
-1
 (P<0.05) in room air (EX trial) and it returned to baseline values during circulatory 
occlusion after exercise.  When breathing the hypercapnic gas mixture (CO2+EX trial) 
exercise increased O by +6.45 ± 0.75 l.min-1 (not different from EX trial, P<0.05) but in 
this case during PECO  it remained elevated close to the exercise level (+7.12 ± 1.13, 
P<0.05) . 
In the CO2+EX trial the further small increase in O during stretch did not reach statistical 
significant (P=0.245). In contrast, figure 3.2.2 shows that without prior exercise (CO2 trial) 
stretch caused a significant increase in O relative to PECO values (+2.5 ± 0.62 l.min-1; 
P<0.05). O was maintained at stretch levels during occlusion phase after stretch in the CO2 
and CO2+EX trials remaining significantly elevated above baseline (+3.72 ± 1.36 and 
+7.65 ± 1.53 l.min
-1
 versus baseline respectively; P<0.05). O then declined in both of these 
trials during recovery to levels similar to baseline (P>0.05). During the CON trial, O was 
not significantly altered from baseline during any of the experimental periods.  
Figure 3.3 shows the mean PETCO2 values during the different periods of the 4 trial 
conditions. During the exercise and circulatory occlusion periods prior to stretch the 
PETCO2 was not significantly changed from baseline. However, in the CO2+EX trial there 
were significant decreases in PETCO2 from baseline during the stretch and subsequent 
circulatory occlusion periods (P<0.05) with a return to baseline levels during the recovery 
period (P<0.05). In the CO2 trial there was a significant fall in PETCO2 during the 
circulatory occlusion period after stretch. There were no significant changes in PETCO2 
from baseline in any of the periods of the 2 normocapnic trials.     
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Figure 3.2.1 Change in O from baseline during each phase of the CO2+EX, and EX trials. The 
black bar shows the periods performed under circulatory occlusion. * Significant difference 
from Baseline value (P<0.05).  
 
* 
* 
* 
* 
† * 
* 
Figure 3.2.2 Change in O from baseline during each phase of the CO2, and CON trials. The 
black bar shows the periods performed under circulatory occlusion. * Significant difference 
from Baseline value (P<0.05). † Significant difference between the Stretch period and the 
previous Rest period (P<0.05).      
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Cardiovascular responses 
Changes in mean HR and MAP, relative to baseline, for each period of the 4 trials are 
shown in  figures 3.4 and 3.6 respectively. Both MAP and HR increased during exercise in 
both the CO2+EX trial (12 ± 1.5 mmHg and 14 ± 2.61 beats.min
-1
; P<0.05 versus baseline) 
and the EX trial (10 ± 1.1 mmHg and 14 ± 2.6;   P<0.05 versus baseline). As expected on 
cessation of exercise MAP fell from exercise levels but still remained significantly 
elevated above baseline during the subsequent circulatory occlusion period (P<0.05) with 
no significant difference between trials.  
Stretch caused a further significant increase (P<0.05) in MAP from the levels recorded 
immediately preceding it during circulatory occlusion in the CO2+EX trial (4 ± 0.85 
mmHg) the CO2 trial (5 ± 1.05 mmHg) and CON trial (4 ± 0.8 mmHg) but not in the EX 
trial (4 ± 1.2 mmHg; P=0.057). Stretch did not cause a significant overall increase in mean 
heart rate from preceding circulatory occlusion levels in any trial. However, stretch did 
cause a significant increase in HR in the first 15 seconds of the stretch period in all 4 trials, 
with increases ranging 5-6 beats.min
-1
 (Figure. 3.5; P<0.05). After the initial 15 seconds 
HR decreased to levels similar to the preceding circulatory occlusion period. 
During the recovery periods of each trial MAP and HR values were not significantly 
different from baseline (P>0.05).  
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Figure 3.4 Change in HR from baseline during each phase of the CO2+EX, CO2, EX and 
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Figure 3.5 Change in HR from levels in the previous period during the first 15 seconds of 
Stretch (STR 15) and the second 15 seconds of Stretch (STR 30) in the CO2+EX, CO2, EX 
and CON trials. * Significant difference from HR levels in the previous Rest period (P<0.05).  
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3.4 Discussion 
This investigation examined the respiratory and cardiovascular responses of humans to 
activation of muscle afferents during concurrent inhalation of a normoxic hypercapnic gas 
mixture. The main findings are that during conditions of hypercapnia, activation of the 
muscle metaboreflex using PECO, maintained ventilation at levels recorded during 
exercise. Furthermore, stimulation of muscle mechanoreceptors by passive muscle stretch 
during hypercapnia resulted in further increases in ventilation.  
Cardiovascular responses to PECO and stretch are reliable and sensitive indicators of 
muscle afferent activation (Coote et al. 1971; McCloskey & Mitchell 1972; Kaufman et al. 
1983; Fisher et al. 2005; Drew et al. 2008). Therefore the similar heart rate and blood 
pressure increases observed during these periods of the normocapnic and hypercapnic 
trials (Figures 3.4 – 3.6) suggests that muscle afferent activation was well controlled and 
matched between trials. In addition, there were no significant differences in the exercise 
intensities performed by the participants and similar stretch torques were applied to the 
calf muscles in each trial. Therefore, the ventilatory responses observed during the muscle 
metaboreflex activation (PECO) and mechanoreflex activation (stretch) periods of the 
hypercapnic trials (Fig 3.2.1 and 3.2.2) is unlikely to be due to increased muscle afferent 
activation (i.e. from enhanced muscle acidosis). This suggests that a central synergistic 
interaction between muscle afferent feedback and the hypercapnia induced chemoreflex is 
more likely. However whether a possible interaction in the peripheral exercised muscle 
contributes to the observed ventilatory responses requires more direct examination 
(chapter 4). 
It is clear that inhalation of the normoxic hypercapnic gas mixture activated the ventilatory 
chemoreflex because baseline minute ventilation increased almost 4 fold compared to 
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control levels. It is also clear that the two experimental procedures, of PECO and passive 
muscle stretch did indeed stimulate metaboreceptive and mechanoreceptive afferents 
within the skeletal muscle. Though this study did not directly measure the activity of group 
III and IV muscle afferents the cardiovascular responses that were observed are well 
established indicators of their activation.  Blood pressure was maintained above baseline 
(~7 mmHg) during PECO whilst HR returned to baseline values in both of the trials 
involving exercise. These findings are consistent with muscle metaboreflex activation and 
sustained sympathoexcitation during PECO (Alam & Smirk, 1937; Seals et al. 1988; Bull 
et al. 1989; Bell & White, 2005; Fisher et al. 2005). That passive stretch produced 
significant increases in HR in all four trials, is again consistent with previous reports in 
humans showing that it does stimulate muscle mechanoreceptors, and initiate tachycardia 
(Gladwell & Coote 2002; Gladwell et al. 2005; Drew et al. 2008). The initial increase in 
HR was shown to decline after 15 seconds towards pre-stretch levels. This is likely due to 
two factors; 1) tendon creep, where there is a progressive decline in tension within the 
muscle during the stretch and thus a lessening of the stimulus to the mechanoreceptors (in 
this study stretch torques declined by ~35%); and 2) adaptation of mechanoreceptive 
afferents to the applied stimulus (Kaufman et al. 1983; Kaufman & Rybicki, 1987).  
The stretch also produced 4-5 mmHg increases in BP from the pre-stretch levels in all four 
trials. Unlike the HR response to stretch, the BP response was sustained, implying that the 
stretch stimulated a population of mechanoreceptive afferents which can increase 
sympathetic vasomotor activity. Again this finding is consistent with other reports in the 
literature in human (Fisher et al. 2005; Drew et al. 2008) and in animal studies (Stebbins et 
al. 1988, Potts & Mitchell 1998) which demonstrated a progressive increase in BP during 
passive muscle stretch.  
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As expected from many previous studies (Rowell et al. 1976, Innes et al. 1989, Scott et al. 
2000, Haouzi et al. 2001, Fukuba et al. 2007) this study found that when breathing air, 
ventilation was not maintained at the exercising levels during PECO, rapidly returning to 
baseline levels when exercise ceased. This suggests that when activated alone, the muscle 
metaboreflex appears unable to evoke a ventilatory response, in healthy individuals. 
However, the current study also showed that during PECO with concurrent hypercapnia, 
ventilation was significantly maintained above baseline, only returning to resting levels 
upon restoration of circulation to the exercised muscle. This consolidates earlier work from 
our laboratory showing that in the presence of a sensitising level of CO2, muscle 
metaboreflex activation is able to stimulate breathing (Lykidis et al. 2010). In this earlier 
study minute ventilation was maintained at the exercising level throughout 2 minutes of 
post handgrip exercise circulatory occlusion with concurrent hypercapnia. The present 
study extends these findings by demonstrating that ventilation is maintained at exercising 
levels during a much longer period of PECO and following exercise of a larger muscle 
mass in the lower limb. This provides strong evidence that ventilation can be driven by 
metaboreflex activation in at least two human muscle groups.  
It was also demonstrated that passive stretch of the calf muscle did not produce any change 
in ventilation while participants were breathing air. In contrast, during hypercapnia the 
current study has shown for the first time in man, that stretch alone produces a further 
increase in ventilation. This effect was not dependent on co-activation of the muscle 
metaboreflex because in the CO2 trial, no prior exercise was performed to activate it, yet 
ventilation increased with stretch. Furthermore this observation suggests that a sensitising 
level of exercise generated metabolites is not necessary for the mechanoreflex to become 
an effective driver of ventilation. However, combined muscle mechanoreflex activation 
with a sensitising level of inhaled CO2 is required to elicit a ventilatory response. One 
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possible reason for the significant ventilatory response in the CO2 trial compared to the 
smaller non-significant increase in the CO2+EX trial, is that when the stretch was applied 
in the CO2+EX trial a small but significant reduction in PETCO2 had occurred, probably 
reducing the central stimulus (see limitations).  
It is possible that the ventilatory baroreflex had an effect on the respiratory responses 
observed during the trials with hypercapnia. Stewart et al. (2011) have shown that when 
blood pressure is changed acutely, using the modified Oxford technique, ventilation 
changes in an inverse relationship with blood pressure. Of particular relevance to the 
current study is their observation that under hypercapnic conditions this reflex was reset to 
higher blood pressures but importantly the sensitivity of the reflex remained unchanged. 
The implications of these new findings for my study are complex but in sum reveal that we 
the effects of muscle afferent activation on ventilation may have been underestimated. 
In the hypercapnia trials of the current study (with its associated baseline hypertension)  
the resetting of the  ventilatory baroreflex with maintained sensitivity means that it should 
still be capable of suppressing a ventilatory response to an acute blood pressure increase in 
PECO. Given that the current study found equal increases in blood pressure from the 
respective baseline levels, during PECO and PECO plus stretch both in the air breathing 
and hypercapnic trials, but only observed a ventilatory response to afferent activation 
during hypercapnia, it suggests that the afferent input was more effective at elevating 
ventilation, against the opposing activity of the ventilatory baroreflex in the hypercapnic 
conditions. This is taken as further indirect evidence for the suggestion that inhalation of 
the hypercapnic gas mixture has a central synergistic effect with afferent feedback.  
There is growing support for the idea that muscle afferent feedback can play a role in 
exercise hyperpnea.  The impressive recent work by Amman et al. (2010) where partial 
blocking of group III and IV afferent input into the spinal cord significantly attenuated the 
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ventilatory response to dynamic exercise has been particularly influential. Reductions in 
ventilation were observed even during mild exercise, where there would likely be little 
muscle metaboreflex activation but some muscle mechanoreflex activation in addition to 
central command. Likewise the current investigation supports the idea that the stimulation 
of both muscle mechano and metabosensitive afferents can generate a hyperpnea. 
 
Limitations  
Unlike in the trials by conducted by Lykidis et al. where PETCO2 was clamped at 47 
mmHg, one limitation with the methodology employed in the current study is that PETCO2 
was not maintained at a constant level throughout the CO2 and CO2+Ex trials. Indeed it fell 
significantly during the periods of muscle stretch due to the resultant hyperventilation. 
Therefore ventilation would be suppressed during these periods due to reduced afferent 
feedback from the central/peripheral chemoreceptors. As such the effects of the passive 
stretch may have an even greater effect on ventilation than those recorded here. 
A further issue within the CO2 and CO2+EX trials is the slight drifting increase in 
ventilation that occurred throughout the protocol. It is well known that after the initial 
increase in ventilation up to a new baseline upon exposure to hypercapnia, ventilation 
gradually drifts upwards and only a reaches a true steady state after 2-3 hours of sustained 
exposure (Reynolds et al. 1972; Tansley et al. 1998). In addition it is conceivable that 
ventilation may have also drifted upwards due to the stimulation of metaboreceptive 
muscle afferents from any slight and gradual metabolite accumulation in the resting 
ischemic leg. Therefore ventilation may have slightly drifted upwards throughout both 
trials involving hypercapnia in the current study. Indeed in the CO2 trial ventilation had 
progressively increased to ~1 l.min
-1
 above baseline in the period immediately prior to 
80 
 
stretching, even though no exercise was performed. As muscle stretching resulted in small 
increases in ventilation (compared with PECO) any drift makes it more difficult to 
determine the true contribution of the muscle mechanoreflex alone to the increase in 
ventilation. However because there was a significant increase in ventilation from this new 
level (or new baseline) immediately prior to the stretch, and there was also a decrease in 
ventilation post-stretch, this does imply that activation of the muscle mechanoreflex did 
enhance ventilation in the CO2 trial.   
 
Conclusion 
In summary the current study has shown that under hypercapnic conditions, stimulation of 
muscle metaboreceptive and mechanoreceptive afferents stimulates ventilation.  Although 
indirect evidence was produced which suggested that this interaction likely takes place 
through a central mechanism, further work is required to determine the nature of this 
interaction. 
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CHAPTER 4: MUSCLE 
METABOREFLEX CAUSES A 
VENTILATORY RESPONSE 
DURING CONCURRENT 
HYPERCAPNIA IN HUMANS: A 
CENTRAL INTERACTION? 
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4.1 Introduction 
The role of muscle afferent feedback in ventilatory control is controversial as evidenced by 
classical finding that ventilation returns to resting level during the stimulation of the 
muscle metaboreceptive afferents via PECO (e.g. Rowell et al. 1976). Recently however 
Lykidis et al. (2010) and the findings made in chapter 3 (Bruce & White 2012) 
demonstrated ventilatory responses to the activation of muscle metaboreflex (PECO) and 
mechanoreflex (passive muscle stretch) but only during concurrent hyperpnea. It was 
thought that the contribution of the muscle metabo and mechanoreflex in driving 
ventilation may have been unmasked by the sensitising effects of the concurrent 
hypercapnia.  
However, the nature of this interaction between muscle afferent feedback and the 
hypercapnia is still yet to be fully elucidated.  It may be that afferent feedback can only be 
effective in driving ventilation in the presence of a potentially interactive/synergistic input 
to the central respiratory neuronal pool such as the hypercapnia-induced ventilatory 
chemoreflex. Alternatively, it is plausible that the acute hypercapnia may exacerbate the 
exercise-induced muscle acidosis and therefore augment the afferent feedback arising from 
the muscle. Indeed muscle acidosis does appears to be a factor in stimulating the exercise 
pressor reflex (Rotto & Kaufman, 1988; Rotto et al. 1989; Sinoway et al. 1992, 1993) and 
ventilatory response (Rotto et al 1989) and so could explain the ventilatory responses 
observed in the studies conducted by Lykidis et al. and in chapter 3 (Bruce & White 2012).  
Therefore the first aim of this study is to examine whether the site of interaction between 
muscle afferent feedback and hypercapnia occurs centrally or at the level of the peripheral 
muscle. This will be achieved by measuring the ventilatory responses to PECO during 
either systemic hypercapnia or during a local hypercapnia (where hypercapnic blood is 
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trapped in the exercised muscle only). It is hypothesised that only during systemic 
hypercapnia activation of the muscle metaboreflex would maintain ventilation at exercise 
levels, (suggesting a central interaction between muscle afferent feedback and afferent 
feedback from central and/or peripheral chemoreceptors). 
Should this hypothesis be accepted, this study also aims to determine if the interaction 
occurs through hypercapnia-induced stimulation of peripheral and/or central 
chemoreceptors. This will be achieved by measuring the ventilatory responses to PECO 
during hyperoxic hypercapnia, which is considered to be an almost pure central 
chemoreceptor stimulus in humans (Miller et al. 1974, Cunningham et al. 1986). It is 
hypothesised that the ventilatory response to PECO would be unaffected by the hyperoxic 
hypercapnia suggesting that the central chemoreceptors are the primary driver of this 
interaction.    
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4.2 Methods 
Participants 
10 healthy male participants (21.1 ± 1.4 years old, 78 ± 5.7 kg, 179 ± 4 cm; mean ± SD) 
from the University of Birmingham student population volunteered to take part in this 
study. All participants received written and verbal information regarding the experimental 
procedures prior to giving informed written consent. All subjects were habituated to all the 
experimental procedures, which conform to the Declaration of Helsinki and approved by 
the ethics committee at the University of Birmingham.  
Following habituation to the procedures, participants visited the laboratory on 2 occasions 
for the 2 parts of the study (study 1 and 2). Before each day participants refrained from 
consuming food and caffeine in the 4 hours before the trial and from performing strenuous 
physical activity or consuming alcohol in the 12 hours before the trial. This study followed 
a within-subject design with all subjects participating in all trials. The order of each trial in 
the study 1 was randomised with a 30 minutes rest period in between.    
     
Study 1: Experimental procedures 
Subjects were seated in the isokinetic dynamometer (figure 2.1) and were prepared for 
experimentation as described in chapter 2. The protocol of the trials are shown in figure 
4.1. Both Trials began with a 2-minute rest period. Prior to the start of the experimental 
portion of the trials (12-22 minutes) the following manoeuvres were performed in order to 
establish either a local hypercapnia in the right leg or a systemic hypercapnia in the body 
excluding the right leg (Local trial and Systemic trial respectively).  
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In the Systemic trial participants rested for a further 5 minutes while inhaling air prior to 
the inflation of a cuff around the participant’s right thigh to 200mmHg by a rapid cuff 
inflator. Following the circulatory occlusion participants then inhaled a normoxic 
hypercapnic gas mixture (5% CO2 in air; BOC gases, Guilford, UK) for 5 minutes and for 
the rest of the trial. This achieved a systemic hypercapnia (excluding the right leg). 
Participants inhaled the 5% CO2 gas mixture for this 5 minutes prior to the start of the 
baseline recording period in order to establish a steady state in the ventilatory response to 
the hypercapnic gas mix. Pilot testing demonstrated that 5 minutes was a long enough 
period to achieve this. In the Local trial, the same procedure was followed but participants 
first inhaled the hypercapnic gas mix first for 5 minutes and then air (following thigh cuff 
inflation) for 5 minutes and for the rest of the trial. This achieved a local hypercapnia of 
the right leg.  
Participants inhaled the 5% CO2 gas mix from a Douglas bag connected to the inspiratory 
side of a breathing valve and mouthpiece via a 2 metre length of corrugated tubing. 
Participants inhaled room air through the corrugated tubing which was attached to a filled 
Douglas bag, but with a tap turned to room air.   
Following these 12-minute manoeuvres achieving a systemic or local hypercapnia both 
trials then consisted of a 2-minute baseline recording period before the 1.5 minute 
isometric plantaflexion exercise with their right calf. Participants then underwent a 3.5 
minute period of PECO before the thigh cuff was deflated and 3 minutes of recovery.    
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Figure 4.1 Schematic diagram of the protocol for study one. Ex signifies the period of 
isometric plantarflexion exercise. Base signifies the 2-minute baseline recording period. 
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Study 2: Experimental procedures 
 Subjects were seated in the isokinetic dynamometer in the same way as the first 
experiment. The protocol of this trial (Hyperoxia trial) is shown in figure 4.2. Prior to the 
start of the 13-minute protocol, participants inhaled a normxic hypercapnic gas mix (5% 
CO2 in air; BOC gases, Guilford, UK) for 5 minutes. Participants inhaled the gas mix from 
a Douglas bag connected to the inspiratory side of a breathing valve and mouthpiece via a 
2 metre length of corrugated tubing.  Following this 5-minute preparation period, data 
gathering commenced (time zero in figure 4.2). Baseline measurements were taken for 2 
minutes while the participants continued to rest. At 1min 55seconds of this period a cuff 
around the participant’s right thigh was inflated to 200 mmHg by a rapid cuff inflator to 
achieve circulatory occlusion. At 2 minutes into the trial participants performed 1.5 
minutes of isometric plantarflexion exercise (50% MVC) with their right leg (between 
minutes 2 - 3.30 in figure 4.2). Participants then rested for 3.5 minutes at which point they 
were switched to inhale a hyperoxic hypercapnic gas mixture (95% O2 and 5% CO2; BOC 
gases, Guilford, UK) for 1 minute. This 1 minute time period what chosen to avoid the 
paradoxical phenomenon known as hyperoxic hyperventilation which arises 1-2 minutes 
after exposure to hyperoxia (see Dean et al. 2004 for a short review). Following this they 
were switched back to the normoxic hypercapnic gas mix which they inhaled until the end 
of the trial. At minute 10 of the trial the thigh cuff was deflated and participants recovered 
for 3 minutes.   
All participants were asked to breathe normally and not to perform any abnormal 
respiratory manoeuvres throughout all trials in study 1 and 2. Participants were also asked 
to notify the experimenter if at any point they felt pain from the circulatory occlusion so 
that the trial would be stopped. 
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Figure 4.2 Schematic diagram of the protocol for study two (hyperoxia trial). Ex signifies the 
period of isometric plantarflexion exercise. 
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Data analysis 
The respiratory and cardiovascular variables were recorded throughout the trial as 
described in chapter 2. Mean averages for minute ventilation (O), heart rate (HR), mean 
arterial pressure (MAP) and PETCO2 during each period of the trials were calculated. For 
all measurements, these averages excluded the first 30 of the PECO period so a new steady 
state post-exercise could be established and the recovery period is a mean of the final 1 
minute to allow adequate time for metabolite washout post occlusion.  A repeated 
measures two-way ANOVA, and then when appropriate multiple comparison post hoc 
analysis, was used to examine differences in O, HR, MAP and PETCO2 between the two 
trials of study 1, and between the periods within the experimental portions of the trials in 
study 1 and 2. A repeated measures one-way ANOVA was used to examine differences in 
O, HR, MAP and PETCO2 between the periods of study 2 and to also examine the 
differences in the MVCs and the baseline O, HR, MAP and PETCO2, between the Central, 
Local and Hyperoxia trials. Data are expressed as mean ± SEM and statistical significance 
was taken as (P<0.05). Statistical analysis was conducted using a standard statistical 
package (SPSS, version 19, Chicago, IL, USA). 
Data are expressed as mean ± SEM and statistical significance was taken as (P<0.05). 
Statistical analysis was conducted using a standard statistical package (SPSS, version 19, 
Chicago, IL, USA). 
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4.3 Results 
Maximal voluntary contraction torques 
The MVCs measured prior to each trial of study 1 were not significantly different (P>0.05) 
from each other with mean values of 84.2 ± 4.2 and 86.1 ± 2.9 ± Nm recorded before the 
Systemic and Local trials respectively. Furthermore these MVCs were not significantly 
different from those recorded prior to the Hyperoxia trial, with a mean value of 82 ± 4.6 
Nm. 
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Differences between trials at baseline 
The mean O, HR, MAP and PETCO2 during baseline are presented in Table 4.1. There 
were no significant differences in any of these variables between the systemic trial and 
Hyperoxia trial. Breathing the normoxic hypercapnic gas mixtures in the systemic trial and 
Hyperoxia trial significantly (P<0.05) increased baseline O from the levels measured 
whilst breathing room air (local trial) by +21.5 ± 3.5 l.min
-1 
and +22.6 ± 3.1 l.min
-1
,
 
respectively. Furthermore MAP was also significantly higher during baseline in both the 
systemic trial (+10 ± 4.3 mmHg) and Hyperoxia trial (+7 ± 3.6 mmHg) relative to the local 
trial. However HR was not significantly different to the values recorded in the local trial. 
The PETCO2 was significantly elevated in the systemic trial (+11 ± 1.3 mmHg) and in the 
Hyperoxia trial (+10 ± 0.9 mmHg; P<0.05) compared with the values recorded in the local 
trial.  
 
 
 
 
 
 
Trial O (l.min
-1
) HR (beats.min
-1
) MAP (mmHg) PETCO2 (mmHg) 
Local 11.7 ± 1.4 71 ± 2.1 96 ± 3.4 39 ± 1.7 
Systemic 33.3 ± 3.8* 74 ± 3.1 106 ± 5.2* 50 ± 1.2* 
Hyperoxia 34.3 ± 2.7 * 73 ± 3.7 103 ± 4.6 * 49 ± 0.6 * 
Table 4.1 Mean O, HR MAP and PETCO2 values recorded during the 2 minute baseline period 
in the Local, Systemic and Hyperoxia trials. * Significant difference from Local trial 
(P<0.05).    
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Respiratory responses 
Figure 4.3 shows changes in mean O relative to baseline during the 2 trials of the study 1. 
Exercise significantly increased O by +3.9 ± 1.1 l.min-1 (P<0.05) in room air (Local trial) 
and it returned to baseline values during PECO. When breathing the normoxic hypercapnic 
gas mixture (Systemic trial) exercise increased OI by +4.5 ± 0.8 l.min
-1
 to a similar level as 
in Local trial but during PECO it remained elevated significantly above baseline (+4.9 ± 
0.8 l.min
-1
; P<0.05). O then declined in the systemic trial post cuff deflation during the 
recovery period to levels similar to baseline (P>0.05).  
Figure 4.4 shows the mean PETCO2 values during the different periods of the Local and 
Systemic trials. Throughout the Systemic trial PETCO2 remained significantly elevated 
above the values recorded in the Local Trial (P<0.05), but within each trial PETCO2 did not 
significantly alter from baseline levels (P>0.05). 
 Figure 4.5 shows changes in mean O relative to baseline during the Hyperoxia trial. 
Exercise resulted in a significant increase in O from baseline (+4.7 ± 1.2 l.min
-1
; P<0.05) 
and this was not significantly different from the responses to exercise in either the 
Systemic or Local trial. O remained significantly above baseline during PECO (+4.3 ± 1 
l.min
-1
; P<0.05) and did not significantly change from this level whilst participants inhaled 
the hyperoxic hypercapnic gas mixture (PECO + hyperoxia period). O then declined in the 
Hyperoxia trial post cuff deflation during the recovery period to levels similar to baseline 
(P>0.05). Figure 4.6 shows the mean PETCO2 values during the different periods of the 
95% trial. Throughout the trial PETCO2 did not significantly alter from baseline levels 
(P>0.05).  
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Figure 4.3 Changes in O relative to baseline in the Systemic and Local trials. The black bar 
indicates the phases of the experimental protocol where circulation of the leg was occluded. * 
significant difference from baseline value (P<0.05).     
* 
* 
Figure 4.4 PETCO2 during the Systemic and Local trials. The black bar indicates the phases of 
the experimental protocol where circulation of the leg was occluded. 
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Figure 4.5 Changes in O relative to baseline in the Hyperoxia trial. The black bar indicates 
the phases of the experimental protocol where circulation of the leg was occluded. * 
significant difference from baseline value (P<0.05).     
Figure 4.6. PETCO2 during the Hyperoxia trial. The black bar indicates the phases of the 
experimental protocol where circulation of the leg was occluded. 
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Cardiovascular responses 
Changes in mean MAP and HR relative to baseline, in the 2 trials of the study 1, are shown 
in figures 4.7 and 4.8, respectively. Both MAP and HR increased during exercise similarly 
in both the Local trial (15 ± 2 mmHg and 15 ± 3 beats.min
-1
; P<0.05 versus baseline) and 
in the Systemic trial (15 ± 4 mmHg and 16 ± 5;   P<0.05 versus baseline). As expected on 
cessation of exercise MAP fell from exercise levels but still remained significantly 
elevated above baseline during PECO (P<0.05) with no significant difference between 
trials. During the recovery periods of each trial MAP and HR values were not significantly 
different from baseline (P>0.05).  
Changes in mean MAP and HR relative to baseline, in the Hyperoxia trial of study 2, are 
shown in figures 4.9 and 4.10 respectively. Both MAP and HR increased during exercise 
in the Hyperoxia trial (14 ± 3 mmHg and 15 ± 2 beats.min
-1
; P<0.05 versus baseline) and 
these values were not significantly different to those recorded in the Local and Systemic 
trials of study 1. Again on cessation of exercise MAP reduced from exercise levels but 
remained significantly elevated above baseline during PECO (P<0.05). Furthermore MAP 
did not significantly alter from this level while participants inhaled the hyperoxic 
hypercapnic gas mix in PECO. During the recovery periods MAP and HR values were not 
significantly different from baseline (P>0.05).   
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Figure 4.7 Changes in MAP relative to baseline in the Systemic and Local trials. The black bar 
indicates the phases of the experimental protocol where circulation of the leg was occluded. * 
significant difference from their respective baseline values (P<0.05).     
Figure 4.8 Changes in HR relative to baseline in the Systemic and Local trials. The black bar 
indicates the phases of the experimental protocol where circulation of the leg was occluded. * 
significant difference from their respective baseline values (P<0.05).     
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Figure 4.9 Changes in MAP relative to baseline in the Hyperoxia trial. The black bar 
indicates the phases of the experimental protocol where circulation of the leg was occluded. 
* significant difference from baseline value (P<0.05).     
Figure 4.10 Changes in HR relative to baseline in the Hyperoxia trial. The black bar 
indicates the phases of the experimental protocol where circulation of the leg was occluded. 
* significant difference from baseline value (P<0.05).     
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4.4 Discussion  
This study investigated the ventilatory and cardiovascular responses of humans to the 
activation of the muscle metaboreflex during either a systemic or local (restricted to the 
exercised muscle) normoxic hypercapnia. The main finding from this experiment was that 
only during systemic hypercapnia did activation of the metaboreflex, using PECO, 
maintain ventilation at the levels recorded during exercise. This suggests a central 
interaction between skeletal muscle afferent feedback and the afferent feedback from 
central and/or peripheral chemoreceptors. Furthermore, this ventilatory response during 
PECO was not altered by the inhalation of a hyperoxic hypercapnic gas mixture suggesting 
that the central chemoreceptors are the primary driver of this interaction.    
The cardiovascular responses to PECO are known to be a sensitive and reliable indicator 
of muscle afferent activation (Coote et al. 1971; McCloskey & Mitchell, 1972; Kaufman & 
Rybicki, 1987) and in all three trials blood pressure during PECO was maintained 
significantly above baseline (~6 mmHg), while heart rate returned to pre-exercise levels. 
This is consistent with muscle metaboreflex activation and sustained sympathoexcitation 
during PECO (Alam & Smirk, 1937; Seals et al. 1988; Bull et al. 1989; Bell & White. 
2005; Fisher et al. 2005). Furthermore, the similar heart rate and blood pressure responses 
recorded in all three trials suggest that the level of muscle afferent activation was similar 
between each trial. 
It has been consistently demonstrated that when breathing air ventilation rapidly returns to 
baseline levels during PECO (Rowell et al. 1976, Innes et al. 1989, Scott et al. 2000, 
Haouzi et al. 2001, Fukuba et al. 2007). These results suggest that activation of the muscle 
metaboreflex alone is unable to stimulate ventilatory responses. However, it has since been 
shown that metaboreflex activation can produce ventilatory responses during concurrent 
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hypercapnia (Lykidis et al. 2010, chapter 3). The current study has shown that this 
interaction is not due to the hypercapnia exacerbating the exercise induced muscle acidosis 
and therefore augmenting the afferent feedback arising from the muscle. This is evidenced 
by the finding that when the hypercapnic blood was restricted to the exercised muscle no 
ventilatory responses to PECO were observed.   
Muscle metaboreflex activation through PECO was only able to stimulate ventilatory 
responses during systemic hypercapnia. These results suggest a central synergistic 
interaction between muscle afferent feedback and the afferent signals from central and/or 
peripheral chemoreceptors as the ventilatory responses were greater than the sum of the 
two individual mechanisms. Indeed it is well known that there are several converging 
signals that can stimulate respiratory neurones within the brainstem (see Daly, 1995 for 
review). In the present study (and the study in the previous chapter) three of these signals 
have been manipulated; 1) skeletal muscle afferent feedback though PECO 2) feedback 
from both central and peripheral chemoreceptors through the inhalation of the hypercapnic 
gas mix and 3) feedback from the ventilatory baroreflex. The observations made in this 
investigation could be explained by a synergistic interaction between the enhanced 
feedback from chemoreceptors during hypercapnia and skeletal muscle afferents. 
Therefore the breathing responses to muscle afferent stimulation (PECO) can only be 
observed under the hypercapnic conditions when the combined actions of muscle afferent 
feedback and chemoreflex overcome the opposing action of the ventilatory baroreflex. So 
in effect the chemoreflex has perhaps unmasked the involvement of muscle afferents in 
ventilatory control. 
Indeed an interaction could well take place in NTS, a vital integrating site in the dorsal 
brainstem and key for autonomic regulation including that of respiration (Paton, 1999). 
Both peripheral chemoreceptor and skeletal muscle afferents are known to project there 
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(Kalia et al. 1981, Donoghue et al. 1984, Li et al. 1998, Potts et al. 1999, Paton et al. 
2001), and it has further been established that the NTS may be one of several sights for 
central chemoreception (Nattie & Li 2002, 2009; Feldman 2003). Therefore, the 
ventilatory responses observed may be the result of the integration between chemoreceptor 
and muscle afferent feedback through the activation of NTS neurones. 
The current study has also established that the central chemoreceptors appear to be the 
primary driver of this interaction. This is because the inhalation of a hyperoxic, 
hypercapnic gas mixture (an almost pure central chemoreceptor stimuli, Miller et al. 1974; 
Cunningham et al. 1986). had no effect on the ventilatory responses recorded during 
muscle metaboreflex activation. However, it must be conceded that there may be an 
element of redundancy and so peripheral chemoreceptors might still play a role in this 
interaction. However the findings do suggest the central chemoreceptors alone are at least 
adequate to stimulate the full response independently. 
 
Implications 
These results may have possible implications for the control of ventilation in exercise. Of 
course in normal exercise arterial blood gases are not altered, and in heavy exercise 
individuals may even become hypocapnic. However because a central interaction was 
observed in the current study it has become possible to speculate that synergistic 
interactions of a comparable nature occur with other medullary inputs active in exercise 
(e.g. central command, which like the chemoreflex can also increase central respiratory 
drive). This will be examined in chapter 5 where I will investigate whether augmented 
levels of muscle afferent feedback can increase the ventilatory responses during exercise 
and/or PECO. If augmented ventilatory responses are only observed in exercise then this 
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again implies that the stimulation of muscle afferents seem to be only able to generate 
ventilatory responses in the presence of other possibly interactive/synergistic inputs that 
are active in exercise. If augmented responses are observed in both exercise and PECO 
then this would imply that muscle afferent stimulation alone can produce ventilatory 
responses but it requires a more powerful activation of the muscle metaboreflex via PECO, 
perhaps to overcome the ventilatory baroreflex.   
 
Conclusion 
During systemic normoxic hypercapnia activation of the metaboreflex using PECO 
maintains ventilation at the levels recorded during exercise suggesting an interaction 
between skeletal muscle afferent feedback and the afferent feedback from central and/or 
peripheral chemoreceptors. Furthermore, this ventilatory response during PECO was not 
altered by the inhalation of a hyperoxic hypercapnic gas mixture suggesting that the central 
chemoreceptors are the primary driver of this interaction.    
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CHAPTER 5: MUSCLE 
METABOREFLEX ACTIVATION 
INCREASES VENTILATION 
DURING EXERCISE BUT NOT 
DURING PECO 
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5.1 Introduction 
The control of the human exercise hyperpnea is still not fully understood, yet the feed-
forward signals from higher brain centres known as central command, which concurrently 
activates motor and cardiorespiratory control areas of the brain, is widely considered to 
contribute. The most compelling evidence for this in humans comes from studies that 
manipulate the level of central command input required to perform a given exercise task 
and a corresponding alteration in ventilation is observed (Asmussen et al. 1965 Goodwin 
et al. 1972, Galbo et al. 1987, Innes et al. 1992). Furthermore several possible sites of the 
neurocircuitry involved in central command have been identified (Thornton et al. 2001, 
Green et al. 2007).  
The role played by group III and IV skeletal muscle afferent fibres in controlling the 
exercise hyperpnea has also been examined. Recently it has been shown that the blockade 
of skeletal muscle afferent feedback, through the intrathecal injection of the μ-opiate 
agonist fentanyl into the L3-L4 vertabral space, significantly reduced the ventilatory and 
cardiovascular responses of humans to a dynamic cycling exercise. However when muscle 
afferents have been stimulated in isolation through the technique of PECO ventilation 
returns to baseline levels immediately upon the cessation of exercise (Rowell 1976, Innes 
et al. 1989, Scott et al. 2000, Haouzi et al 2001, Fukuba et al. 2007).  
It is possible that the effects of muscle afferent activation can only be observed during 
exercise where the neural feedback from active muscles is working in combination with 
other potentially synergistic inputs that increase central respiratory drive in exercise, e.g. 
central command. Indeed interactions between muscle afferent activation and the 
hypercapnia-induced ventilatory chemoreflex have been observed (Lykidis et al., 2010; 
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Chapters 3 and 4), so it is possible that there are other neural interactions that occur with 
muscle afferent feedback in exercise and cause ventilatory responses.  
 One method that has tested this is the application of circulatory occlusion during dynamic 
exercise. As such the metabolic by-products of exercise are trapped within the exercising 
muscle, and provide additional stimulus for muscle metaboreceptive afferents, where they 
would normally be washed away during the relaxation phase of the rhythmic muscle 
contractions. Asmussen & Nielsen (1964) occluded the circulation to the legs of human 
subjects with upper thigh cuffs for 3 minutes during a 60 W cycling exercise task. During 
occlusion ventilation increased from a steady state of approximately 25 l.min
-1
 to a 
maximum of 45 l.min
-1
 at the end of the 3 minute occlusion period. Heart rate (+35 
beats.min
-1
) and blood pressure (+30 mmHg) increases during the occlusion phase were 
also observed. Similar effects of circulatory occlusion during dynamic cycling exercise 
have also been shown elsewhere (Sargeant et al. 1981; Stanley et al. 1985), where the 
significant increases in ventilation and reductions in PETCO2 were maintained until cuff 
deflation.  
However as ventilation returns to normal upon the cessation of exercise despite sustained 
muscle ischemia Asmussen & Nielsen concluded that perhaps the ventilatory responses 
recorded during occlusion are not due to muscle metaboreflex activation but are a 
reflection of greater central motor neural drive and central command activation being 
required to compensate for the reduced capability of the ischemic muscle. Indeed the use 
of surface EMG suggested that more motor units were active during the occlusion 
implying that central command input may have been increased (Asmussen & Nielsen, 
1964).  
Nevertheless, the augmented ventilatory response during exercise could also be explained 
by an increased activation of the metaboreflex, suggesting that muscle afferent feedback 
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can stimulate ventilatory responses. As ventilation returns to baseline in PECO this would 
imply that muscle afferent stimulation can only increase ventilation during exercise, 
perhaps while other synergistic inputs such as central command are active and elevating 
central respiratory drive. However, one concern with these studies is that the vast 
metabolic build up that presumably took place during circulatory occlusion does not 
happen in normal dynamic exercise. As such these studies do not provide strong evidence 
that the metaboreflex plays a role in stimulating the normal exercise hyperpnea. 
Therefore the protocol of the current study aims to resolve these issues. It involves the 
dynamic exercise of a single leg with free flowing circulation followed by PECO of that 
leg immediately upon cessation of the exercise. Once ventilation has returned to baseline 
then the contralateral leg will perform dynamic exercise. It is hypothesised that the 
ventilatory response to the exercise of the contralateral leg will be augmented by the 
metaboreflex activation from PECO of the first leg. This protocol is advantageous not only 
because the level of metabolite build up may more closely reflect that during normal 
exercise but also because the level of neural drive (central command) required to activate 
the second leg will not be affected by the ischemia of the first. 
If augmented ventilatory responses to exercise are observed from the enhanced muscle 
metaboreflex activity a secondary aim is to determine whether there are any differences 
between the ventilatory responses to PECO of one leg vs. two legs. Indeed ventilatory 
responses to PECO have been demonstrated but only if the muscle mass and consequential 
local metabolite accumulation is great enough (Iellemo et al. 1999). If augmented 
ventilatory responses were found in response to greater metaboreflex activation during 
exercise and PECO then this would imply that the cause of the enhanced response was due 
solely to the greater metaboreceptor stimulation. Conversely, if this response is only 
observed during exercise then this implies that the effects of muscle afferent feedback on 
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ventilation may have been unmasked by a possible synergistic interaction with another 
control mechanism of the exercise hyperpnea (e.g. central command).  
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5.2 Methods 
12 healthy male participants (21.7 ± 2.1 years old; 76.2 ± 7.8 kg; 175 ± 9.7 cm; mean ± 
SD) from the University of Birmingham student population took part in this study. All 
participants received written and verbal information regarding the experimental procedures 
prior to giving informed written consent. All subjects were habituated to all the 
experimental procedures, which conform to the Declaration of Helsinki and were approved 
by the local ethics committee. Participants visited the laboratory for one day following 
habituation to perform the trials. Before the trial day participants refrained from 
consuming food and caffeine in the 4 hours before the trials and from performing 
strenuous physical activity or consuming alcohol in the 12 hours before the trial. This 
study followed a within subject design with all subjects participating in both trials. The 
order of each trial was randomised with a 30 minutes rest period in between.    
 
Experimental procedures 
Participants were seated in the customised electrically braked cycle ergometer (figure 2.3) 
and were prepared for the experiment as described in chapter 2. The experimental protocol 
is shown in figure 5.1. Prior to the start of each 17-minute trial, participants sat quietly for 
5 minutes so that the cardiorespiratory variables reached a steady state. Following this 5 
minute period, data gathering commenced (time zero in figure 5.1). Baseline 
measurements were taken for 2 minutes while the participants continued to rest. 
Participants then performed a right-legged cycling exercise task for 2 minutes. The 2 trials 
which then followed were: 
1) Control trial (CON), where participants rested for 4 minutes and then performed a 2 
minute left-legged cycling exercise task. Upon cessation of exercise a cuff around the 
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participant’s left upper thigh was inflated to 200 mmHg by a rapid cuff inflator to achieve 
circulatory occlusion. This period of PECO continued for 4 minutes until the cuff was 
deflated. 
2) PECO trial (PECO), where upon cessation of the right legged exercise a cuff around the 
participant’s right upper thigh was inflated to 200 mmHg. This period of PECO continued 
until the 14
th
 minute of the protocol. Then identically with the control trial at 8 minutes 
participants performed the 2-minute left-legged cycling exercise task and upon cessation of 
exercise a cuff around the participant’s left upper thigh was inflated to 200 mmHg. At the 
14
th
 minute of the trial both thigh cuffs were deflated. 
In both trials after the cuff/s was deflated participants rested in a 3 minute recovery period.  
All participants were asked to breathe normally and not to perform any abnormal 
respiratory manoeuvres throughout the protocol. Participants were also asked to notify the 
experimenter if at any point they felt pain from the circulatory occlusion so that the trial 
would be stopped. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Schematic diagram of the protocol. Ex signifies the period of one-legged cycling 
exercise. PECO signifies the period of post-exercise circulatory occlusion. R and L signifies 
whether the right or left leg respectively is performing the exercise or undergoing PECO. 
Trial 
CON 
PECO 
0 1 2 3 4 5 6 
 
7 8 9 10 11 12 13 14 
Minutes 
15 16 17 
Baseline Ex (R) Ex (L) Rest PECO (L) Recovery 
Baseline Ex (R) 
Ex (L) + 
PECO (R) PECO (R) PECO (R & L) Recovery 
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Data analysis 
The respiratory and cardiovascular variables were recorded as described in chapter 2. 
Mean averages for each O, HR, MAP and PETCO2 during each minute of the protocols 
were calculated. A repeated measures two-way ANOVA, and where appropriate multiple 
comparison post hoc analysis, was used to examine differences in O, HR, MAP and 
PETCO2 within the two trials and between each minute of the two trials. Data are expressed 
as mean ± SEM and statistical significance was taken as (P<0.05). Statistical analysis was 
conducted using a standard statistical package (SPSS, Chicago, IL, USA). 
 
 
 
 
 
 
 
 
 
 
 
 
110 
 
5.3 Results 
Differences between trials at baseline 
The mean O, HR, MAP and PETCO2 during baseline are presented in Table 5.1 
There were no significant differences in any of these variables between the CON and 
PECO trials.  
 
 
 
Respiratory responses 
Figure 5.2 shows changes in mean O relative to baseline during the CON and PECO trials. 
Right leg exercise significantly increased O from baseline in both trials and by the second 
minute of exercise it increased by +14.8 ± 1 l.min
-1
 and 14.1 ± 0.7 l.min
-1
 (P<0.05) in the 
CON and PECO trials, respectively. O returned back to baseline levels following exercise. 
Left leg exercise then significantly increased O in both the CON (+14.2 ± 0.8 l.min-1, 
P<0.05 versus baseline) and PECO trials (+16.9 ± 1.4 l.min
-1
, P<0.05 versus baseline). 
This increase in O during exercise was significantly greater during the second minute of 
the PECO trial compared with the CON trial (+2.8 ± 0.7 l.min
-1
, P<0.05). O then returned 
back to baseline levels following exercise in both trials. Upon cuff deflation and 
metabolite washout, O increased significantly in the first minute of the recovery period of 
PECO trial (P<0.05) but not the CON trial.  
Trial O(l.min-1) HR (beats.min-1) MAP (mmHg) PETCO2 (mmHg) 
CON 6.87 ± 1.1 68 ± 2.1 84 ± 2.7 40 ± 0.4 
PECO 6.7 ± 1.2 67 ± 1.6 83 ± 1.7 40 ± 0.3 
Table 5.1 Mean O, HR MAP and PETCO2 values recorded during the two-minute baseline 
period in the CON and PECO trials. 
. * Significant difference from Control trial (P<0.05).    
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Table 5.2 shows the mean PETCO2 values during the different periods of the 2 trial 
conditions. Throughout both trials, there was no significant change in PETCO2 from 
baseline levels and no difference between the 2 trials. 
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Control 
PECO 
Trial 
Baseline Exercise R Rest/ 
PECO R 
Exercise L PECO L/ 
PECO LR 
Recovery 
CON 40 ± 0.4 39 ± 0.6 41 ± 0.4 39 ± 0.4 41 ± 0.6 39 ± 0.6 
PECO 40 ± 0.4 39 ± 0.4 41 ± 0.3 37 ± 0.4 40 ± 0.3 40 ± 0.6 
Exercise R Rest/PECO R Exercise L PECO L/ PECO RL Recovery 
Figure 5.2. Change in O from baseline (Base) during each minute of the CON and PECO 
trials. * Significant difference from Baseline  value (P<0.05). † Significant difference 
between trials. 
Time (Minutes) 
Table 5.2 PETCO2 during each phase of the CON and PECO trials. * Significant difference 
from Baseline value (P<0.05). 
* 
* 
* 
* 
* * 
† 
* 
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Cardiovascular responses 
Changes in mean MAP and HR relative to baseline in the 2 trials are shown in figures 5.3 
and 5.4, respectively. Right-legged exercise increased HR and MAP in both trials similarly 
and by the second minute of exercise they increased by (12 ± 1 mmHg and 32 ± 4 
beats.min
-1
; P<0.05 versus baseline) in the CON trial and (13 ± 2 mmHg and 33 ± 2;   
P<0.05 versus baseline) in the PECO trial. As expected on cessation of exercise HR fell 
from exercise levels and returned to baseline during the last 3 minutes of the Rest/PECO R 
period in both trials. MAP also returned to baseline in the CON trial, however in the PECO 
trial MAP remained significantly elevated above baseline during the PECO R period 
(P<0.05 versus baseline).  
During left-legged exercise HR again increased in both the CON trial (32 ± 1 beats.min
-1
; 
P<0.05 versus baseline) and in the PECO trial (38 ± 2; P<0.05 versus baseline). This 
increase in heart rate in response to the exercise was significantly greater during the 
second minute of the PECO trial compared with the CON trial (+6 ± 2 beats.min
-1
, 
P<0.05). MAP also significantly increased in the CON trial during the left legged exercise 
(13 ± 1 mmHg; P<0.05 versus baseline) and from an elevated level MAP increased in the 
PECO trial (16 ± 2 mmHg; P<0.05). This exercise produced a similar increase in MAP 
from the previous period (Rest/PECO R) in both the CON (12 ± 2 mmHg) and PECO trials 
(10 ± 2 mmHg). 
Following the exercise of the left leg HR returned to baseline in the CON and PECO trials. 
However, MAP remained significantly elevated above baseline during both the trials 
(P<0.05). Furthermore MAP was significantly higher during the PECO L/PECO RL 
period in the PECO trial compared with the CON trial (P<0.05). During the recovery 
period of each trial, MAP and HR values were not significantly different from baseline 
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(P>0.05) except during the first minute of the recovery period in the PECO trial where HR 
was transiently increased. 
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Figure 5.3. Change in MAP from baseline (Base) during each minute of the CON and PECO trials. * 
Significant difference from Baseline value (P<0.05). † Significant difference between trials. 
 
Figure 5.4. Change in HR from baseline (Base) during each minute of the CON and PECO trials. * 
Significant difference from Baseline value (P<0.05). † Significant difference between trials. 
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5.4 Discussion 
This investigation examined the respiratory and cardiovascular responses of humans to 
exercise during enhanced muscle afferent activation. The main findings are that during 
conditions of increased muscle metaboreflex activity, through PECO of one leg, the 
ventilatory and heart rate responses to the exercise of the contralateral leg were 
augmented. This suggests that during exercise the stimulation of metabolically sensitive 
afferent receptors in skeletal muscle contribute to the ventilatory and heart rate responses. 
Furthermore both ventilation and heart rate returned to baseline levels upon cessation of 
exercise despite the continued circulatory occlusion which activated the muscle 
metaboreflex in isolation. Therefore as ventilation and heart rate were only augmented by 
additional metaboreflex activation during exercise, it suggests a possible synergistic 
interaction between the neural feedback from the working muscle and other inputs active 
during exercise that can increase central respiratory drive and heart rate.  
 
Muscle afferent activation 
Although the activity of group III and IV muscle afferents were not directly measured, the 
cardiovascular responses to PECO are reliable and sensitive indicators of muscle afferent 
activation (Coote et al. 1971; McCloskey & Mitchell, 1972; Kaufman et al.  1983). 
Therefore the blood pressure increases and heart rate recovery observed during PECO of a 
single leg clearly suggests that metabolically sensitive muscle afferent fibres were 
stimulated during the circulatory occlusion and resulted in a sustained sympathoexcitation. 
(Alam & Smirk, 1937; Rowell et al. 1976, Seals et al. 1988; Bull et al. 1989; Bell & 
White, 2005)  In addition, the blood pressure response to PECO of both legs was 
significantly higher still and therefore suggests a greater metaboreflex activation.   
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Respiratory responses 
The results above show that the PECO-induced stimulation of muscle metaboreceptors in 
one leg potentiates the ventilatory response to exercise of the contralateral leg. This clearly 
suggests that metabolically sensitive muscle afferents can stimulate increases in ventilation 
during exercise. These results are supported by studies that applied circulatory occlusion 
during concurrent dynamic cycling exercise (Asmussen & Nielsen, 1964; Sargeant et al. 
1981; Stanley et al. 1985). They demonstrated significant elevations in ventilation while 
the circulatory occlusion of the exercising muscles persisted and then returned to steady 
state after circulation was restored. An alternate method of examining the role of human 
muscle afferent activation in the control of ventilation is lower body positive pressure 
(LBPP). This technique reduces muscle blood flow to the lower limbs (Rowell et al., 
1991) and slows the washout of exercise induced metabolites. It has been shown that 
during LBPP, the ventilatory responses to dynamic exercise are increased and can be 
graded proportionately to the level of pressure (Williamson et al., 1993). This again 
implies that an augmented metabolic build up stimulates ventilation and supports the 
concept that muscle afferents can contribute to the exercise ventilatory response. 
However the design of the current investigation is advantageous as circulatory occlusion of 
each leg took place immediately upon cessation of the dynamic cycling exercise and 
therefore the level of metabolite build up may more closely reflect that during normal 
exercise. Furthermore, the circulatory occlusion or reduction in blood flow through LBPP 
of the exercising muscle may result in a greater level of neural drive (i.e. central 
command) being required to compensate for any reduced functional capability of the 
ischemic muscle. Therefore a greater level of central command activation may account for 
the greater ventilatory responses observed by the studies above. However in the current 
investigation the level of central motor drive required to activate the contralateral leg will 
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likely not be affected by the post-exercise ischemia of the first. Consequently any change 
in the ventilation (and heart rate) response to exercise will arguably not be due to any 
alteration in central command activation.  
In the current investigation minute ventilation during exercise of the left leg was ~15% 
greater during PECO of the right leg. Conversely Asmussen & Nielson (1964) found that 
minute ventilation almost doubled by the end of their 3 minute circulatory occlusion 
period. The difference in the augmented responses between studies could be due to several 
reasons. Firstly, as described above, there may be differences in the levels of central 
command activation and metabolic build up in the muscle. In addition some group III 
afferents display polymodal characteristics and as such their responses to mechanical 
stimuli can be potentiated by metabolic by products of muscle contraction (Hayes et al. 
2006). Therefore circulatory occlusion during exercise may result in an increased 
discharge of these afferents for the same mechanical stimulus. In the current investigation 
this sensitisation is not possible as the circulation of the resting leg was occluded.  
However not all studies have observed an increase in minute ventilation to the circulatory 
occlusion of dynamically exercising muscles. For example Fordyce et al. (1982) found no 
change in the ventilatory response to a rhythmic foot dorsiflexion exercise. In this study, 
the duration of this “mild” exercise was only 30 seconds and the ventilatory response to it 
was relatively small compared to the studies of Asmussen & Nielsen, Sargeant et al. and 
Stanley et al. Because only a small muscle mass was exercise at a low intensity and for a 
short duration it is likely that an inadequate metabolic build-up developed in order for a 
difference in the ventilatory response between trials to be observed.    
When developing the current protocol, static calf plantarflexion exercise was used in a 
pilot study. Interestingly, a small increase in minute ventilation was observed, similar to 
that seen by Fordyce et al. but there was no augmented ventilatory response to single-
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legged exercise during PECO of the contralateral leg (for reference this data is shown in 
appendix, figure 8.2). This trial followed an almost identical protocol to that of the current 
study except that the exercise was a 2-minute isometric calf plantarflexion at 50% MVC. 
Because of the exercise intensity/duration this null finding is unlikely due to an inadequate 
metabolic stimulus. Indeed there was a difference of ~5mmHg in the MAP response to 
exercise of the left leg between trials. Rather it is probably more likely that ventilatory 
response to static exercise was not large enough for a small percentage difference to be 
detected.  
In the present study, during exercise the circulatory occlusion of the previously exercised 
leg caused increased ventilatory responses and yet as expected during PECO alone (one 
and two legged) ventilation returned to baseline levels. This latter finding is consistent 
with many previous reports (Rowell 1976, Innes et al. 1989, Scott et al. 2000, Haouzi et al 
2001, Fukuba et al. 2007). So why was a ventilatory response seen during exercise but not 
during PECO?  
Metaboreflex activation through PECO seems to give precedence to a blood pressure 
response, presumably to maintain adequate perfusion to the muscle and facilitate the 
washout of trapped metabolites. However, the resultant pressor response to PECO, in the 
absence of central command, may suppress ventilation through the ventilatory baroreflex. 
So perhaps only during exercise where the muscle metaboreflex is operating in 
combination with other possibly synergistic inputs to central respiratory neuronal pool 
(e.g. central command) can the stimulation of metabolically sensitive afferents cause an 
increase in ventilation against the opposing actions of the ventilatory baroreflex.   
In contrast to the findings of the current study, Iellamo et al. (1999) has provided evidence 
that metaboreflex activation via PECO can induce ventilatory responses. These responses 
however only manifested when a larger muscle mass (static knee extesnion vs. static 
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handgrip) was exercised at a higher intensity (30% vs. 15% MVC for 3 minutes), so that 
the resultant metabolite accumulation was great enough. As such it seems that PECO can 
cause ventilatory rate responses if the metaboreflex activation is robust enough. If not then 
the current study has provided evidence that the muscle metaboreflex can operate in 
combination with other possibly synergistic inputs active during exercise (e.g. central 
command) and cause ventilatory responses.  
Indeed there is evidence that central interactions between central command and muscle 
afferent feedback might be possible. Intriguing new evidence in humans has been 
produced suggesting a potential role of the PAG in the integration of central command and 
muscle afferent feedback. The PAG is thought to be a component in the neurocircuitry of 
central command as the stimulation of the dorsal PAG increases blood pressure (Green et 
al. 2005) and the anticipation to exercise and actual exercise causes increases in the neural 
activity of the PAG (Green et al. 2007). Now it has been shown that both blood pressure 
and the neural activity of the PAG can also increase in response to muscle afferent 
activation via PECO (Basnayake et al. 2011). Therefore the PAG is an area of the 
brainstem where synergistic interactions like those described above could conceivably 
occur.  
 
Heart rate responses 
Although this study was principally concerned with ventilation, augmented heart rate 
responses were also produced to the left legged exercise during the PECO of the 
contralateral leg. This suggests that metabolically sensitive muscle afferents can also 
stimulate increases in heart rate during exercise. Indeed increased heart rate responses to 
cycling exercise have also been found by Asmussen & Nielsen (1964) during the 
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circulatory occlusion of the exercising muscle. These current findings are in contrast to 
much of the literature which suggests that central command (Krogh & Lindhard 1913; 
Goodwin et al. 1972) and the muscle mechanoreflex (Gladwell & Coote, 2002; Gladwell 
et al. 2005) are the major contributors to the increase in heart rate during exercise, whereas 
the muscle metaboreflex plays little or no role as classically evidenced by the return of 
heart rate to resting levels during PECO (Rowell et al. 1976).  
However the elimination of cardiac parasympathetic tone, with glycopyrrolate, results in 
the incomplete recovery of heart rate during circulatory occlusion following a moderate 
intensity static handgrip exercise (25% MVC; Fisher et al. 2010). These results suggest 
that the PECO induced metaboreflex can increase cardiac SNA in humans and elicit heart 
rate response, but it is usually masked by parasympathetic reactivation post exercise. This 
reactivation is likely due to the loss of central command and mechanoreflex input and also 
the influence of the baroreflex on the heart. 
The results of the current investigation may support this conclusion as heart rate responses 
to the additional metaboreflex activation in the PECO trials were only shown during the 
exercise of the contralateral leg. Therefore only during concurrent central command and 
muscle mechanoreflex activation, where parasympathetic activity will be withdrawn, could 
the metaboreflex induced increases in cardiac SNA be manifested as a tachycardia. 
Moreover there is evidence in animals and humans that in addition to a further upward and 
rightward resetting of the cardiac baroreflex, its sensitivity is decreased in response to 
augmented metaboreflex activation during dynamic exercise (Sala-Mercado et al. 2007, 
2010; Hartwich et al. 2011). All together these findings provide evidence that 
metaboreflex activation can drive heart rate during exercise.  
In the current investigation no heart rate responses were observed to PECO alone. 
However, Fisher et al. also found that circulatory occlusion following a higher intensity 
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static handgrip exercise (40% MVC), where there will be a greater degree of local 
metabolite accumulation, resulted in the incomplete recovery of heart rate. As this was not 
affected by parasympathetic blockade it provides evidence that a stronger muscle 
metaboreflex activation is capable of increasing cardiac SNA (and heart rate) and 
overcome the cardiac parasympathetic reactivation post exercise itself.  
 
Limitations  
Ideally greater exercise intensities would also be used to assess the effects of muscle 
metaboreflex activation at a wider range of minute ventilations and heart rates. However 
due to the study design we are limited to the current exercise intensity (50 watts for 2 
minutes) as a maximum. This is because the greater the intensity the more time required 
for ventilation and heart rate to return back to baseline levels flowing the initial right 
legged exercise. This means that the period of PECO of the right leg would need to be 
extended beyond 10 minutes and based upon our own observations this is approximately 
the maximum length of time before the circulatory occlusion following a cycling exercise 
becomes uncomfortable or even painful for the participant. 
One further limitation with the methodology employed is that PETCO2 was not maintained 
at a constant level throughout the trials and slightly fell during the left-legged exercise 
period of the PECO trial, (although this remained a statistically non-significant change). 
As a result ventilation could potentially be suppressed through reduced feedback from 
central and/or peripheral chemoreceptors and so the effects of the additional metaboreflex 
activity during exercise may have an even greater effect on ventilation than that recorded 
here. Because in normal exercise PaCO2 does not change then any future studies should 
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perhaps employ a methodology that clamps PETCO2 at resting levels so a truer contribution 
of muscle afferent feedback might be observed. 
 
Conclusion 
This current investigation examined the ventilatory responses of humans to exercise during 
enhanced muscle afferent activation. It was shown that during conditions of increased 
muscle metaboreflex activity, the ventilatory responses to the exercise were augmented. 
However when the metaboreflex was activated in isolation, via PECO, blood pressure 
remained elevated but ventilation returned to baseline levels, possibly due to the effects of 
the ventilatory baroreflex. These findings suggest that only during exercise where the 
muscle metaboreflex is operating in combination with other possibly synergistic inputs, 
such as central command, can the stimulation of metabolically sensitive afferents drive 
increases in ventilation.  
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CHAPTER 6: THE VENTILATORY 
AND CARDIOVASCULAR 
RESPONSES TO MUSCLE 
METABOREFLEX ACTIVATION IN 
COPD 
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6.1. Introduction 
COPD is an umbrella term for the occurrence of both chronic bronchitis and emphysema 
which commonly co-exist and classically cause increases in airflow resistance and lung 
hyperinflation. Chronic bronchitis is associated with a narrowing of the airways resulting 
in airflow limitation and the inadequate ventilation of the lungs. The damage to alveolar 
walls in emphysema results in the enlargement of these air spaces and therefore the surface 
area available for gas exchange is reduced. Emphysema also reduces the elasticity of the 
lung which reduces the support for the airways making them likely to collapse and further 
limit airflow. Airflow limitation and reduced elastic recoil of the lungs slows the rate at 
which the lungs empty in expiration. Hence during exercise, where respiratory rate is 
increased, air can remain trapped in the lungs resulting in lung hyperinflation and increases 
in the mechanical work required to breathe. 
One of the most common symptoms of COPD is that of exercise intolerance which is in 
part caused by the physiological respiratory impairments described above and the 
consequential psychological sensations of dyspnea (O’Donnell & Webb 2008; O’Donnell 
et al. 2009). Dyspnea (or breathlessness) arises during exercise due to the combined effects 
of the increased central respiratory drive and the already impaired respiratory function 
(O’Donnell et al. 2009). However, the weak correlation between FEV1 and exercise 
capacity suggests that factors other than impaired lung function must also be involved 
(Killian et al. 1992; Gosselink et al. 1996). Indeed there is considerable evidence that in 
addition to respiratory impairments exercise can be limited by skeletal muscle 
weakness/fatigue, so abnormalities in skeletal muscle function also seems to significantly 
contribute to the exercise intolerance of COPD patients (Killian et al. 1992; Hamilton et 
al. 1996, Gosselink et al. 1996, Serres et al. 1998 Aliverti & Macklem, 2001; Casaburi et 
al. 2001; Man et al. 2003).  
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Skeletal muscle atrophy is common in COPD and results in the significant reductions in 
strength associated with the disease (Gosselink et al. 1996; Bernard et al. 1998; Engelen et 
al. 2000). In terms of the contractile and metabolic characteristics of skeletal muscle, it is 
well documented that there is a slow to fast transition of muscle fibre types (Whittom et al. 
1998; Jobin et al. 1998; Gosker et al. 2002), that glycolytic enzyme activity is increased 
(Jakobsson et al. 1995; Gea et al. 2001) and that mitochondrial density and (accordingly) 
oxidative enzyme activity is reduced (Jakobsson et al. 1995; Gosker et al. 2002, 2007). 
These maladaptations may be important determinants in reducing fatigue resistance 
commonly found in COPD (Serres et al. 1998; Coronell et al. 2004; Allaire et al. 2004; 
Saey et al. 2005). During exercise the increased glycolytic capacity and shift away from 
oxidative metabolism results in an early onset lactic acidosis and decreased muscle pH. 
(Casaburi et al. 1991; Kutsuzawa et al. 1992; Maltais et al. 1996). Furthermore this lactic 
acidosis has been shown to increase the ventilatory response to a given exercise intensity 
in COPD (Casaburi et al. 1991) and so may contribute to the sensations of dyspnea and 
exercise intolerance.   
The factors which underlie this skeletal muscle dysfunction have also been examined and 
muscular disuse caused by the physical inactivity generally displayed by COPD patients 
likely contributes (Serres et al. 1998). Indeed this concept is part of the dyspnea spiral 
(figure 6.1) described by Prefaut et al. (1995). Patients avoid physical exertion to prevent 
the unpleasant sensations of dyspnea. This however has the consequence of causing further 
deconditioning of skeletal muscles along with the associated metabolic changes in muscle 
and early lactic acidosis in exercise. Hence this provides a stimulus to exaggerate the 
exercise ventilatory response further and exacerbate the sensations of dyspnea. In this way, 
dyspnea and exercise tolerance can spiral downwards over time.  
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Figure 6.1 Dyspnea spiral from Serres et al. (1998a). 
 
 
Furthermore the chronic hypoxemia, caused by the mismatch between alveolar ventilation 
and perfusion (Kent et al. 2011), and resultant muscle tissue hypoxia is also a possible 
factor in the derangements of skeletal muscle function and metabolism. It has been 
demonstrated in humans that chronic exposure to hypoxia results in the increase in 
glycolytic enzymes and decrease in oxidative enzymes within skeletal muscle (Howald et 
al. 1990, Hoppeler et al. 2003) and also causes muscle atrophy (Hoppeler et al. 2003). In 
addition, malnutrition and the use of corticosteriods in the treatment of exacerbations have 
also been implicated as possible factors in the development of muscle atrophy and 
consequential weakness. For review see Wüst & Degens, (2007) and Man et al. (2009).   
The features of the skeletal muscle dysfiunction described above appear to be similar to 
that shown in CHF (Franssen et al. 2002) which are likely caused by factors such as 
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chronic under perfusion of the muscle (due to increased sympathetic vasomotor activity) 
and the deconditioning associated with inactivity (Piepoli et al. 2008; Rehn et al. 2012). In 
addition to the derangements in central haemodynamics, these muscle abnormalities are 
thought to be a key factor in the exercise intolerance caused by the disease (Rehn et al. 
2012). During exercise CHF is associated with excessive sympathoexcitation and 
cardiovascular responses and also with the sensations of dyspnea from excessive 
ventilatory responses, both of which contribute to exercise limitation (Sinoway & Li, 
2005; Piepoli et al. 2008). Augmented skeletal muscle afferent feedback is widely 
considered to be a contributing factor to these abnormal responses to exercise, but it is still 
hotly debated whether this is due to increased stimulation of muscle metaboreceptors or 
greater activation/sensitivity of muscle mechanoreceptors (Sterns et al. 1991; Piepoli et al. 
1996; Silber et al. 1998, Notarius et al. 2001; Middlekauff et al. 2004; Middlekauff & 
Sinoway, 2007; Piepoli & Coats, 2007).  
Nevertheless there is considerable reproducible evidence that CHF patients can display 
exaggerated muscle metaboreflex activity to PECO, after both handgrip exercise (rhythmic 
and static) and cycling exercise, resulting in augmented ventilatory and cardiovascular 
responses (Piepoli et al. 1996, 1999; Silber et al. 1998, Scott et al. 2000, 2002; 
Ponikowski et al. 2001; Notarius et al. 2001; Crisafulli et al. 2007; Olson et al. 2010). 
Indeed an exaggerated metaboreflex may provide a ‘neural link’ between the known 
skeletal muscle dysfunction in these patients and their exercise intolerance. Thus a 
‘muscle-hypothesis’ of exercise intolerance was developed (Piepoli et al. 1999). It is 
proposed that the abnormalities in skeletal muscle (e.g. decreased oxidative capacity, early 
muscle acidosis, impaired muscle perfusion) may enhance metabolite accumulation in 
exercise, and as such increase the stimulation of muscle metaboreceptive afferents 
resulting in exaggerated increases in ventilatory drive and sympathetic vasomotor 
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activation.  This may contribute to the common symptoms of early onset fatigue and 
dyspnea during physical activity and so exacerbate the skeletal muscle abnormalities 
further due the intolerance to exercise resulting in inactivity and deconditioning of the 
muscle.  This process is described as a “vicious cycle” and it of course has obvious 
parallels to the aforementioned dyspnea spiral in COPD. 
It is therefore plausible that an exaggerated metaboreflex response may provide a neural 
link between skeletal muscle abnormalities and the sensations of dyspnea and exercise 
intolerance in COPD, and as such may play a role in the “dyspnea spiral”. However, 
whether these patients have an augmented metaboreflex and/or a metaboreflex induced 
ventilatory response is still yet to be fully examined. Therefore the first aim of this study is 
to examine whether patients with moderate to severe COPD have greater ventilatory 
responses to PECO in comparison to healthy controls 
Some patients with COPD retain CO2 and are chronically hypercapnic, the mechanisms of 
which have been reviewed elsewhere (Roussos & Koutsoukou, 2003). In brief the airflow 
resistance and ventilation/perfusion mismatch do not always correlate well with PaCO2 
and other mechanisms have been implicated. These include a desensitisation of central 
chemoreceptors to CO2 and impairments in respiratory mechanics. However because many 
chronically hypercapnic patients can voluntarily ventilate more to become normocapnic 
(Robin & O’Neill, 1963) this lead to the concept of the “wise fighter” where some patients 
may ‘choose’ to hypoventilate, presumably to prevent respiratory muscle fatigue.   
This incidence of a chronically elevated PaCO2, which can further increase during exercise 
(Jones, 1966; Light et al. 1988), is another possible factor involved in generating the 
sensations of dyspnea upon exertion in COPD. It has been shown in patients with a wide 
ranging severity of COPD and who also retain CO2, that the most important stimulus for 
dyspnea in these patients, during incremental exercise on a cycle ergometer, is an 
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increased arterial PCO2 (Cloosterman et al. 1998). It has recently been shown in healthy 
individuals that ventilation can remain elevated during PECO but only under conditions of 
acute hypercapnia (Lykdis et al. 2010; Bruce & White, 2012). Therefore it is possible that 
the ventilatory response to metaboreflex activation will be augmented further in 
chronically hypercapnic COPD patients and contribute to sensations of dyspnea. As such 
the secondary aim is to examine whether there are any differences in these responses to 
PECO between patients who are hypercapnic (PaCO2 > 45 mmHg) and patients who are 
normocapnic. 
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6.2 Methods 
18 patients with stable moderate to severe COPD were recruited from the outpatient clinics 
in the respiratory medicine department at Heartlands Hospital. Patients were not 
considered stable and excluded from participation if in the previous 6 weeks they had been 
hospitalised or had exacerbations. Patients with heart failure/disease or an active 
malignancy revealed by medical history were also excluded. COPD and its severity were 
defined according to Global Initiative for Obstructive Lung Disease (GOLD) criteria. 
Hence COPD was defined as FEV1/FVC ratio <70% after the application of bronchodilator 
medication. Moderate COPD was defined as a FEV1% predicted between 50%-79% and 
severe COPD between 30%-49%. 9 healthy age and gender matched controls also 
volunteered for this study. Patient pulmonary function data and participant characteristics 
are shown in table 6.1. All participants received written and verbal information regarding 
the experimental procedures prior to giving informed written consent. All subjects were 
habituated to all the experimental procedures, which conform to the Declaration of 
Helsinki and were approved by an NHS ethical committee.  
Participants visited the laboratory for 1 trial day following habituation. On the trial day 
participants refrained from consuming food and caffeine in the 4 hours before the trial and 
from performing strenuous physical activity or consuming alcohol in the 12 hours before 
the trial. This study followed a within subject design with all subjects participating in both 
trials. The order of each 8-minute trial was randomised with a 30 minutes rest period in 
between.    
Experimental procedures 
Participants were seated in an upright position, held a custom-made handgrip 
dynamometer (figure 2.4) with their right hand and were prepared for the experiments as 
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described in chapter 2. The experimental protocol is shown in figure 6.2. Prior to the start 
of each trial participants rested for 5 minutes in order to establish a steady-state in 
ventilation and cardiovascular variables. Both trials then consisted of a 2-minute baseline 
recording period before a 2-minute rhythmic handgrip exercise task. Participants then 
either: 
1) Rested for a further 4 minutes (Control trial) or  
2) A cuff was rapidly inflated to 200mmHg around the upper right arm by a rapid cuff 
inflator immediately after exercise to achieve circulatory occlusion and so participants 
went through a 2-minute period of PECO. Then the cuff was deflated and participants 
rested for 2 minutes (PECO trial) 
 
 
 
 
 
Data analysis 
Respiratory and cardiovascular variables were recorded as described in chapter 2. Mean 
averages for O, HR, MAP and PETCO2 during each minute of the trials were calculated.  A 
repeated measures two-way ANOVA, and then when appropriate multiple comparison post 
hoc analysis, was used to examine the differences in O, HR, MAP and PETCO2 responses 
within each of the trials (baseline and minutes 3-8) and also the differences between trials 
(COPD vs. Healthy trials and also COPD hypercapnic vs. COPD normocapnic trials). A 
Student’s unpaired samples t-test (two-tailed) was used to examine differences between the 
group means shown in table 6.1 and 6.3. Data are expressed as mean ± SEM and statistical 
Figure 6.2. Schematic diagram of the 8-minute protocol for the Control and PECO trials. 
131 
 
significance was taken as (P<0.05). Statistical analysis was conducted using a standard 
statistical package (SPSS, version 19, Chicago, IL, USA). 
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6.3 Results 
Participant characteristics 
 Participant characteristics are presented in Table 6.1 COPD patients produced 
significantly lower handgrip forces (P<0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Healthy COPD 
N 9 (5 male) 18 (10 male) 
Age 67.7 ± 6.1 65.1 ± 5.1 
Height (cm) 167.1 ± 4.9 162.2 ± 3.2 
Weight (Kg) 71.8 ± 3.7 75.6 ± 3.1 
Handgrip Force (N) 298 ± 45 246 ± 37* 
Resting SBP (mmHg) 125 ± 3.2 119 ± 2.4 
Resting DBP (mmHg) 78 ± 2.6 75 ± 1.9 
Resting MAP (mmHg) 93 ± 3.1 89 ± 1.6 
Resting HR (bpm) 71 ± 1.6 68 ± 1.3 
FEV1 (L) - 1.06 ± 0.3 
FEV1 (% predicted) - 42 ± 5.7 
FVC (L) - 2.35 ± 0.9 
FEV1/FVC (%) - 45 ± 3.4 
PaO2 (mmHg) - 67.4 ± 9.2  
PaCO2 (mmHg) - 43.4 ± 6.5 
pH - 7.41 ± 0.03 
HCO3 (mEq.L
-1
) - 27.8 ± 3.1  
Table 6.1 Participant characteristics (± SD). * Significant difference from Healthy Control 
participants (P<0.05). FEV1, forced expiratory volume in one second; FVC, forced vital 
capacity; HCO3, arterial bicarbonate content. 
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Differences between trials at baseline 
The mean O, HR, MAP and PETCO2 during baseline are presented in Table 6.2 There were 
no significant differences in any of these variables between the Control and COPD 
participants.  
 
 
 
 
 
 
 
 
 
 
 
 
Trial O (l.min-1) HR (beats.min-1) MAP (mmHg) PETCO2 (mmHg) 
Healthy Control 8.72 ± 0.92 68 ± 1.3 93 ± 3.1 39 ± 1.6 
Healthy PECO 9.09 ± 1.02 69 ± 1.4 95± 3.8 39 ± 0.9 
COPD Control 9.94 ± 0.6 71 ± 1.6 89 ± 1.6 45 ± 2.2 
COPD PECO 10.37 ± 0.54 72 ± 1.6 90 ± 1.9 44 ± 2.3 
Table 6.2 Mean O, HR MAP and PETCO2 values recorded during the two-minute baseline 
period in the Healthy Control, Healthy PECO, COPD Control and COPD PECO trials. 
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Respiratory responses 
Changes in mean O relative to baseline that were recorded during each of the 4 trials are 
shown in figure 6.3.1 and 6.3.2. Exercise caused a significant increase in O during the first 
and second minute of exercise in all trials. During the second minute of exercise O 
increased by 6.33 ± 0.82 l.min
-1
 and 5.64 ± 0.68 l.min
-1
 in the Healthy Control and Healthy 
PECO trials respectively. In the COPD Control and COPD PECO trials O increased by 8.1 
± 0.64 l.min
-1
 and 8.38 ± 0.81 l.min
-1
 respectively. The differences in the ventilatory 
response to exercise between the Healthy Control and COPD Control trials and between 
the PECO and COPD Control trials both reached significance in the second minute of 
exercise (P<0.05). O retuned to baseline levels in both the Healthy Control and Healthy 
PECO trials following exercise. O remained significantly above baseline during the first 
minute after exercise in the COPD Control trial (2.23 ± 0.33 l.min
-1
) but returned to 
baseline in the second minute. During the COPD PECO trial O remained significantly 
elevated above baseline during both minutes post exercise (3.82 ± 0.68 l.min
-1
 and 2.78 ± 
0.51 l.min
-1
) and only returned to baseline after cuff deflation. O during PECO in the 
COPD PECO trial was significantly higher than that in the Healthy PECO trial. During the 
recovery period, O was not significantly different from baseline in all 4 trials (P>0.05). 
Figure 6.4 shows the mean PETCO2 values during throughout the 4 trials. There was no 
significant change in PETCO2 from baseline levels within each trial and no difference 
between the trials. 
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Figure 6.3.1 Change in O from baseline during each phase of the Healthy Control and COPD 
Control trials. * Significant difference from respective baseline values (P<0.05). 
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Figure 6.3.2 Change in O from baseline during each minute of the Healthy PECO and COPD 
PECO trials. The black bar shows the periods performed under circulatory occlusion. * 
Significant difference from respective baseline values (P<0.05). † Significant difference 
between COPD and Healthy trials. 
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Cardiovascular responses 
Changes in mean HR and MAP relative to baseline during the 4 trials are shown in figures 
6.5-6.6. Both MAP and HR significantly increased during exercise in the Healthy Control 
trial (13 ± 2.3 mmHg and 12 ± 1.5 beats.min
-1
; P<0.05 versus baseline), in the Healthy 
PECO trial (13 ± 1.6 mmHg and 14 ± 1;   P<0.05 versus baseline), in the COPD Control 
trial (14 ± 1.1 mmHg and 13 ± 1 beats.min
-1
; P<0.05 versus baseline) and in the COPD 
PECO trial (13 ± 1 mmHg and 12 ± 1.2 beats.min
-1
;   P<0.05 versus baseline). MAP and 
HR returned to baseline levels after exercise in the Healthy Control and COPD Control 
trials. However in both the PECO trials MAP fell from exercise levels but remained 
significantly elevated above baseline during the 2 minutes post exercise (P<0.05) and only 
returned to baseline after cuff deflation. There were no significant differences in the MAP 
responses during PECO in both the Healthy PECO and COPD PECO trials. During the 
recovery period, both MAP and HR values were not significantly different from baseline 
in all 4 trials (P>0.05).  
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Figure 6.5.1 Change in MAP from baseline during each minute of the Healthy Control and 
COPD Control trials. * Significant difference from respective baseline values (P<0.05). 
 
Figure 6.5.2 Change in MAP from baseline during each minute of the Healthy PECO and 
COPD PECO trials. The black bar shows the periods performed under circulatory occlusion. 
* Significant difference from respective baseline values (P<0.05). 
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Figure 6.6.1 Change HR from baseline during each minute of the Healthy Control and COPD 
Control trials. * Significant difference from respective baseline values (P<0.05). 
 
Figure 6.6.2 Change in HR from baseline during each phase of the Healthy Control and 
COPD PECO trials. The black bar shows the periods performed under circulatory occlusion. 
* Significant difference from respective baseline values (P<0.05). 
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Hypercapnic vs. Normocapnic COPD patients 
COPD patients have been separated into two groups for further analysis: Hypercapnic 
patients (PaCO2 > 45mmHg) and normocapnic patients 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
COPD 
normocapnic 
COPD 
hypercapnic 
N 9 (5 male) 9 (5 male) 
Age 64.3 ± 6.1 67.6 ± 5.1 
Height (cm) 160.1 ± 3.8 164.6 ± 3.2 
Weight (Kg) 76.8 ± 3.7 74.6 ± 3.1 
Handgrip Force (N) 239 ± 56 250 ± 51 
Resting SBP (mmHg) 116 ± 4.6 121 ± 3.9 
Resting DBP (mmHg) 79 ± 2.6 74 ± 1.9 
Resting MAP (mmHg) 91 ± 3.2 89 ± 3.6 
Resting HR (bpm) 71 ± 1.6 67 ± 1.3 
FEV1 (L) 1 ± 0.2 1.13 ± 0.3 
FEV1 (% predicted) 43.5 ± 5.1 40.5 ± 6.4 
FVC (L) 2.24 ± 0.7 2.45 ± 0.8 
FEV1/FVC (%) 44 ± 5.1 47 ± 4.3 
PaO2 (mmHg) 71.6 ± 5.3 63.3 ± 6.4*  
PaCO2 (mmHg) 37.7 ± 3.3 49.2 ± 2.7* 
pH 7.41 ± 0.04 7.4 ± 0.03 
HCO3 (mEq.L
-1
) 25.3 ± 1.4  30.2 ± 1.6* 
Table 6.3 Characteristics of patients (±SD) separated into hypercapnic and normocapnic 
groups. * Significant difference from Normocapnic participants (P<0.05). FEV1, forced 
expiratory volume in one second; FVC, forced vital capacity; HCO3, arterial bicarbonate 
content. 
 
* 
* 
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Table 6.3 shows that participants in the hypercapnic group had a significantly higher 
PaCO2, arterial bicarbonate content and lower PaO2 values than those in the normocapnic 
group (P<0.05). No other significant differences were observed. 
 
Respiratory and cardiovascular responses during the PECO trial 
Changes in mean O relative to baseline in hypercapnic and normocapnic COPD patients 
during each minute of the PECO trial are shown in figure 6.7. No significant differences in 
O were observed between the hypercapnic and normocapnic patients at any time point in 
the trial (P>0.05). As expected the PETCO2 of hypercapnic patients was significantly 
higher than normocapnic patients during baseline (+15 ± 1.3 mmHg) and throughout the 
trial (P<0.05). 
Changes in mean HR and MAP relative to baseline in hypercapnic and normocapnic 
COPD patients during each minute of the PECO trial are shown in figure 6.8 and 6.9. No 
significant differences in HR and MAP were observed between the hypercapnic and 
normocapnic patients at any time point in the trial (P>0.05). 
The mean O, PETCO2, MAP and HR recorded during each minute of the Control and 
PECO trials in hypercapnic and normocapnic COPD patients are shown in the appendix 
(table 8.2). 
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Figure 6.7 Change in O from baseline during each minute of the PECO trial in hypercapnic 
and normocapnic COPD patients. The black bar shows the periods performed under 
circulatory occlusion. * Significant difference from respective baseline values (P<0.05). 
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Figure 6.9 Change in heart rate from baseline during each minute of the PECO trial in hypercapnic 
and normocapnic COPD patients. The black bar shows the periods performed under circulatory 
occlusion. * Significant difference from respective baseline values (P<0.05). 
 
Figure 6.8 Change in mean arterial pressure from baseline during each minute of the PECO trial in 
hypercapnic and normocapnic COPD patients. The black bar shows the periods performed under 
circulatory occlusion. * Significant difference from respective baseline values (P<0.05). 
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6.4 Discussion 
This study investigated the ventilatory and cardiovascular responses of patients with 
moderate-severe COPD and healthy aged matched controls to activation of the muscle 
metaboreflex. The main findings were that activation of the metaboreflex via PECO 
maintained ventilation significantly above baseline in COPD patients but not in the healthy 
controls. However, there was no difference in this response between hypercapnic and 
normocapnic COPD patients.  
The cardiovascular responses recorded during PECO are known to be reliable indicators of 
muscle afferent activation (Coote et al.  1971 , McCloskey & Mitchell 1972, Kaufman et 
al.  1983). Therefore the blood pressure increases observed during PECO in the current 
study suggests that the muscle metaboreflex had been activated. Hence the ventilatory 
responses of COPD patients observed throughout the period of PECO are likely caused by 
muscle metaboreflex activation. This is supported by the findings that ventilation only 
returned back to baseline after arm cuff deflation and the consequential reduction in blood 
pressure and metaboreflex activity. Furthermore ventilation was not maintained above 
baseline after exercise if circulatory occlusion was not applied. Similar ventilatory 
responses during circulatory occlusion following a rhythmic handgrip task has been 
reported by Grieve (2008). However no control subjects were used this study making it 
impossible to determine if this is a normal response to PECO in their study or if it is an 
abnormal response related to the disease.  
In the current study age-matched control subjects did participate and by contrast they did 
not display any ventilatory responses to the activation of the muscle metaboreflex during 
PECO. This finding is consistent with several studies with healthy individuals using 
circulatory occlusion following handgrip and cycling exercise (Rowell et al. 1976, Innes et 
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al. 1989, Scott et al. 2000; Haouzi et al. 2001, Fukuba et al. 2007 and chapters 3, 4 and 5). 
Therefore it seems likely that the ventilatory response to PECO found in COPD patients is 
related to the disease. 
The current study also demonstrated that the COPD patients tended to produce a greater 
ventilatory response during the rhythmic handgrip exercise task compared with healthy 
aged matched controls, although this difference failed to reach statistical significance 
(P=0.07 in the Control trial and P=0.11 in the PECO trial). Nevertheless the 
disproportionate exercise ventilatory response in COPD is well documented and is thought 
to be caused by factors such as the greater mechanical work required to ventilate the lungs, 
impaired gas exchange and early onset of lactate production (Levison & Cherniack, 1968; 
O’Donnell, 2001). However because these patients displayed an augmented ventilatory 
response to PECO compared with healthy controls it is possible that metaboreflex 
activation contributes to this excessive exercise ventilatory response. 
The differences in the ventilatory response to PECO found between COPD patients and 
healthy individuals in this study could be explained a greater stimulation of muscle 
metaboreceptive afferents in COPD, possibly because of a greater local metabolite 
accumulation in the muscle for the same relative workload. This explanation is plausible as 
COPD is associated with the down regulation of skeletal muscle oxidative enzyme activity, 
an increased lactic acidosis and a lower muscle pH in exercise (Casaburi et al. 1991 
Kutsuzawa et al. 1992, Gosker et al. 2002). Indeed Kutsuzawa et al. found an exaggerated 
decrease in the pH of forearm muscles during a handgrip exercise in patients with COPD 
compared with healthy controls. In anaesthetised cats it has been shown that the arterial 
injection of lactic acid/H
+ 
causes an increase in the discharge of group III and IV muscle 
afferent fibres (Rotto & Kaufman 1988) and an increase in ventilation and blood pressure 
(Rotto et al. 1989). This is likely mediated, in part at least, by the stimulation of ASICs 
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located on the free nerve endings of muscle afferent fibres (Li et al. 2004; Hayes et al. 
2008). Therefore the skeletal muscle dysfunction associated with COPD may result in the 
increased stimulation of these metabosensitive receptors and an augmented metaboreflex. 
Thus the abnormal ventilatory response to PECO may be consequently observed, as the 
enhanced muscle afferent feedback could provide a greater stimulus to respiratory control 
centres in the brain and increase ventilatory drive. 
Furthermore similar augmented ventilatory responses to PECO have been observed in 
patients with chronic heart failure and are thought to be caused by an enhanced activation 
of the muscle metaboreflex (Piepoli et al. 1996, 1999; Scott et al. 2000, 2002; Ponikowski 
et al. 2001; Crisafulli et al. 2007; Olson et al. 2010). Heart failure is known to result in 
similar abnormalities in skeletal muscle to that described above in COPD (Franssen et al. 
2002), so it is possible that this ventilatory response to PECO in heart failure patients, and 
COPD alike, is a result of an abnormal skeletal muscle milieu.  
However in the current study the blood pressure responses of the COPD patients to PECO 
were not significantly different to that of healthy controls. This indicates that the level of 
muscle afferent activation may have been similar between these two groups. These 
findings are consistent with that of Roseguini et al. (2008) and Sherman et al. (2011) who 
also found similar blood pressure responses in both COPD patients and controls to 
circulatory occlusion following an isometric handgrip exercise task. Although no 
respiratory data was collected in either study these combined findings suggest that the 
ventilatory responses of COPD patients to PECO in the current investigation were not 
caused by an augmented muscle metaboreflex. Instead it may imply that the respiratory 
control centres in the brainstem are by some means more sensitive to muscle afferent 
feedback and as such a greater ventilatory response is generated for a given metabolic 
stimulus.  
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There is evidence however that chronic hypoxemia, which is commonly found in COPD 
patients, can blunt the vascular responsiveness to a sympathetic stimuli. Heisted et al. 
(1972) observed that forearm vasoconstriction to lower body negative pressure was 
significantly attenuated in patients who were chronically hypoxemic. Furthermore 
evidence in animals has shown that chronic hypoxemia can result in the attenuation of the 
vasoconstriction response to direct sympathetic nerve stimulation (Coney et al. 2004). 
Although the degree of hypoxemia displayed by the patients of the current investigation 
(PaO2 = 68.9 mmHg) was significantly less severe that those in the studies above (e.g. 
~45mmHg in Heisted et al.), it is possible that hypoxemia attenuated the blood pressure 
response to metaboreflex activation in these patients. Furthermore, much like with CHF, 
patients with COPD appear to display a tonic activation of the sympathetic nervous system 
(Heindl et al. 2001) which in turn has been associated with reduced α-adrenergic 
vasoconstrictor responsiveness (Seals et al. 2004).  All together these findings suggest that 
the muscle metaboreflex could be enhanced in COPD but any augmented blood pressure 
responses to PECO may be cancelled out by a blunted vascular responsiveness to 
sympathetic stimuli. 
An investigation recording MSNA during exercise and PECO would obviously clarify the 
issue. However, more simply, a further investigation with the leg muscles of COPD 
patients may also help to elucidate this point. Although it has been demonstrated that the 
glycolytic enzyme activity of leg (vastus lateralis) and arm (deltoid) muscles are increased 
in COPD (Jakobsson et al. 1995, Gea et al 2001), there is evidence that only leg muscle 
oxidative enzyme activity appears significantly reduced (Jakobsson et al. 1995, Gosker et 
al. 2002) as it seems to be relatively well maintained in arm muscles (Gea et al 2001). As 
such muscular exercise may generate a greater stimulus (e.g. lactic acid/H
+
) for 
metabolically sensitive muscle afferents. One obvious reason as to why COPD appears to 
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cause greater changes in the metabolic characteristics of leg muscles in comparison to 
upper body muscles is the different levels of disuse that these muscles will likely 
experience as a consequence of the disease.  
Therefore it is possible that differences in the blood pressure response to PECO between 
COPD and healthy controls may be better observed following a leg exercise (e.g. cycle 
ergometry, calf plantarflexion, knee extensions), and so a new investigation involving leg 
exercise may help establish whether the muscle metaboreflex is enhanced by COPD. An 
added benefit of this new investigation is that it might find even greater and more 
functionally significant ventilatory responses to muscle metaboreflex activation, due to the 
differences in the metabolic characteristics and muscle mass of leg compared to arm 
muscles. Furthermore these findings may provide greater insight into the intolerance of 
day to day activities, e.g. walking, stair climbing. 
 
Implications 
Regardless of the precise mechanism, this study has demonstrated that activation of the 
muscle metaboreflex via PECO causes ventilatory responses in COPD but not in healthy 
controls. This may have important implications for these patients as it could contribute to 
the augmented exercise ventilatory response and sensations of dyspnea that are associated 
with the disease. Indeed recently Gagnon et al. (2012) blocked the neurotransmission of 
group III and IV muscle afferents from the lower exercising limbs of COPD patients by 
injecting the μ-opiate agonist fentanyl intrathecally into the L3-L4 vertebral space. During 
this spinal anaesthesia the exercise ventilatory response was significantly reduced. 
Furthermore exercise duration at a constant work rate significantly increased from 
approximately 7 minutes to 10.5 minutes, which was strongly related to the delay in the 
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ventilatory response and sensations of dyspnea. This study clearly suggests that skeletal 
muscle afferent feedback may limit exercise capacity in COPD patients and that if these 
neural signals can be attenuated the exercise ventilatory response and sensations of 
dyspnea can be reduced and so improve exercise tolerance.  
In addition the study by Gagnon et al. provides a further possible explanation as to why the 
exercise training of COPD patients reduces the ventilatory requirements to exercise, along 
with the sensations of dyspnea, and enhance exercise tolerance (Casaburi et al. 1991; 
Serres et al. 1997; Casaburi et al. 1997; O’Donnell et al. 1998; Gigliotti et al. 2003). 
Endurance training in COPD patients has shown to improve the metabolic efficiency of 
skeletal muscle by increasing oxidative enzyme activities and reducing lactic acid 
production and skeletal muscle acidosis in exercise (Casaburi et al. 1991; Maltias et al. 
1996; Whittom et al. 1998; Sala et al. 1999). An improvement in skeletal muscle oxidative 
capacity and increased muscle pH may reduce the stimulation of metabolically sensitive 
receptors in skeletal muscle and thus reduce the central respiratory drive and ventilatory 
requirements of the exercise. As such the sensations of dyspnea upon exertion may be 
attenuated and exercise tolerance may increase. Indeed a 6 week training programme of 
the forearm muscles in CHF has shown to reduce the ventilatory and cardiovascular 
responses to PECO following rhythmic handgrip exercise (Piepoli et al. 1996), and this 
was thought to be achieved through improvements in skeletal muscle metabolism and the 
reduced stimulation of the muscle metaboreflex (Piepoli et al. 2008). However similar 
studies are yet to be conducted in COPD patients to determine if training can reduce the 
ventilatory responses to metaboreflex activation in this patient group. 
As an alternative to (or in combination with) exercise training, future work could examine 
the effects of pharmacological substances that alters the metabolism within skeletal 
muscle. For example the infusion of Dichloroacetate in healthy humans, which reduces 
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lactic acid production by stimulating pyruvate dehydrogenase activity, has shown to 
reduce the sympathetic nerve responses to both static exercise and PECO (Ettinger et al. 
1991). Because its infusion reduces the discharge of group III afferent fibres to electrically 
induced static contractions of the hindlimb of cats (Sinoway et al. 1993), it was suggested 
that this reduced sympathetic activity was a result of a blunted lactic acidosis and a 
consequential reduction in muscle afferent activation. It is therefore possible that the 
application of Dichloroacetate in COPD patients may reduce the stimulation of 
metabolically sensitive afferents and result in a reduced ventilatory response to exercise 
and PECO.     
 
Hypercapnic vs. normocapnic COPD patients 
The current study also examined whether there would be differences in the ventilatory 
responses to muscle metaboreflex activation via PECO between chronically hypercapnic 
and normocapnic patients with COPD. It has been previously demonstrated that the 
ventilation of healthy individuals can remain elevated above baseline during PECO under 
conditions of acute hypercapnia but not normocapnia (Lykidis et al. 2010, Chapters 3 and 
4). In the current investigation the blood pressure responses to PECO were similar in both 
the hypercapnic and normocapnic COPD patients suggesting that the level of metaboreflex 
activation was matched between groups. However we found no differences in the 
ventilatory responses to PECO between hypercapnic and normocapnic COPD patients. 
There are several explanations why these findings with chronic hypercapnia seemingly 
differ from those recorded during acute hypercapnia.  
Firstly, ventilation was maintained significantly above baseline during PECO in 
normocapnic COPD patients, which was likely a consequence of the disease as healthy 
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normocapnic participants display no ventilatory responses to the PECO stimulus. It is 
therefore possible that hypercapnia will have no additional impact as the entire (or a large 
proportion of the) ventilatory response to muscle metaboreflex activation is observed in 
COPD under normocapnic conditions 
Second, it was demonstrated in chapter 4 that the ventilatory responses to PECO during 
acute hypercapnia likely occur via a central interaction between the muscle afferent 
feedback and the hypercapnia-induced stimulation of the central chemoreceptors. Chronic 
hypercapnia however is associated with a desensitisation of central chemoreceptors to CO2 
(Richerson & Boron, 2005). It is therefore less likely that a central interaction between the 
muscle metaboreflex and a hypercapnia-induced chemoreflex occurs in these patients.  
Finally, although the effects of chronic hypercapnia on skeletal muscle function and 
metabolism is poorly understood (Man et al. 2009), the effects of acute hypercapnia has 
been more widely examined. There is evidence that acute hypercapnia results in skeletal 
muscle weakness in healthy humans (Vianna et al. 1990) and derangements in the muscle 
metabolism in COPD patients with acute hypercapnic respiratory failure (Gertz et al. 1977; 
Fiaccadori et al. 1987). The mechanism for these maladaptations was thought to be related 
to the resultant intracellular acidosis
1
. However as chronic hypercapnia in COPD results in 
the expected slow renal compensation and increases in bicarbonate concentration, pH is 
usually maintained or only slightly decreased (Bruno & Valenti, 2012). In accordance with 
this, the hypercapnic patients in the current investigation had significantly higher arterial 
bicarbonate concentrations with no difference in pH. As such it is unlikely that muscle 
                                                 
1
 It is worth noting that the skeletal muscle dysfunction observed in acute hypercapnia will 
not alter the interpretation of the findings in chapter 3 and 4 as the ventilatory responses to 
PECO were observed during systemic hypercapnia and not the local hypercapnia of the 
exercised leg. 
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metaboreceptor stimulation could be enhanced by a chronic hypercapnia induced muscle 
acidosis or any resultant abnormalities in skeletal muscle metabolism. Therefore this may 
provide an additional reason why the ventilatory responses to PECO appear not to be 
altered by chronic hypercapnia. 
The lack of clinical evidence regarding the contribution of chronic hypercapnia on skeletal 
muscle dysfunction in COPD is largely because it primarily co-exists with confounding 
variables such as chronic hypoxemia.  Indeed the hypercapnic COPD patients in the 
current study showed a significantly lower PaO2, compared with normocapnic patients, 
despite no difference in FEV1% predicted (Table 6.3). These observations are consistent 
with several other investigations (Van Meerhaeghe & Sergysels, 1983; Scano et al. 1995; 
Topeli et al. 2001). As such this may confound the findings of the current study as a 
greater degree of chronic hypoxemia could result in the development of further 
abnormities in skeletal muscle function and metabolism (see introduction). Therefore the 
data must be interpreted with caution as we may not be examining the true effects of 
chronic hypercapnia, in isolation, on the magnitude of the ventilatory response to PECO. 
Clearly further work with animals will be required to elucidate this issue where a sustained 
normoxic hypercapnia can be induced, and so should be able to determine with more 
confidence whether chronic hypercapnia alone alters the ventilatory responses to muscle 
afferent stimulation.  Nevertheless, the data from the current investigation does at least 
clearly suggest that ventilatory responses to PECO are generated in both normocapnic and 
hypercapnic COPD patients alike. 
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COPD severity  
Ideally the patients in the current study would have been stratified into groups depending 
on the severity of their COPD in order to assess any differences in the ventilatory 
responses to PECO via post-hoc analysis. However in the current investigation the patients 
examined only had a small range in disease severity (35-53 FEV1 % predicted) where 15 of 
the 18 patients had severe COPD and the remaining 3 were moderate as defined by GOLD 
criteria. Conversely the studies by Grieve (2008) and Sherman et al. (2011) utilised 
patients with a larger range in FEV1 % predicted values. However they observed that the 
magnitude of the blood pressure and ventilatory response to PECO was not related to 
disease severity. So why has no relationship been observed?     
Firstly, the wrong muscles may have been examined in these studies. As described above 
arm muscles are relatively well preserved in COPD whereas leg muscles appear to exhibit 
a greater degree of dysfunction which is thought to be related to differing degrees of 
disuse. Therefore the metaboreflex may be up-regulated more in leg muscles and so the 
cardiorespiratory responses to circulatory occlusion following a leg exercise may be more 
related to disease severity. Secondly, the severity of COPD was defined by the patients 
FEV1 % predicted. However FEV1 % predicted seems to correlate poorly with exercise 
capacity and physical activity (Killian et al. 1992, Gosselink et al. 1996) whereas dyspnea, 
using the Medical Research Council (MRC) breathlessness scale, has been shown to relate 
more strongly (Fletcher et al. 1959, Bestall et al. 1999). Therefore perhaps future 
investigations should examine whether the ventilatory and cardiovascular responses to 
metaboreflex activation are related to the sensations of dyspnea. 
 
 
154 
 
Conclusion 
In conclusion this study demonstrated that the activation of the metaboreflex via 
PECO maintains ventilation significantly above baseline in COPD patients but not in the 
healthy controls. However these ventilatory responses to PECO were not related to PaCO2. 
The findings of this study add to the emerging concept that skeletal muscle afferent 
feedback may contribute to the augmented ventilation and sensations of dyspnea that is 
associated with COPD during exercise.  
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CHAPTER 7: GENERAL 
CONCLUSIONS 
 
 
 
 
 
 
 
 
 
 
156 
 
The cardiovascular responses to exercise are known to be regulated by both central and 
peripheral neural mechanisms. This includes the feedforward control mechanism of central 
command and also the neural feedback from group III and IV skeletal muscle afferent 
which responds to mechanical and metabolic stimuli in the exercising muscle. In contrast 
the control mechanisms of the exercise hyperpnea are still not fully understood, yet central 
command is widely considered to play a role. Recently however evidence has suggested 
that muscle afferent feedback is also capable of driving ventilatory responses in humans 
as: the inhibiting its neurotransmission of group III and IV muscle afferents reduces the 
exercise hyperpnea, and the stimulation of muscle afferents via PECO in combination with 
the sensitising effects of hypercapnia causes ventilatory responses. However the latter 
piece of evidence requires further examination which was the aim of the first two chapters 
of this thesis. 
The aim of the first study (chapter 3) was to examine whether the stimulation of muscle 
metaboreceptive afferents (via PECO) and muscle mechanoreceptive afferents (via passive 
calf stretching) results in ventilatory responses during concurrent hypercapnia and 
normocapnia. It was shown that under hypercapnic conditions ventilation was maintained 
significantly above baseline levels during the stimulation of metabolically sensitive 
afferents. In addition the stimulation mechanoreceptive afferents generated further 
increases in ventilation during concurrent hypercapnia. However no ventilatory responses 
were produced to both PECO and passive calf muscle stretching during normocapnia.   
The studies in chapter 4 attempted to determine whether this apparent interaction between 
muscle afferent feedback and the concurrent hypercapnia occurs centrally (i.e. in the CNS) 
or peripherally in the exercised muscle. During an isolated local hypercapnia of the 
peripheral exercised muscle, PECO had no effect on ventilation. However during systemic 
hypercapnia, PECO maintained ventilation significantly above baseline. This provides 
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evidence for a central synergistic interaction between muscle afferent feedback and the 
afferent signals from central and/or peripheral chemoreceptors as the ventilatory responses 
were greater than the sum of the two individual mechanisms. Furthermore, this ventilatory 
response during PECO was not altered by the inhalation of a hyperoxic hypercapnic gas 
mixture suggesting that the central chemoreceptors are the primary driver of this 
interaction.    
During exercise PaCO2 does not increase, but as the studies of chapter 4 demonstrate that 
central synergistic interactions with muscle afferent feedback are possible perhaps 
interactions of a similar nature occur with other inputs active in exercise (e.g. central 
command, which like the chemoreflex can also increase central respiratory drive). This 
concept was examined in chapter 5 where a study investigated whether augmented levels 
of muscle afferent feedback can increase the ventilatory responses during exercise and/or 
PECO. It was shown that during conditions of increased muscle metaboreflex activity, 
through PECO of one leg, the ventilatory responses to the exercise of the contralateral leg 
were augmented. This suggests that during exercise the stimulation of metabolically 
sensitive afferent receptors in skeletal muscle can contribute to the ventilatory response. 
However ventilation returned to baseline levels upon cessation of exercise despite the 
continued circulatory occlusion which activated the muscle metaboreflex in isolation. 
Therefore as ventilation was only augmented by additional metaboreflex activation during 
exercise, it suggests a possible synergistic interaction between the neural feedback from 
the working muscle and other inputs active during exercise  that can increase central 
respiratory drive (central command). 
The enhanced ventilatory responses to metaboreflex activation during hypercapnia 
observed in chapters 3 and 4 could have important implications for patients with COPD. 
COPD is associated with abnormalities in skeletal muscle metabolism but whether this 
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leads to exaggerated ventilatory responses to muscle metaboreflex activation was 
unknown. Furthermore as some patients are chronically hypercapnic this might 
conceivably also enhance the ventilatory response to muscle metaboreflex activation? The 
study in chapter 6 demonstrated that PECO-induced metaboreflex activation in COPD 
patients, but not healthy aged matched controls, resulted in ventilation being significantly 
maintained above baseline until cuff deflation. However this ventilatory response to PECO 
was not associated with the disease-related chronic hypercapnia. The exaggerated 
respiratory response might be related to enhanced muscle afferent stimulation during 
PECO, but further work is required to elucidate this possibility.    
Figure 7.1 illustrates the possible integration of inputs to respiratory control areas of the 
brainstem which together may explain some of the findings in this thesis. In healthy 
individuals under normal conditions ventilation consistently returned to baseline levels 
during the stimulation of metaboreceptive afferents alone through PECO. This might be 
incorrectly interpreted that activation of the muscle metaboreflex has no effect on 
ventilation. Metaboreflex activation through PECO seems to give precedence to increasing 
sympathetic vasomotor activity and blood pressure, presumably to maintain adequate 
perfusion to the muscle and to wash out trapped metabolites. However this increase in 
blood pressure will suppress ventilation through the ventilatory baroreflex. Therefore any 
stimulatory effects that the metaboreflex has on ventilation may be cancelled by inhibitory 
inputs from the ventilatory baroreflex. Indeed this may also be much the same with the 
stimulation of mechanoreceptive afferents, as sustained passive calf stretching results in 
blood pressure increases but no ventilatory response under normal conditions.  
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However under conditions of enhanced central respiratory drive, through systemic 
hypercapnia, ventilation was maintained significantly above baseline levels during PECO 
and further increased in response to sustained passive muscle stretching. This suggests a 
synergistic interaction between muscle afferent feedback and the afferent signals from 
Figure 7.1 A simplified diagram illustrating the possible integration of central command, 
ventilatory baroreflex inputs, afferent feedback from skeletal muscle 
metabo/mechanoreceptors and neural feedback from central and/or peripheral chemoreceptors 
in respiratory control centres in the brainstem. + is a stimulatory input; - is an inhibitory input. 
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central and/or peripheral chemoreceptors. It may be that afferent feedback is only effective 
in driving ventilation in the presence of a synergistic input to the central respiratory 
neuronal pool. So in effect the chemoreflex may have unmasked the involvement of 
muscle afferents in ventilatory control.  
The precise nature of this interaction is currently unknown. However it was suggested by 
Coote, (2012) that the hypercapnia-induced chemoreflex may …   
“increase the subliminal fringe of the central neuronal circuits by 
increasing the excitability of central respiratory neurones…. This 
enabled the central synaptic effects to summate sufficiently to activate 
the respiratory effectors. The results convincingly show that 
facilitation of central neurones by hypercapnia results in a significant 
increase in ventilation when either muscle mechanoreceptors alone or 
muscle metaboreceptors alone are activated”. 
In other words the observations made in this investigation could be explained by the 
enhanced feedback from chemoreceptors during hypercapnia increasing the receptivity of 
respiratory neurones to inputs from muscle afferents.  Therefore only under the 
hypercapnic conditions can the effects of muscle afferent feedback be observed when the 
combined actions of muscle afferent feedback and chemoreflex overcome the opposing 
action of the ventilatory baroreflex. 
 
An alternative explanation could be that the feedback from skeletal muscle afferents may 
modulate the medullary input of the central and/or peripheral chemoreceptors and enhance 
their sensitivity to CO2. This would result in a greater level of ventilatory drive for a given 
level of CO2 and so would explain the ventilatory responses to PECO during concurrent 
161 
 
hypercapnia. However, although this is possible, it has been shown by several investigators 
(and in this thesis) that during exercise where muscle afferents are activated, CO2 
inhalation only has additive effects on ventilation, with no observable changes in CO2 
sensitivity reported (Asmussen & Nielson, 1957; Clark et al. 1980; Duffin et al. 1980; 
Poon et al. 1987).  
Therefore a mechanism akin to that described by Coote (2012) is perhaps more likely, 
where the neural inputs from the chemoreceptors may sufficiently enhance the excitability 
of central respiratory neurones so that muscle afferent activation alone is able to stimulate 
ventilation. No enhanced ventilatory responses to exercise are observed during concurrent 
hypercapnia probably because muscle afferent feedback already appears able to stimulate 
breathing in exercise (Amann et al. 2010). Thus the hypercapnic stimulus may have no 
additional effect.      
Despite the fact that the precise nature of this interaction is speculative, the findings of 
chapter 3 and 4 clearly suggest that: 1) muscle afferent feedback can stimulate ventilation 
(under some conditions) and 2) central interactions with muscle afferent feedback are 
possible. By attempting to apply these findings to more normal physiological conditions 
we then observed that PECO of one leg can cause increases in ventilation during the 
exercise of the contralateral leg. This also implies a possibly similar synergistic interaction 
to that described above between muscle afferent feedback and other inputs to the central 
neuronal pool active in exercise. These findings clearly suggest that muscle afferents are 
capable of driving ventilation in exercise. Indeed they seem to compliment the work of 
Amann et al. (2010) as at an equivalent work load for a two-legged cycling exercise the 
inhibition of muscle afferent neurotransmission attenuated the increase in ventilation, 
whereas this study has shown that the additional stimulation of metabolically sensitive 
muscle afferents enhances it. As central command can increase central respiratory drive, 
162 
 
and is active in exercise, this might be an input that plays a comparable role to that of the 
chemoreflex above.  
Interactions between muscle afferent feedback, the chemoreflex and/or central command, 
shown in figure 7.1, are possible at different sites in the brainstem and two of these are 
illustrated in figure 7.2. The NTS is a vital integrating site in the dorsal brainstem for 
autonomic and respiratory regulation (Paton, 1999) and both peripheral chemoreceptor and 
skeletal muscle afferents are known to project there (Kalia et al. 1981, Donoghue et al. 
1984, Li et al. 1998, Potts et al. 1999, Paton et al 2001). Furthermore it has been 
established that the NTS may be a sights for central chemoreception (Nattie & Li 2002, 
2009; Feldman 2003). As such the NTS may be a region where an interaction between 
muscle afferent feedback and neural feedback from chemoreceptors can occur.  
However more recent evidence has suggested a role for the PAG as a potentially important 
site of neural integration in the brainstem for cardiorespiratory control (see Paterson, 2013 
for review). Findings in humans made by Green et al (2005, 2007) suggests that the PAG 
may form part of the neurocircuitry of central command as the stimulation of the dorsal 
PAG can increase blood pressure and the anticipation to exercise and actual exercise 
causes increases in the neural activity of the PAG. It has also been established that the 
neural activity of the PAG can also be increased in response to muscle afferent activation 
via PECO (Basnayake et al. 2011). Therefore the PAG may also be a potential site of 
integration for central command and muscle afferent feedback in eliciting 
cardiorespiratory responses. Furthermore it has recently been shown that the PAG may 
also be a site sensitive to CO2/H
+
 as partial lesions of this area in a rats brainstem results in 
a significant reduction in the ventilatory response to hypercapnia (Lopes et al. 2012). All 
together these findings suggest that the PAG could conceivably be a site where muscle 
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afferents, central command and chemoreceptor activity can integrate and generate the 
respiratory responses observed in the chapters 3-5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2 Possible sites of integration in the brainstem between central command, 
muscle afferent feedback and neural feedback from central/peripheral chemoreceptors. 
PAG, Periaqueductal gray; NTS, nucleus tractus solitarius; CSF, cerebral spinal fluid. 
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However there is evidence that under some conditions PECO alone can induce ventilatory 
responses if the metabolite accumulation and metaboreflex activation is great enough. For 
example in healthy individuals ventilation can remain just above baseline in PECO if the 
preceding exercise is at high enough intensity and in a large enough muscle mass (Iellamo 
et al. 1999). In addition patient groups, that have been associated with abnormalities in 
skeletal muscle metabolism, have also shown ventilatory responses to PECO, which 
includes CHF (e.g. Piepoli et al. 1996) and now COPD (chapter 6). These findings are 
seemingly incompatible with integration of inputs and resultant ventilatory responses 
described above and illustrated in figures 7.1 and 7.2, as if metaboreflex activity is greater 
then arguably so will the effects of the ventilatory baroreflex. However the diseased states 
above tend to display a tonic activation of the sympathetic nervous system which is 
associated with reduced α-adrenergic vasoconstrictor responsiveness (Seals et al. 2004). 
This could result in an attenuated blood pressure response for a given level of 
metaboreflex activity. Furthermore in healthy or diseased states, once metaboreflex 
activity and blood pressure is great enough the ventilatory baroreflex may hit its saturation 
point where no further increase in blood pressure results in a suppression of ventilation. As 
such from this point onwards metaboreflex activation may be able to drive increases in 
ventilation. One way this could be examined experimentally would be to measure the 
ventilatory responses to PECO while manipulating blood pressure, perhaps via the 
modified Oxford technique. 
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Final conclusion 
In summary stimulation of skeletal muscle metabo and mechanosensitive afferents with 
PECO and passive muscle stretching do not consistently stimulate ventilation. Used in 
isolation these techniques may not be appropriate methods for examining the role of 
muscle afferents in ventilatory control which may in part be due to the effects of the 
ventilatory baroreflex.  During systemic hypercapnia both PECO and passive muscle 
stretching stimulates ventilation suggesting a synergistic interaction between muscle 
afferent feedback and the afferent signals from central and/or peripheral chemoreceptors. It 
is suggested that feedback from the ventilatory chemoreflex may alter the 
receptivity/sensitivity of respiratory neurones to inputs from muscle afferents.  Therefore 
only under the hypercapnic conditions can the effects of muscle afferent feedback be 
observed when the combined actions of muscle afferent feedback and chemoreflex 
overcome the opposing action of the ventilatory baroreflex. Similar interactions may exist 
between muscle afferents and inputs active during exercise (e.g. central command) as 
additional metaboreflex activation can augment the ventilatory response to exercise but not 
PECO.  However the activation of the metaboreflex in isolation via PECO maintains 
ventilation significantly above baseline in COPD patients. These ventilatory responses to 
PECO were not related to PaCO2. These findings may add to the emerging concept that 
skeletal muscle afferent feedback may contribute to the augmented ventilatory responses 
and sensations of dyspnea associated with COPD during exercise, but further work is 
required.  
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The ventilatory and cardiovascular responses to augmented muscle metaboreflex 
activation during a static calf plantarflexion exercise 
This Data was taken from 8 participants performing a similar protocol to that in chapter 5 
except that a 2 minute static calf plantaflexion exercise was employed (Figure 8.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trial 
Control 
PECO Baseline Ex (R) 
Ex (L) + 
PECO 
(R) 
PECO (R) PECO (R & L) Recovery 
Baseline Ex (R) Ex (L) Rest PECO (L) Recovery 
15 0 1 2 3 4 5 6 
 
7 8 9 10 11 12 13 14 
Minutes 
Figure 8.1 Schematic diagram of the protocol. Ex signifies the period of one static calf 
plantarflexion exercise. PECO signifies the period of post exercise circulatory occlusion. R 
and L signifies whether the right or left leg respectively is performing the exercise or 
undergoing PECO. 
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Differences between trials at baseline 
The mean O, HR, MAP and PETCO2 during baseline are presented in Table 1. 
There were no significant differences in any of these variables between the Control and 
PECO trials.  
 
 
 
Respiratory responses 
Figure 2 shows changes in mean minute ventilation relative to baseline during the control 
trial and PECO trial. Left leg exercise significantly increased Minute ventilation from 
baseline by +4.2 ± 1 l.min
-1
 and 4.4 ± 0.8 l.min
-1
 (P<0.05) in the Control and PECO trials 
respectively. Minute ventilation returned back to baseline levels following exercise. Right 
leg exercise then again significantly increased Minute ventilation in both the Control (+4.3 
± 0.6 l.min
-1
; P<0.05 versus baseline) and PECO trials (4.5 ± 0.7 l.min
-1
; P<0.05 versus 
baseline). Minute ventilation returned back to baseline levels. There was no significant 
difference in minute ventilation between the trials.  
Figure 3 shows the mean PETCO2 values during the different periods of the 2 trial 
conditions. Throughout both trials, there was no significant change in PETCO2 from 
baseline levels and no difference between the two trials 
  
Trial VI (l.min
-1
) HR (beats.min-1) MAP (mmHg) PETCO2 (mmHg) 
Control 9.77 ± 1.4 72 ± 2.9 91 ± 3.4 38 ± 1 
PECO 10.48 ± 0.7 71 ± 2.2 94 ± 3.9 39 ± 1 
Table 8.1 Mean values recorded during the two minute baseline period. * Significant 
difference from Control trial (P<0.05).    
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Figure 8.2 Change in Minute ventilation from baseline during each phase of the Control and 
PECO trials. * Significant difference from Baseline value (P<0.05).  
* * 
Figure 8.3 PETCO2 during each phase of the Control and PECO trials. * Significant difference 
from Baseline value (P<0.05).  
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Cardiovascular responses 
Changes in mean MAP and HR relative to baseline in the 2 trials are shown in  
figures 4 and 5 respectively. Both MAP and HR during Exercise R increased similarly in 
both the Control trial (15 ± 2 mmHg and 18 ± 3 beats.min
-1
; P<0.05 versus baseline) and 
in the PECO trial (15 ± 3 mmHg and 19 ± 2;   P<0.05 versus baseline). As expected on 
cessation of exercise HR fell from exercise levels and returned to baseline in the Control 
trial and PECO trials and MAP also retuned to baseline in the Control trial. However in the 
PECO trial MAP remained significantly elevated above baseline during PECO R (P<0.05).  
During Exercise L both HR again increased similarly in both the Control trial (19 ± 2 
beats.min
-1
; P<0.05 versus baseline) and in the PECO trial (21 ± 2;   P<0.05 versus 
baseline). MAP also significantly increased in the Control trial (15 ± 3 mmHg;   P<0.05 
versus baseline) and from an increased level MAP also increased in the PECO trial (19 ± 4 
mmHg;   P<0.05). The exercise of the left leg produced a similar increase in MAP from 
the previous period (Rest/PECO R) in both the Control (12 ± 3 mmHg) and PECO trials 
(11 ± 3 mmHg). 
Following the exercise of the left leg HR returned to baseline in the Control trial and 
PECO trials. However MAP remained significantly elevated above baseline during both 
the Control and PECO trials (P<0.05). During the recovery periods of each trial MAP and 
HR values were not significantly different from baseline (P>0.05). 
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Figure 8.5 Change in Heart rate from baseline during each phase of the Control and PECO 
trials. * Significant difference from Baseline value (P<0.05).  
Figure 8.4 Change in Mean arterial pressure from baseline during each phase of the Control 
and PECO trials. * Significant difference from Baseline value (P<0.05).  
* 
* 
* 
* 
* 
* 
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The ventilatory and cardiovascular responses to muscle metaboreflex activation in 
COPD 
Table 8.2 shows additional O, HR, MAP and PETCO2 data from the 18 COPD patients 
when divided in to normocapnic/hypercapnic subgroups.  
215 
 
 
Trial O (l.min-1) HR 
(beats.min
-1
) 
MAP 
(mmHg) 
PETCO2 
(mmHg) 
COPD Control (normocapnic)     
Baseline 8.86 ± 0.97 
 
69 ± 2.9 91 ± 1.7 37 ± 1.4 
Exercise 3 13.37 ± 1.13 77 ± 2.1  99 ± 2.3 38 ± 2 
Exercise 4 16.8 ± 1.29 82 ± 1.6 106 ± 1.1 
  
37 ± 2.8 
Rest/PECO 5 10.86 ± 0.63 76 ± 1.4 91 ± 1.3 39 ± 2.6 
Rest/ PECO 6 7.85 ± 0.45 69 ± 1 90 ± 1.6 37 ± 1.6 
Recovery 7 7.82 ± 0.98 69 ± 0.9 90 ± 2.1 37 ± 1.5 
Recovery 8 7.97 ± 0.89 69 ± 1.6 89 ± 2.4  38 ± 1.6 
COPD PECO (normocapnic)     
Baseline 9.67 ± 0.9 70 ±2.6 93 ± 2.9 37 ± 1.6 
Exercise 3 14.07 ± 0.93 78 ± 1.2 99 ± 1.6 38 ± 2.1 
Exercise 4 17.56 ± 1.63 82 ± 2.4 106 ± 1.9 36 ± 2.8 
Rest/PECO 5 12.78 ± 1.18 74 ± 2 101 ± 2.6 37 ± 2.2 
Rest/ PECO 6 12.6 ± 0.98 72 ± 1.5 101 ± 1.1 36 ± 2.3 
Recovery 7 9.36 ± 0.82 72 ± 1.7 91 ± 1.3 37 ± 1.2 
Recovery 8 8.42 ± 0.57 71 ± 1.5 91 ± 3 38 ± 3 
COPD Control (hypercapnic)     
Baseline 10.62 ± 0.55 73 ± 2.2 87 ± 3.2 52 ± 1.1 
Exercise 3 14.73 ± 0.93 79 ± 2.9 93 ± 0.9 52 ± 2.9 
Exercise 4 18.38 ± 1.63 87 ± 3.2 101 ± 2.6 51 ± 3.2 
Rest/PECO 5 13.08 ± 0.72 77 ± 1.2 87 ± 1.9 51 ± 4.1 
Rest/ PECO 6 10.49 ± 1.11 74 ± 1 85 ± 1.4 52 ± 3.6 
Recovery 7 10.64 ± 1.25 74 ± 2.1 85 ± 1.6 52 ± 3.8 
Recovery 8 10.05 ± 1.31 74 ± 2.4 86 ± 3.1 52 ± 2.2 
COPD PECO (hypercapnic)     
Baseline 11.08 ± 0.97 74 ± 1.9 89 ± 3.6 51 ± 1.6 
Exercise 3 15.23 ± 0.89 79 ± 1.2 97 ± 1.5 51 ± 2.3 
Exercise 4 19.71 ± 1.69 87 ± 2.3 103 ± 1.8 50 ± 3.4 
Rest/PECO 5 15.01 ± 1.13 78 ± 3 97 ± 1.3 49 ± 4.1 
Rest/ PECO 6 13.8 ± 0.92 75 ± 2.9 96 ± 1.9 49 ± 4.8 
Recovery 7 12.14 ± 0.85 75 ± 1.3 89 ± 2.1 50 ± 2.1 
Recovery 8 10.37 ± 0.69 73 ± 1.6 89 ± 2.9 51 ± 1.8 
Table 8.2. Mean O, HR, MAP and PETCO2 during each minute of the control and PECO trials. 
Participants have been separated into hypercapnic and normocapnic groups.  
